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Prologue
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In the following, a case example of a MCI patient and her husband, who consulted 
the memory clinic of the University Medical Centre Nijmegen, is presented. 
Mrs. de Groot, a 68 years old retired clinical social worker, visited the memory 
clinic together with her husband. Mrs. de Groot became increasingly worried 
because of her forgetfulness. She forgets ordinary things like appointments, 
names, and sometimes a complete conversation. Recently she became upset 
because when she accidently met a former colleague she couldn’t remember her 
name at that moment. Moreover, Mrs. de Groot is a passionate choir member. 
Since a year, she has had increasingly difficulties studying new songs, which 
makes her nervous. Although other choir members did reassure her that she was 
not the only one having difficulties, she felt a shame and found a place at the back. 
Since 4 years, Mrs. de Groot has visited weekly her demented, 86 years old aunt 
living in a nursing home. This aunt is the youngest unmarried sister of her mother, 
and Mrs. de Groot takes care of her laundry and functions as her mentor. These 
visits become increasingly a burden especially because afterwards she is worried 
about her own forgetfulness. Furthermore Mrs. de Groot enjoys her grandchildren, 
she weekly takes care of them on Tuesdays because of her daughters’ work. 
Mostly she does this without her husband but last months she feels a bit insecure 
because of her forgetfulness, so her husband is accompanying her.  Her husband 
was not worried about her forgetfulness because he attributes it to her busy time 
schedule and her worrying. More and more they discusses and quarrel about her 
mistakes. At those times she feels annoyed with him because she thinks he is not 
taking her worries seriously. But, when she recently called him because she was 
in panic since she lost her way, he became worried too, and decided that she 
should consult her general practitioner. The general practitioner talked with her 
and ‘assessed’ her with a Mini Mental State Examination, on which she got a score 
of 29 out of 30 points. He reassured her that nothing seriously was wrong with her. 
Since Mrs. de Groot insisted him to do, he referred her to the memory clinic. She 
and her husband hope they will get more clearness about what is wrong with her 
and how they can cope with it. 
At the memory clinic Mrs. de Groot underwent a thorough examination by the 
geriatrician; taking the history of her complaints (anamnese), an extensive physical 
examination including blood sampling, an MRI of the brain and a lumbal punction. 
Additionally, a neuropsychologist and assistant did a comprehensive neuropsycho-
logical assessment. 
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One month later Mrs. de Groot and her husband got the final diagnostic outcome: 
The geriatrician explains that the neuropsychological assessment showed indeed 
memory impairment; her performances on memory tasks were below the expected 
level, compared to the level of persons with the same age and education. Her 
intelligence level was found to be normal and so were the performances on tests 
for language, praxis and concentration. The MRI did not show clear abnormalities 
but the liquor showed lowered levels of the ß amyloid and heightened Tau levels. 
The geriatrician concludes there is no dementia but there is mild cognitive 
impairment, especially with respect to her memory ability. Mrs. de Groot asked her 
geriatrician if this could be an early phase of dementia. Her geriatrician explained 
her that at this moment he could not tell her without doubt that she will develop a 
kind of dementia but he could say that the chance that she will develop dementia 
next year is definitely higher, about 10 to 15%, than if she had not had these test 
results. Mrs. de Groot asked if she might benefit from medication that is used to 
influence the memory problems in dementia. The specialists answer was that 
unfortunately for this kind of mild cognitive impairment a medicine has not been 
proven effective jet. During this consultation Mrs. de Groot became increasingly 
upset. She wonders what she could do to minimize the chance of decline.
Finally the geriatrician gives her the advice to consult the memory clinic again in 
one year.
This short case description illustrates the reasons for starting a support programme 
for patients with MCI and their partners. More and more patients and their significant 
others expressed a need for information and support in their changing situation. 
Mild cognitive impairment induces changes in daily life for both patients and their 
significant others to which they have to find their way to deal with. 
PROLOGUE
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Mild cognitive impairment; definition and background
As people get older the chance of developing dementia grows. At the age of 65 
years the probability to become demented in the next 10 years is 1,4%. It becomes 
10.9 % at the age of 75 and increases substantially to 34% at the age of 85 years 
(Berr, 2005). Dementia is a serious mental health problem, lasting for 8 to 15 
years, affecting not only the patient’s life and well-being, but also that of his or her 
significant others and even the whole society. Developing dementia however is a 
process, which may take years, as signs and symptoms develop gradually. Most 
patients go through a prodromal phase in which they experience subtle cognitive 
decrements. These changes are sometimes difficult to discriminate from decline 
due to normal aging. In our society general knowledge about dementia grows as 
a result of campaigns of the Alzheimer association and frequent articles in daily 
newspapers or popular magazines, which inform us about new treatments, 
prevention, discovery of genes or how people can cope with this disease. As a 
result of this widespread awareness of dementia, a growing amount of people is 
consulting memory clinics with memory complaints (Ramakers, 2011). Some of 
these subjects can be regarded as overly focused on non pathological, 
age-related cognitive decline (i.e. the “worried well”), others may show objective 
deficits on sensitive neuropsychological tests that may be the result of a neurode-
generative disease, such as Alzheimer’s disease. Many of these persons with 
memory complaints are motivated by the idea that interventions in a very early 
stage of the disease might be able to postpone or even prevent the disease 
process. The identification of the earliest features of neurodegenerative diseases 
resulted in the construct of Mild Cognitive Impairment (MCI) to capture the 
prodromal phase with cognitive dysfunction (Petersen, 1999). The MCI construct 
is not the first construct used to classify persons who are at increased risk of 
developing dementia. In 1982 two staging systems, the clinical dementia rating 
scale (CDR) by Hughes (Hughes, 1982), and the global deterioration scale (GDS) 
by Reisberg et al (Reisberg, 1982), were published to classify progressive memory 
or cognitive complaints associated with dementia and gave detailed descriptions 
of the stages from normal aging, to early complaints without objective memory 
impairment until the severe end stage of dementia. The CDR 0.5 and GDS 3 
stages are somewhat comparable with the MCI definition of Petersen. Another 
concept related tot MCI is Cognitive Impairment and No Dementia (CIND) [Ritchie, 
2000; Dubois, 2007). In contrast, Age-Associated Cognitive Decline (AACD) and 
Age Associated Memory Impairment (AAMI) are two constructs that describe the 
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benign age associated forgetfulness (i.e., cognitive deterioration in older people 
compared to young adults). Prevalence of MCI in population based epidemio-
logical studies ranges from 3% to 19% in adults older than 65 years (Gauthier 
2006).  A survey by the American Academy of Neurology indicated that 80% of 
neurologists uses the term MCI in clinical practice. 
The criteria for MCI proposed by Petersen et al. after an international consensus 
meeting in 2004 (Petersen, 2004):
1. Presence of a cognitive complaint from either the subject and/or a family member
2. Absence of dementia
3. Decline in any area of cognitive functioning
4. Preserved overall general functioning but possibly with increasing difficulty in 
the performance
Diagnosis
MCI is diagnosed mostly using a multi-disciplinary approach that includes a 
thorough clinical interview with the patient dyads, medical examination of the health 
status, neuropsychological assessment, and psychiatric, neurologic and neuro-
radiological findings. With a thorough medical examination possibly reversible 
aetiologies such as thyroid dysfunction, alcohol abuse or depression are ruled 
out (Hejl, 2002). In general, cognitive performance is a key determinant that is 
assessed with a comprehensive neuropsychological assessment. Ratings of 
performance on neuropsychological tests are based on age-, sex- and/or educa-
tion-adjusted normative data, with performance between 1 SD below or above 
the normative mean being defined as unimpaired, between –1 SD and –1.65 SD 
below the normative mean as below average, and more than –1.65 SD below the 
normative mean as impaired (Berg van den 2005). In general, MCI criteria are met 
if a patient’s performance is in the impaired range on one of the cognitive domains, 
or if more than one cognitive domain shows a below-average performance, all in 
the absence of a decline in activities of daily living or dementia.
The original criteria of Petersen focussed only on memory impairment and 
excluded other types of dementias than Alzheimer diseases. Since many patients 
in memory clinics present with complaints in non-memory domains or in multiple 
domains, these criteria were revised in 2004 (Petersen, 2004) (see Figure1.1). 
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Conversion to dementia
Originally, each MCI subtype was related to a presumed aetiology. These 
presumed aetiologies and the conversion rates to dementia have been subject of 
many epidemiological studies on MCI. Ten years after Petersen’s description of 
MCI, progress on clinical, epidemiological disease mechanisms and intervention 
trials were summarized. It was found that annual progression to dementia varies 
from 6% to 10% in a general population and from 10% to 15% in memory clinic 
populations. These rates are seriously elevated compared to the base incidence 
rates of dementia of 1% to 2% per year. Factors related to an increased rate of 
progression include age, delayed-recall performance on memory tests, atrophy 
on MRI and CSF markers compatible with Alzheimer’s disease (Petersen, 2009). 
A recent study showed that below-average performance on several cognitive 
domains, including the memory domain, is associated with an increased risk to 
develop Alzheimer’s dementia (Visser, 2009). Although the risk to develop 
dementia is heightened, a substantial group of MCI patients remains stable over 
longer periods of time (sometimes even up to several years), and a third small 
group will even revert to age-normal levels of cognitive functioning. MCI patients 
can ‘recover’ when aetiologies such as a depression or cardiovascular disease 
underlie the symptoms. In summary, MCI reflects a very heterogeneous group of 
patients with different courses and causes. 
1INTRODUCTION
Figure 1.1   Continuum of cognitive changes and possible relations of the 
subtypes of MCI with aetiologies 
MD: Multiple Domains; AD: Dementia of Alzheimer’s Disease; VaD: Vascular Dementia; FTD: Fronto 
Temporal Dementia; DLB: Dementia of Lewy Body type
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Consequences of MCI for patients
In terms of daily functioning, persons with MCI show, by definition, little need for 
assistance with activities of daily living (ADL), in agreement with the diagnostic 
criteria (Mc Illvane, 2008). Previous research on psychiatric symptoms in persons 
with MCI showed that the incidence of mood disorders, such as dysphoria, 
anxiety, restlessness or irritability, is higher in persons with MCI than in a healthy 
age-matched control group, although lower than found in patients diagnosed 
with dementia (Apostovola, 2007; Hwang, 2004). Persons with MCI tend to 
minimize the risk of developing dementia and show endorsement of the 
effectiveness of health-promotion activities for preventing dementia. In the MCI 
stage, actively developing adequate coping strategies is crucial and may protect 
from mood disorders in later phases. Minimizing the risk of developing dementia 
is related to denial, which may also be the result of impaired insight into or 
reduced awareness of cognitive impairment, which is frequently found in early 
stage dementia (Vasterling, 1995). Awareness is found to be related to well-being 
in MCI patients, but also in their caregivers as well, and may be an important 
mediating factor in the process of adaptation (Clare, 2004a) that should be 
addressed in the early stages in order to advance adaptation. (Bahro, 1995).
Consequences of MCI for significant others
While the patients with MCI may express little need for every-day assistance, 
there is evidence that their care partners or significant others encounter changes 
in their loved ones even two to three years before a medical specialist was 
consulted with respect to everyday function. (Davies, 2010). Significant others 
often have provided assistance in more complex daily activities for almost 2 years 
and at the time of diagnosis at average for about 24 hours per week helping their 
loved one. Especially on instrumental activities of daily living such as administration, 
shopping, managing medication or using public transportation, assistance is 
offered. The transition from being a partner to being a care partner of a person 
with MCI is accompanied by ambiguous feelings, behaviour and interpretations 
of the changes, which can result in heightened stress levels (Blieszner, 2007). 
Although the changes are not as stressful and devastating as for dementia 
caregivers, there is evidence that MCI care partners have already begun to 
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experience distress in association with elevated care-giving burden (Garand, 
2005; Adams, 2006; Bruce, 2008a; Davies, 2010). While some authors report 
normal mood in MCI partners (McIlvane, 2008) most studies show depressive 
symptoms (Yueh-Feng, 2009; Garand, 2005; Blieszner, 2010). Younger age, lower 
education, greater relational deprivation and higher levels of self-loss and 
personal gain are associated with higher risk of depressed mood in caregivers. 
(Yueh-Feng, 2009). Recent studies suggest that early use of household support, 
health support services or psychoeducation programmes for caregivers may 
help to delay the institutionalization of the person with dementia at a later stage 
(Adams, 2006). 
MCI has shown to negatively affect on couples, particularly on communication, 
marital cohesion, and affectionate expression (Blieszner, 2007). Although the 
perception that communication is intact and preserved to some degree, care 
partners report that they experience feelings of irritation and tension. They may 
be inclined to moderate their conversation by simplifying or holding back complex 
thoughts and feelings in order to avoid frustration in their MCI partners. (Davies, 2010). 
Theoretical models on coping with MCI 
When people become aware that they have a serious illness, the diagnosis quickly 
changes the way they view themselves, their future and their lives. A condition like 
MCI leaves the patients and their loved ones with many uncertainties. As a result, 
people’s adjustment to an illness or potentially disabling may require considerable 
coping effort. A model that describes and aims to explain how persons cope 
differently with stress can be derived from the stress adaptation coping theory of 
Lazarus and Folkman (1984).
In this model, persons experience stress when demands in the environment are 
exceeding the persons’ recourses. At the core of the model is the appraisal or 
personal evaluation of illness symptoms or changes. Not the symptoms themselves, 
but their appraisal will induce an emotional and behavioural reaction. The qualitative 
study of Lingler et al. (Lingler, 2007) clearly illustrates the consequences of symptom 
appraisals for the experienced distress in persons with MCI. It was found that the 
meaning participants attributed to their diagnosis widely varied depending on 
their expectations with respect to normal aging, personal experience with dementia, 
and concurrent health problems. For example, an individual who viewed memory 
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loss as an expected part of the aging process was relatively unaffected by the 
MCI label, stating, “It’s just a matter of putting a name on the condition I was 
aware of.” (Lingler et al., p. 796). In contrast, those who viewed MCI as a definite 
precursor to Alzheimer’s dementia voiced significant distress. The appraisal of 
the symptoms thus depends on factors such as the person’s knowledge, previous 
experiences, personality characteristics and, of course, the nature and severity of 
the symptoms. The outcome of this appraisal leads the individual to formulate an 
array of adaptive tasks and to apply various coping skills to deal with the tasks. 
The tasks are well described by Moos (Moos, 1982) and have been translated for 
patients with dementia by Dröes (Dröes, 1991). The adaptive tasks for coping with 
MCI derived from Dröes' adaptive tasks for patients with dementia are shown in 
table 1.1.
Significant others
Caregivers of patients with dementia are also exposed to a life-changing situation 
with daily stressful demands. To describe the ways caregivers cope with this 
changing situation, the adaptation coping model of Folkman and Lazarus was 
somewhat adapted for caregivers by Pearlin (Pearlin, 1990). Main differences 
between this model for caregivers and that of patients are the descriptions of 
secondary stressors such as conflicts with other persons or financial problems, 
in addition to the adaptive tasks that are the same as in the patients. 
CHAPTER 1
Figure 1.2   Model of Lazaras and Folkman (1984) 
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Interventions 
To date, no studies have demonstrated that persons with MCI benefit from 
pharma cological intervention. (Aisen, 2008). In contrast, there is increasing 
evidence for an important role for non-pharmacological interventions in early 
dementia in diminishing distress in both patients and caregivers and in promoting 
behavioural change in both (Olazaran, 2010). Such interventions may be effective 
in both MCI patients and their significant others. In general, psychological 
interventions provide strategies to cope with the changes, and aim at reducing 
distress levels and increasing well-being. In caregivers, these interventions also 
intend to reduce burden. Non-pharmacological interventions can be grouped into 
the following categories: Support groups, psycho education and counselling or 
psychotherapy for both patients and caregivers, and cognitive training for the 
patients. In general, interventions combine several categories. (Acton, 2001). 
Support groups are mostly unstructured and stimulate exchanging and sharing 
experiences and mutual understanding. They are usually led by laypersons with 
experience in care giving or group facilitation (Yale. 1995). Psychoeducation 
interventions are designed to provide information about the disease process, the 
symptoms and to discuss skills to manage these symptoms. Psychotherapy 
differs from psycho education interventions in that they do not provide standardized 
information to the participants, but assist to understand and resolve their reactions 
in a more individualized manner (Acton, 2001). Psychotherapeutic interventions in 
persons with dementia are derived from the main theoretical schools, ranging 
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Table 1.1   The adaptive tasks for coping with MCI
Tasks related to the illness of treatment
1. Cope with the symptoms or disability caused by MCI 
2. Adjust to the medical environment and procedures
3. Develop and maintain a good relationship with the healthcare professionals and 
practitioners
Tasks related to general psychosocial functioning
1. Keep one’s emotional equilibrium; control negative feelings and retain a positive 
outlook for the future
2. Keep a positive self-image and sense of competence 
3. Prepare oneself for an uncertain future
4. Develop an adequate relationship with supporting others
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from psychodynamic approaches, Rogers’ patient-centred therapy, cognitive-
behavioural therapy to systemic approaches. Psychotherapy has been described 
as suitable for patients suffering from (early) dementia, both at an individual level 
as in groups (Cheston, 1998). 
Individual or group therapy
Except for support groups, all psychotherapeutic interventions can be offered 
individually as well in a group format. Cost efficiency may be an important factor 
in the selection of individual or group interventions. Also, additional therapeutic 
effects of inter-patient interactions within groups have been demonstrated 
especially in interventions aimed at chronic diseases (Yalom, 1995). Yalom 
describes nine additional therapeutic factors that groups offer over individual 
therapies: (1) Instillation of hope, (2) universality, (3) Imparting information, (4) 
altruism, (5) the corrective capitulation of the primary family group and 
interpersonal learning, (6) development of socializing techniques, (7) imitative 
behaviour, (8) group cohesion, and (9) catharsis. 
Cognitive interventions 
Recent studies indicate that persons with MCI exhibit learning potential and 
cognitive plasticity (Akhtar, 2006; Schreiber, 2007), suggesting that persons with 
MCI may benefit from cognitive interventions. Clare et al.(2003), describes three 
approaches to cognitive interventions: Firstly, cognitive training refers to teaching 
strategies and skills in order to optimize cognitive functioning; secondly cognitive 
stimulation mostly is offered in a group involving activities such as discussions, 
memorisation games or supervised leisure activities; thirdly cognitive rehabilitation 
is often individually tailored to resume activities by learning to use strategies and 
skills adapted to these specific activities. The beneficial effects in MCI patients of 
cognitive training are confirmed by a review (Belleville, 2008). Cognitive training 
might postpone cognitive decline in persons with MCI. Belleville suggests in her 
review to combine cognitive interventions with interventions that address 
psychosocial, attribution or self-regulatory factors. 
Studies on psychosocial interventions for caregivers of dementia patients suggest 
that these interventions can reduce caregiver co-morbidity and burden and help 
patients with dementia stay at home longer (Lavoie, 2005). The most effective 
programs are characterized in that both patients and their caregivers are involved, 
that they are multi-component and make use of techniques from cognitive-be-
havioural therapy. (Brodaty, 2003; Acton, 2001). Primary objectives in cognitive 
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therapy are altering dysfunctional thoughts, achieving a sense of control by 
learning problem solving techniques; increasing practical coping skills like asking 
for help and finally stress management techniques. To date, descriptions or 
evaluations of psychotherapeutic interventions for MCI patients and their partners 
are lacking, although there is evidence that equipping the person in an early 
stage of the chronic disease to cope with the challenges of the disease is at the 
heart of self-management (Mountain, 2006; Vernooij-Dassen, 2005). 
In summary, the diagnosis MCI results in distress in patients and their significant 
others, but no pharmacological therapies are currently available. As a result, a 
supportive psychological intervention to strengthen the adaptation to this 
condition is warranted. No psychological interventions for MCI patients and their 
significant others have been described and evaluated, with the exception of 
cognitive rehabilitation programs aimed at the MCI patients. Although well-docu-
mented controlled studies are scarce, beneficial effects on well-being of 
psychological interventions in patients with early stage dementia and/ or their 
caregivers have been shown. Therefore developing and evaluating a supportive 
intervention for MCI patients and their significant others is much needed. 
Aims and outline of this thesis 
The objectives of the studies presented in this thesis were to identify the main 
consequences of MCI, to develop a supportive group intervention for MCI patients 
and their significant others and to evaluate this programme using a controlled 
design.  
Part I investigates the consequences of MCI for the patients. Chapter 2 provides 
background information on how MCI patients experience and cope with their 
cognitive decline. This qualitative study, based on grounded theory informs about 
themes that should be used in the intervention programme. In Chapter 3 
awareness of memory impairment in MCI patients was examined.  Discrepancies 
between MCI patients’ subjective reports on their cognitive decline and the 
corresponding reports of their caregivers were analysed and translated into 
presence or absence of awareness. 
In Part II the development of the intervention is presented. Chapter 4 reports a 
survey among participants of a support group for Alzheimer patients. The 
evaluation provided information on outcome measures and important ingredients 
for the intervention. In Chapter 5 feasibility and preliminary outcome on distress, 
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well-being, burden and illness cognitions of the newly developed program are 
investigated and estimation for the sample size used in the controlled study was 
provided.
In Part III we present three studies on efficacy of the intervention. The evaluation 
of the group intervention with a controlled study design is presented in Chapter 6 
concerning the patients, and in Chapter 7 the results for the care partners are 
presented. Finally the long-term effects of the intervention are presented and 
discussed in Chapter 8. Part IV concludes this thesis, summarizing the main 
results of the reported studies (Chapter 9). Chapter 10 addresses the theoretical 
and clinical implications of our findings and discusses directions for future 
research. 
CHAPTER 1
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Chapter 2
Mild Cognitive Impairment: 
Coping with an uncertain label
Part I  consequences of MCI for the patients
Joosten-Weyn Banningh L, Vernooij-Dassen M, Olde Rikkert M, Teunisse, JP. 
International Journal of Geriatric Psychiatry, 2008, 23(2): 148-154.
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Abstract
Background: The recently introduced diagnostic label of Mild Cognitive 
Impairment (MCI) identifies patients with a cognitive decline that is more 
pronounced than is usual for a person’s age and educational level but does not 
notably interfere with activities of daily living (ADL). The natural course of the 
syndrome is uncertain although MCI sufferers have a higher risk of developing 
dementia.
Objectives: To investigate how patients fulfilling MCI criteria experience and cope 
with their cognitive decline with the secondary aim to derive key themes for a 
prospective MCI support-group programme.
Methods: The grounded theory approach.
Results: Analysis of guided interviews with eight MCI patients revealed four 
common themes. Changes related to cognitive abilities, mobility, affect, vitality 
and somatic complaints. Attributions were numerous and concerned aetiologies 
such as personality traits and overload of information. Consequences were all 
negative and concerned the patients themselves such as anxiety and loss of self-
confidence, others such as feelings of irritation and anger towards others or 
activities like abandoning leisure activities. Patients applied emotion-oriented, 
problem-focused and avoidant coping strategies.
Conclusion: MCI patients encounter stress-inducing practical, social and 
psychological difficulties. Based on the current preliminary findings, the key 
themes for an MCI support-group programme should include the provision of 
information about the syndrome’s causes, course, concomitant symptoms, 
attributions, social consequences, and available treatments. The impact of 
receiving an MCI label warrants further investigation. 
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Introduction 
Improvements in diagnostics have caused a shift in the diagnosis of Alzheimer’s 
disease (AD) and other dementias towards earlier stages (Olde Rikkert et al., 
2006). Early diagnoses allow well-timed treatments and psychosocial interventions 
preventing secondary problems. Increasingly, individuals exhibiting cognitive 
deficits that exceed the normal physiological aging processes but do not fulfil the 
criteria for dementia are being identified. Petersen et al. (2001) proposed the 
concept of Mild Cognitive Impairment (MCI) to describe this state of below-normal 
cognitive functioning. This clinical label is applied to people suffering from 
cognitive impairments, which unlike dementia do not significantly impede 
activities of daily living.
Yet, despite abundant evidence that MCI indeed is a syndrome with a high rate of 
progression to AD in particular, not all patients with MCI will develop dementia 
(Panza et al., 2005). Longitudinal and prospective studies reported annual 
MCI-dementia conversion rates from 6 to 25%, (Feldman and Jacova, 2005; 
Panza et al., 2005). People diagnosed with MCI may show further cognitive 
decline, stabilise, or even improve. Hence, the diagnosis may increase people’s 
uncertainty, forcing them to reappraise their psychosocial situation. However, 
whereas experiences from patients diagnosed with dementia have been 
described frequently (Bahro et al., 1995; Cohen et al., 1984; Keady and Nolan, 
1994; Clare, 2002), none of the numerous recent reports on MCI have examined 
this aspect in MCI. To provide adequate support for MCI patients, in-depth 
knowledge of their specific perspectives is indispensable. Although we expected 
the experiences of MCI patients to resemble those of early-Alzheimer patients, we 
hypothesised that the prognostic uncertainty inherent to the diagnosis of MCI 
leads to other perspectives. Our primary aim hence was to explore how MCI 
patients experience and cope with their cognitive decline and the second 
objective was to derive key themes for our prospective MCI support-group 
programme. 
Methods
Sample recruitment and selection
We opted for a qualitative approach as it is deemed an appropriate method to 
explore patients’ experiences and reactions, especially when little is known on 
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the subject (Mays and Pope, 1995). To compose a purposive sample that included 
patients with diverse MCI experiences and coping mechanisms, three geriatricians 
of the Memory Clinic of the Nijmegen University Medical Centre were asked to 
nominate characteristic MCI patients for an interview. The guided interviews were 
held within one to three weeks of the patients’ MCI diagnoses. Patients all 
volunteered and received no incentives or payment. All newly-referred patients 
were evaluated with state-of-the-art diagnostic facilities, a neuropsychological 
test battery and a multidisciplinary diagnostic assessment, resulting in Petersen’s 
amnestic MCI diagnosis (Petersen et al., 2001). The inclusion criteria included the 
presence of (1) self-reported memory complaints, preferably corroborated by 
proxy information, (2) normal general cognitive functioning objectified with a 
neuropsychological examination, (3) normal ADL functioning, assessed with the 
Lawton scale (Lawton and Brody, 1969) and (4) memory impairment objectified 
relative to age- and education-corrected normal values. The main exclusion 
criterion was the presence of dementia according to the Clinical Dementia Rating; 
CDR › 0.5, (Hughes et al., 1982). Other exclusion criteria were psychiatric co- 
morbidity and co-existing somatic disorders when these were dominant to the MCI.
Normal general cognitive functioning was assessed using neuropsychological 
tests with normative data concerning the cognitive function domains of 
concentration, language, praxis and executive functions. A subtest score below 
1.5 SD after correction for age and educational level was interpreted as deviant. 
Patients were included until the saturation point of the qualitative data was 
reached and no new themes or issues emerged. All invited patients agreed to 
participate with the final cohort comprising 8 patients, (1 man, 7 women). 
Data collection and analysis
Interviews took place at home (n=6) or in the outpatient clinic (n=2) consistent 
with the patients’ wishes. An experienced medical psychologist (L.J-WB.) 
conducted the 60-75minute protocol-based interviews, which were audio taped 
with the patient’s permission, between March and June 2003. Table 2.1 lists the 
protocol’s key topics that were derived from the relevant literature about coping 
with early dementia and chronic diseases in general. (Keady and Nolan, 1994; 
Clare, 2002; Werezak and Stewart, 2002). 
The audio taped interviews were transcribed and the resultant, anonymous 
transcriptions were analysed using the qualitative method of the grounded theory 
(Corbin and Strauss, 1990). Two researchers involved in this study, and two 
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experts in the field of dementia and qualitative research independently analysed 
the interviews using the principle of open coding of early data. After comparison 
and discussions of the emerging coding scheme and coding decisions, consensus 
was reached on the common themes and subthemes to be presented below.
Results
The patients’ demographics are presented in Table 2.2. One patient had a low 
IADL score (3), due to her living in a home for the elderly where she had no 
cooking or laundry facilities. Four common themes emerged: changes, 
attributions, consequences and coping. These themes differed slightly from the 
original interview topics (see Table 2.1). Most of the responses relating to Thoughts 
were categorised under the theme attributions, with the remaining reflections 
being assigned to coping. The responses with respect to Emotions were 
categorised as consequences (i.e. reactions to the symptoms) and changes (i.e. 
symptoms of the condition). The numbers 1 to 8 following the quotations in the 
tables, indicate individual interviewees. 
Changes 
The changes the interviewees mentioned in connection with MCI concerned: 
a) Cognitive abilities, i.e. forgetfulness, poorer concentration; slight problems 
with geographical orientation and performing parallel actions, and slowness
b) Motor behaviour and mobility
c) Affect
d) Vitality
e) Somatic complaints. 
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Table 2.1   Key topics of the interview guide
•  Changes
•  Thoughts or reflections  
•  Emotions
•  Behaviour
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Table 2.2   Demographic features of the patients diagnosed with MCI (n=8)
Mean (sd) Range
Age 74.8 (8.1) 58-83
Education* 4.2 (1.8) 2-6
MMSE** 25.6 (2.1) 23-29
IADL*** 7.1 (7.1) 3-8
Sex Female: 7     Male: 1
Marital status Single: 1     Married: 5   Widowed:2 (women)
*  Educational level was determined using Verhage’s 7-point scale (Verhage, 1964) where 1 
denotes less than elementary school and 7 university education or higher. 
**   General level of cognitive functioning was assessed with the MMSE (Folstein et al., 1975) 
MMSE range: 0-30). Cut-off score for dementia: 23 or 24 depending on age and education 
(Crum et al., 1993). 
***  Functioning in activities of daily living was evaluated using Lawton’s 8-point rating scale 
(Lawton and Brody, 1969).
Table 2.3   Quotations from interviewees concerning changes
Subthemes Quotations
Cognitive abilities:
•  Forgettfullnes 
•  poorer concentration
•  slight problems with 
geographical orientation 
• problems performing  
parallel actions 
• slowness
“I forget where I put down my notes.” (3)
“Sometimes I repeat my questions.” (2)
“ Since we have moved to this new apartment I can’t  
find things in the kitchen cupboards anymore”. (1)
“ The concentration problems are as bad as my 
forgetfulness.”(7)
“I had to ask somebody to show me the way.” (1) 
“Can do less things at the same time.” (2)
“I need more time to sort things out.” (2) 
Motor behaviour and mobility “I’m less mobile than I used to be.” (1)
Affect “I’ve felt sad without any obvious reason.” (3)
“I’ve been depressed.” (7)
Vitality “I’m less energetic.” (1,3)
Somatic complaints “I’ve got more severe headaches.” (6).
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Attributions 
The patients gave a wide range of explanations for the changes they experienced. 
Forgetfulness was ascribed to: 
a) Normal conditions
b) Personality traits or habits
c) Dementia
d) Somatic origins
e) Unknown causes 
Various attributions were hence associated with several aetiologies like personality 
traits, information overload, biological life events or normal aging. Patients had 
several kinds of attributions at the same time. Finally, patients reported recurrent 
thoughts and reflections concerned insoluble questions about the origin of the 
patients’ problems and their future. 
Consequences
The reported consequences concerned the patients themselves, others and 
activities. 
a) Consequences regarding themselves always involved negative emotions and 
reactions among which sadness, anger, anxiety, loneliness, rejection, shame, 
loss of self-confidence, and self-blame. 
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Table 2.4   Quotations from interviewees concerning attributions
Subthemes Quotations
Normal conditions “It’s my age.” (1)
“It’s because of the tremendous amount of information.” (3)
“Others speak too softly.” (2)
“I’m not interested.” (4)
Personality traits or habits “I’ve always been very absent-minded.” (3)
Dementia “Will I become demented?” (2)
“ He calls it forgetfulness, I call it the beginning of 
dementia.”(5)
Somatic origins “It’s because of my hearing problems.” (2)
“It’s the medication.” (3,5)
“ I think my hip surgery is the cause. I’ve never recovered 
from it.” (5) 
Unknown causes “I wonder where it comes from.” (2)
“Why’m I acting so strangely?” (1)
“This is the beginning, but where will it end?” (5).
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b) Consequences concerning others were almost all negative and related to 
being angry or irritated by the (re)actions of spouses or family members. 
Patients also described their concerns about being valued less and becoming 
a burden to others. Some also expressed alertness to others noticing their 
forgetfulness. 
c) The consequences relating to activities, especially complex activities. When 
the patients were additionally asked for any positive MCI-related consequences 
they couldn’t think of one. 
In sum, most of the negative reactions MCI patients reported concerned them - 
selves and to a lesser extent others, the latter often involving minor conflicts and 
arguments with their partners. Having to abandon demanding activities was a 
recurrent theme. Also manifest was a profound awareness of the (perceived) 
reactions of others, whose interpretations resulted in feelings of shame and 
rejection although sometimes help from others was also perceived as positive. 
Finally, when asked specifically, no positive consequences of MCI surfaced. 
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Table 2.5   Quotations from interviewees concerning consequences
Subthemes Quotations
Themselves “I feel sad.” (2)
“I get angry with myself at such occasions.” (2) 
“I’m angry with myself but I take it out on him.” (5)
“It’s threatening.” (5)
“ When I visit my sister in the nursing home I get upset and think:  
I’ll end up here too.” (1)
“I’ve lost my self-confidence.” (8)
“I’m a complete failure.” (7)
“I feel annoyed with myself when I’m acting like that!” (2)
“ When I observe that other people tell things twice, I think:  
So I’m not alone.” (1) 
Others “My husband is controlling me, which makes me angry.” (7)
“My husband thinks that I’m getting senile, which I resent.” (5)
“I get irritated when my husband is sure he’s right.” (5)
“ Others will see me as someone with memory problems.  
They won’t consult me anymore.” (7)
“I keep worrying about becoming a burden to my children.”(3)
“They haven’t noticed my forgetfulness.” (1)
“I thought that everybody would notice it.” (3)
“When people look at me they appear concerned.” (7)
“They help me and offer the word I was looking for.” (7)
“I feel great when others don’t notice it.” (2) 
Activities “I recently stopped playing bridge.” (5)
“I ceased doing the administration for the association.” (7)
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Coping 
We observed three coping mechanisms: emotion-, problem- and avoidance- oriented 
coping (Zeidner and Endler, 1996). 
a) Emotion-oriented coping became manifest from thoughts reflecting acceptance 
and resignation. Comforting thoughts were abundantly mentioned and patients 
normalized their forgetfulness. 
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Table 2.6   Quotations from interviewees concerning coping
Subthemes Quotations
Emotion-oriented coping “I have to resign myself to it.” (1) 
“ I have to believe that they couldn’t find anything and  
that it’s not dementia.” (2)
“ After the consultation with the geriatrician I stopped 
looking for causes.”(3)
“ I have to convince myself that they couldn’t find anything 
and accept that it’s not dementia I’m suffering from.” (3)
“ I tell myself: what I can do, I will do; if I can’t, I just  
leave it.” (8) 
“I look for the things that go well.” (5)
“I’m still being asked for the  choir. ”(3)
“Many people of my age have this.” (3)
“It’s because I can’t hear very well.” (2)
Problem-focused coping
• External strategies
• Internal strategies
• Training mental abilities
• Exploring information and 
medication possibilities
• Getting help
“I started to organise more.” (3) 
“I make notes.” (1)
“I repeat the information I want to remember.” (7)
“I keep on looking for it.”(4)
“ I try to make the things I need to remember less 
important.” (3) 
“ When I have to go somewhere, I need to visualise the 
route in advance and then I’m all right.”(5)
“ I started doing crosswords and playing memory  
games.” (5)
“ I went to the drugstore to ask whether they had   
something to improve my memory.” (1) 
“I visited my GP.” (3) 
“I take Aspirin and I think it helps.” (8) 
“I ask my husband.” (8) 
“I phone my son and ask him.” (3)
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b) Problem-focused coping was reflected by responses featuring external and 
internal memory strategies to prevent forgetting and to optimise memory 
performance. Mental abilities were actively trained and information or treatment 
possibilities actively explored.
c) Avoidance-oriented coping was reflected by hiding their memory problems 
from others; preventing their mistakes by avoiding difficult situations and 
denying the forgetfulness. 
Summarising, our patients tried to cope with MCI by managing their emotions 
with comforting thoughts, by trying to improve their memory performance using 
internal and external memory strategies and by avoiding mistakes and hiding 
their problems from others. 
Discussion 
To our knowledge, ours is the first study to explore the symptoms, experiences 
and coping strategies in amnestic MCI from the patient’s perspective. Overall, the 
patients’ reactions reflected four common themes: changes, attributions, 
consequences and coping.
Besides forgetfulness, the patients reported additional cognitive changes such 
as diminished concentration, minor problems with geographical orientation and 
performing parallel actions, and slowness. This is consistent with what Salmon 
and Hodges (Salmon and Hodges, 2005) reported but seems to contradict the 
definition of Petersen (2001), who assumed memory impairment but normal 
general cognitive functioning. There seems to be a significant discrepancy 
between subjective complaints and objectified impairments. The patients also 
mentioned failing mobility, vitality and affect and somatic symptoms like (severer) 
headaches, all comparable to the changes (Snyder, 2001) described for patients 
with early dementia. This strongly suggests that in our patient group, MCI involved 
more than cognitive impairment alone.
Striking are the numerous explanations our MCI patients gave for their memory 
failure, reflecting their continuous search for information and possible causes, 
clearly distinguishes them from patients with early dementia. Many of the 
attributions and recurrent thoughts resembled the future-oriented worries typical 
of anxious and depressive patients (Watkins et al., 2005). This feature may 
contribute to the development of an anxious or depressive mood, which is more 
prevalent in MCI patients than in the healthy elderly. (Hwang et al., 2004)
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The patients reported a wide range of consequences that affected their personal 
and interpersonal well-being. They tended to disagree and argue with their 
spouses about the nature of their memory failure. (Duijnstee, 1992) described 
similar communication problems between dementia patients and their spouses. 
Our patients’ sensations of being observed or devalued by others were also 
observed by (Macquarrie, 2005) in patients with early Alzheimer’s. Such sensations 
can easily lead to social isolation and consequently to depression. Finally, the 
various negative emotional reactions (irritability, exasperation, sadness and 
panic) our MCI patients reported also resemble those observed in early stage 
dementia (Snyder, 2001). 
The coping styles found in our MCI sample were characterised by efforts to 
manage fear for dementia and progression, the use of problem-solving techniques 
and avoidance mechanisms such as denying their forgetfulness or hiding the 
problems from and blaming others. 
The sample size was sufficient to reach information saturation for amnestic MCI. 
It needs to be noted that since we did not include proxy information, it cannot be 
excluded that we missed changes and consequences the patients failed to 
recognise or mention. Neither did we monitor the effect of the consultation in which 
the geriatrician disclosed and explained the MCI diagnosis, which prevented us 
from discriminating the patients’ direct MCI-related experiences and consequences 
from those caused by the information they received. With their European, 
multi-centre DESCRIPA study on MCI (Derksen et al., 2005) showed that geriatricians 
and neurologists vary widely in their disclosure of MCI. Besides MCI, clinicians use 
numerous other diagnostic labels, among which pre-dementia. Diagnostic labels 
can significantly influence a patient’s emotional response, symptom perception, 
attributions and coping skills. (Wadley and Haley, 2001).
Because patients newly diagnosed with MCI encounter practical, social and 
psychological difficulties that generally induce stress, their cognition and 
well-being can be seriously affected by it. To support adaptation to their condition 
and to answer their queries and those of their families, their treatment is 
recommended to also include a psychosocial training programme. The 
intervention should entail the provision of accurate and current information about 
MCI, separating facts from fiction. The patient’s cognitions and attributions 
should be explored to identify and modify inappropriate attributions and thoughts 
that educe a negative mood. Additionally, to prevent social isolation, interactions 
between the patients and their partners and social environment should be 
encouraged and enhanced.
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Finally, Derksen et al. (2005) reported several advantages the disclosure of 
dementia had for both patients and partners or carers. It offered all parties the 
opportunity to adapt themselves to the disease, helped them to identify and 
exploit residual cognitive functions and to appreciate life’s remaining blessings. 
For the time being, however, disclosure of an MCI diagnosis does not provide 
such relief because many questions will remain unanswered, which may aggravate 
the patients’ concerns and relational problems. Based on our preliminary findings 
we acknowledge the disadvantages of the label and would like to stimulate 
discussion on it. Those patients that do meet the MCI label should be provided 
with comprehensive MCI-oriented information. 
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Abstract
Patients with Mild Cognitive Impairment (MCI) have a higher risk for the 
development of a dementia. Lack of awareness of cognitive deficits is a symptom 
that could be a predictor for the development of dementia during early assessment. 
This awareness can be assessed by means of the discrepancy between the 
reports of cognitive problems by patient and the cognitive problems of the patient 
as observed by the partner. In this study, the Informant Questionnaire on Cognitive 
Decline in the Elderly (IQCODE-N) was used to assess awareness. The results 
show that the discrepancy score (the difference between the IQCODE-N score of 
the patient and the IQCODE-N score of the partner) was significantly higher for 
the 61 MCI-patients when compared to the 40 healthy elderly (p=0.01). This 
suggests a diminished awareness in MCI-patients. Individual analysis of the MCI 
patients shows that this was true for 60% of the patients. Patients with a disturbed 
awareness score have significantly lower scores on the MMSE (p<0.01) than 
patients with an intact awareness.
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Introduction
A diminished awareness of deficits, sometimes called anosognosia, is a 
well-known phenomenon in patients with dementia, and this deficit grows as the 
severity of the dementia increases (Derouesné , 1999; Schneck , 1982; Starkstein, 
1997; Vasterling, 1997). Green et al. (1993) showed that Alzheimer patients over - 
estimate their memory function. They also proved that a decreased awareness 
does not need to be an all-or-nothing phenomenon. In their study, Alzheimer 
patients appeared to overestimate their memory for recent events as well as their 
daily activities, whereas they were better able to estimate their attentional function 
and their memory of events from the remote past.
Mild Cognitive Impairment (MCI) is seen as a transitional process between normal 
ageing and dementia (Petersen, 2001). In MCI subjective memory complaints 
supported by reports of an informant, together with an objective memory imapirment 
on neuropsychological testing is the key deficit, which does not result in limitations 
in daily activities, while the intellectual capabilities remain intact for the greater 
part (Petersen, 2001). The percentage of patients who develop dementia after a 
follow-up investigation depends on the MCI criteria that are used, as well as their 
age. Consequently, estimates range from 2% to 31% (Bruscoli, 2004).
With respect to the lack of awareness in patients with MCI, Farias et al. (2005) 
already showed that MCI patients report even more changes than their partners, 
whereas patients with dementia overestimated their cognitive capabilities. Kalbe 
et al. (2005) also discovered a diminished awareness in people with very mild 
Alzheimer’s dementia, but not in people with MCI. Furthermore, in MCI patients, a 
correlation was found between the subjectively assessed memory capacity and 
the actual memory performance (Cook and Marsiske, 2005). This relationship 
was not found in healthy participants, probably because MCI are more focused 
on their memory deficits than healthy elderly. However, in another study (Tabert 
et al., 2002), MCI patients overestimated their cognitive capabilities and reported 
fewer problems than their informants. The MCI patients, however, reported more 
problems than age-matched controls without cognitive deificts. This suggests 
that awareness in MCI patients is not completely absent. In this study, a four-year 
follow-up investigation revealed that MCI-patients who have a higher discrepancy 
score, compared to their partners’ awareness, developed Alzheimer’s dementia 
more often than the group of MCI patients whose subjective assessment more or 
less coincided with the rating of the partner.
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In sum, the results of various studies on awareness of deficits in MCI are inconclusive. 
A measure that is often used for the assessment of awareness is the discrepancy 
between the rating of cognitive deficits by the patient and the rating by their 
partners (Clare et al., 2005). Using this method, it is assumed that the partner is 
capable of giving a reliable and valid estimate of the cognitive functioning. The 
Dutch version of IQCODE (IQCODE-N) is a questionnaire in which the partner has 
to rate various aspects of the present daily function in comparison to ten years 
ago (Jonghe, 1997a). The strong correlation between the scores on the IQCODE-N 
and MMSE suggest that partners are able to estimate cognitive functioning of 
patients with dementia on the basis of IQCODE-N (Jorm, 2004; De Jonghe, 1997a).
The IQCODE-N is validated for the assessment of cognitive symptoms in patients 
with dementia. In MCI, however, the changes in cognitive function are more subtle 
than in dementia. Nevertheless, the IQCODE has been found to be a valid tool to 
discriminate between the mild cognitive changes in MCI and normal ageing 
(Isella et al., 2006). 
In the present study, we investigated whether awareness of deficits in MCI patients 
differs from the awareness in healthy elderly by means of the discrepancy scores 
of the IQCODE-N, and whether there is a correlation between awareness and the 
severity of the cognitive deficits.
Method
Participants and procedure
MCI patients were included in this study during the period 2004 to 2006. Eligible 
MCI patients and their significant others were recruited via four regional outpatient 
memory clinics in the east of the Netherlands were recruited (i.e., Radboud 
University Nijmegen Medical Centre and three general hospitals, namely 
‘Maasziekenhuis Pantein’ in Boxmeer, ‘Rijnstate’ in Arnhem and ‘Slingeland’ in 
Doetinchem). With respect to MCI the criteria described by Petersen (2001) were 
used. Inclusion criteria were an MCI diagnosis (i.e., amnestic MCI, non-memory 
single-domain MCI or multiple-domains MCI), age over 50 years, and the 
availability of a partner/spouse, relative, or close friend willing to participate in the 
study. In all four participating centres MCI was diagnosed using a multidiscipli-
nary approach supervised by a geriatrician or neurologist, according to generally 
accepted criteria described by Petersen (2001). This approach consisted of a 
thorough clinical interview with the patient dyads, supported by an extensive neu-
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ropsychological assessment, neurological and radiological findings and 
assessment of activities of daily living. Performance on the neuropsychological 
tests was rated as within the normal range, below average, or impaired based on 
available age- and education-adjusted normative data. A performance between 
1 SD below or above the normative mean was defined as normal, between –1 SD 
and –1.65 SD below the normative mean as below average, and more than –1.65 
SD below the normative mean as impaired (van den Berg, 2005). The MCI criteria 
were met if a patient’s performance was impaired in one of the cognitive domains, 
or if more than one cognitive domain showed his/her performance to be below 
average, in the absence of a decline in activities of daily living (i.e., dementia). 
Instrumental activities of daily living were assessed using validated rating scales 
(such as the Lawton Instrumental Activities of Daily Living Scale; Lawton and 
Brody, 1969) and/or by structured observation of daily-life activities by an 
occupational therapists (either in the patient’s home environment or in the 
outpatient clinic). Participants were excluded if they fulfilled the criteria for 
dementia. Exclusion criteria were the absence of informed consent, the presence 
of psychiatric comorbidity, co-existing somatic disorders if dominant to MCI, 
severe concentration difficulties, impairments in hearing and/or vision, which 
were determined during clinical interview.
For the recruitment of a control group, invitations were sent to a number of 
accommodations for self-supporting elderly in Nijmegen and surroundings. 
Exclusion criteria were a Mini Mental State Examination (MMSE) score below 26, 
a neurological or psychiatric hisory affecting cognitive function and problems in 
hearing and/or vision.
Measures
The Dutch version of the Informant Questionnaire on Cognitive Decline, short 
version (IQCODE-N) (Jonghe et al.,1997a) was used to asses the ratings of 
cognitive function by the patient’s partner. In order to obtain the same rating by 
the MCI patients themselves, the identical items from this questionnaire were 
used with a slightly adjusted instruction. The maximum score of the IQCODE-N is 
16. Each item deals with an every-day activity during which clear thinking and 
remembering are required. The respondent rates the performance in daily life 
relative to the level of functioning ten years before, on a 5-point scale ranging 
from ‘Much improved’, (1 point) to ‘Much worse’ (5 points), with a score of 3 
reflecting ‘No change’. The discrepancy score is the difference between the 
IQCODE-N score of the partner and the IQCODE-N-Pt score of the MCI patient, 
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which was used to measure the level of awareness of the patient. A positive 
discrepancy score means that the self-assessor (the MCI patient) experiences 
the changes in his memory less dramatically than the partner does. 
Memory function was assessed with the Dutch version of the Rey Auditory Verbal 
Learning Test (RAVLT) (van der Elst, 2005), which requires the participant to recall 
15 auditorily presented words across 5 trials, immediately after their presentation 
and after a 20-minute delay, followed by a recognition trial in which the 15 words 
are presented among 15 distracter items. The Mini Mental State Examination 
(MMSE) was used as an overall index of the cognitive decline (Folstein, Folstein, 
McHugh, 1975; Cammen, 1992).
Statistical analyses
To measure whether the level of awareness was different for MCI patients 
compared to the control group, an ANOVA was performed on the discrepancy 
score with Group (MCI-patients/control group) as a between-subject factor. To 
obtain the percentage of MCI patients with a diminished awareness and the 
percentage of those with an intact awareness (compared to the awareness of the 
control group) the group of MCI patients has been subdivided into 2 groups:
•	 Group 1: normal awareness: patients who estimate their memory problems 
equal to or more severe than their partners. The mean discrepancy score + 
1SD of the controls was used as a cut-off value. A discrepancy score lower 
than or equal to the average discrepancy score of the control group was 
considered to be normal awareness.
•	 Group 2: diminished awareness: patients who report considerable fewer 
changes in their memory function than their partners: the discrepancy score 
is higher than or equal to the mean discrepancy score + 1 SD of the controls. 
To account for the differences between the groups with respect to age, level 
of education and cognitive impairment (MMSE, total reproduction, delayed 
reproduction and recognition on the RAVLT) an ANOVA was performed on 
these variables with Group as a between-subject factor.
Next it was investigated whether MCI patients assess their cognitive decline in a 
different way compared to the control group by applying an ANOVA to the variable 
self-assessment (by means of the IQCODE-N) with Group (MCI patient versus 
control group) as the between-subject factor.
The relationship between awareness and the cognitive impairments has been 
investigated by means of Pearson correlations between the discrepancy score of 
the total group and the MMSE, total reproduction, delayed reproduction and 
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recognition on the RAVLT. Based on the assumption that there is an overall 
relationship that is not limited to the MCI diagnosis, Pearson correlations of the 
total group have been computed.
Results
Sixty-one MCI patients and their partners participated in the study, aged 50 – 80 
years. The majority of the significant others (n=56) was husband/wife of the 
MCI-patient. In the control group, 20 couples and 2 sisters took part in the survey. 
One couple dropped out because of a MMSE score lower than 26.
All participants in the control group completed the IQCODE-N for themselves and 
their partner, resulting in a total of 40 healthy participants for the calculation of a 
discrepancy score. The level of education ranged from primary school to 
university degree in both groups.
Table 3.1 showws the demographic variables. The two groups did not significantly 
differ in age or level of education. Because some of the participants did not 
complete the whole questionnaire, the number of participants slightly varied per 
group and per variable.
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Table 3.1   Demographic variables of the MCI patients and controls; means, 
standard deviations (SD), frequency (N), F-values and p-values
MCI-patients
N=61
Healthty elderly
N=40
F P
Men 46,3% 47,5%
Age 72 (7.32) 73 (6.71) 0.25 0.62
Education 4 .69 (1.13) 5 .10 (1.35) 2.09 0.15
IQCODE-N-pt 57 .7 (6.1) 51 .2 (3.8) 37.1 <0.01
IQCODE-N 63 .1 (7.4) 52 .0 (5.2) 68.1 <0.01
Discrepancy score 5 .3 (9.7) 0 .8 (4.1) 7.9 <0.01
MMSE 25 .7 (3.0) 28 .9 (1.0) 40.3 <0.01
RAVLT total reproduction 24 .9 (7.9) N=58 36 .5 (10.3) N=38 39.4 <0.01
RAVLT delayed recall 2 .7 (2.9) N=58 6 .4 (2.9)   N=38 38.8 <0.01
RAVLT recognition 25 .0 (3.9) N=56 28 .3 (2.6)   N=38 21.2 <0.01
IQCODE-N = Informant Questionnaire on Cognitive Decline in the Elderly - Dutch version; IQCODE-N-pt  = 
self-report IQCODE; MMSE = Mini Mental State Examination; RAVLT = Rey Auditory Verbal Learning Test
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Awareness of deficits in MCI
The discrepancy score was significantly higher (M=5.3) for the MCI patients than 
for the control group (M=0.8); (F(1,99)= 7.9, p<0.01). On average MCI patients 
rated their cognitive decline significantly more severe (M=57.8) than people from 
the control group (M=51.2), F(1,99)= 37.1, p<0.01. 
The mean item score of the patient’s self reports was 3.61, and therefore a score 
somewhere between the item categories “no change” and “slightly worse”. The mean 
item score in the control group was 3.2; very near to the category “no change”.
The range of the discrepancy scores (the difference between self-assessment 
and assessment by the informant), with a standard deviation of 9.7 (range -17 to 
+20), was higher in the MCI patients than in the control group (SD=4.1; range -6 
to +13). The cut-off value for a “normal” discrepancy score was determined based 
on the average discrepancy score of the control group + 1SD (that is 0.8+4.1=4.9). 
A discrepancy score > 4.9 was considered to reflect impaired awareness.
60% of the MCI patients had impaired awareness. Table 3.2 shows that the two 
groups (with and without lowered awareness) did not differ in age or education 
level, but patients with awareness show a significant higher mean MMSE score 
than patients with lack of awareness. No differences on the RAVLT were found 
between these two groups.
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Table 3.2   Comparing patients with normal awareness to patients with 
lowered awareness on participants’ demographic and  
characteristics on cognitive functioning; Means, standard 
deviations (SD), Frequency (N), F-scores and p-values
Illness 
awareness
N=25
Lowered awareness
N=36
F P
Age 69 .4 (7.7) 69 .8 (7.2)  0.7 0.78
Education 4 .9 (1.0) 5 .0 (1.2)  0.03 0.86
MMSE 26 .9 (2.6) 24 .9 (3.1)  6.6 0.01
RAVLT total reproduction 27 .1 (7.5)  N=23 23 .3 (8.0)  N=35  3.1 0.07
RAVLT delayed recall 3 .1 (3.2)  N=23 2 .2 (2.4)  N=35  1.5 0.22
RAVLT recognition 24 .9 (4.6)  N=21 24 .9 (3.5)  N=35  0.0 0.97
MMSE = Mini Mental State Examination; RAVLT = Rey Auditory Verbal Learning Test
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Awareness and the severity of cognitive disturbances
Table 3.3 shows the Pearson correlation between the discrepancy scores of 
the IQCODE and several cognitive parameters. A significant negative relationship 
(r= -0.25) between discrepancy scores and the MMSE was found, indicating that 
the larger the difference between self-assessment and informant assessment 
(i.e., overestimation of everyday functioning), the lower the MMSE. For the 
RAVLT indices immediate and delayed recall similar significant correlations were 
found. No significant correlation was found between delayed recognition and the 
discrepancy score.
Discussion
Overall discrepancy scores in MCI patients are higher than in healthy elderly, 
which suggests that MCI patients have a diminished awareness. The extent of this 
awareness depends, as expected, on their cognitive performance as measured 
by the MMSE and the RAVLT. Some critical remarks can be made concerning the 
conclusion that there is a diminished awareness of deficits in MCI, after a more 
precise analysis of the discrepancy scores. That is, the range of MCI patients is 
very large and there is a huge overlap between the discrepancy scores of MCI 
patients and healthy persons. Some MCI patients reported more memory 
problems than their partners did, which means that they did not underestimate 
their problems at all. This is in agreement with the findings of Farias et al. (2005) 
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Table 3.3   Correlations between the discrepancy scores and the  
MMSE (N=74), total reproduction RAVLT (N=72), delayed recall 
RAVLT (N= 70) and recognition RAVLT (N=68)
Discrepancy score
Pearson correlation
 P value
MMSE Discrepance score -0.25 0.01
RAVLT total reproduction -0.24 0.02
RAVLT delayed recall -0.22 0.03
RAVLT recognition -0.13 0.19
MMSE = Mini Mental State Examination; RAVLT = Rey Auditory Verbal Learning Test. 
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who described in their study that both some of the MCI patients and some of the 
healthy controls reported more problems compared to their informants. Tabert et 
al. (2002) found a significant difference between the discrepancy scores of the 
MCI patients and those of the control group but even in that study, some of the 
MCI-patients had a discrepancy score that remained within the range of the 
control group. However, Tabert et al. did not include the number of participants in 
this group. In our current study, 40% of the MCI patients rated their memory 
problem equal to or as more severe than their partners, and they had an awareness 
equal to the control group. This group of MCI patients with an intact awareness 
level performed significantly higher on the MMSE than the MCI-patients with a 
diminished awareness.
Conclusion
In summary, this study indicates that awareness in MCI patients as a group is 
slightly  diminished, but closer inspection of the range of discrepancy scores 
shows that this is not true for all MCI patients  (i.e., 40% have intact awareness). 
The extent to which awareness has diminished was related to the severity of the 
cognitive deficits. Clearly, disturbed awareness can be the result of mild cognitive 
impairment and lack of awareness is not exclusively present in patients with 
dementia. The results of this study are important for psychoeducation purposes 
related to MCI patients and their partners. In the diagnostic process of MCI, 
awareness of deficits should be assessed and it is important to inform partners 
about a possibly diminished awareness in order to increase their understanding 
of their partners’ changed behaviour.
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Abstract
Support groups can provide a forum for socialization and learning for people with 
mild to moderate Alzheimer’s disease. The aim of this study was to evaluate the 
effectiveness of these groups based on participant feedback. A survey questionnaire 
was administered to 70 support group participants with Alzheimer’s disease from 
8 well-established groups across the United States. Participants reported on the 
educational value, positive socialization, and improved ability to cope with 
symptoms and to accept the diagnosis as a result of participating in a support 
group. These reported outcomes suggest the importance of creating more 
sensitive measures to better evaluate the effectiveness of support groups and 
other educational or social support programs for persons with dementia. 
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Introduction
With advances in early detection and diagnosis of Alzheimer’s disease (AD), the 
last decade has witnessed a growth in program development created specifically 
for the social and emotional support needs of people in the early stages of the 
disease. Common concerns for those with mild AD include receiving the diagnosis, 
disclosing the diagnosis to others, developing coping strategies for cognitive and 
functional loss, finding meaningful activity, planning for the future, and struggling 
with role changes and autonomy (Harris and Keady, 2004; Clare, 2002; Phinney, 
2002; Snyder, 2001).  Many clinicians have noted the therapeutic effects of 
support groups as a forum for discussion and problem solving for people with 
mild AD and early-stage support groups remain the most popular program model 
for this population (Yale and Snyder, 2002).  Support group facilitators report on 
the decreased sense of isolation expressed by participants and the significant 
level of self-disclosure, empathy, altruism, and cohesion observed early on 
among group participants. (LaBarge & Trtanj 1995; Reichlin, 1999; Snyder, 
Quayhagen, Shepherd & Bower 1995; Yale 1995).  Case examples and participant 
statements reveal positive outcomes in peer group problem solving, the alleviation 
of depression, acceptance of the diagnosis, and communication between group 
participants as well as between group participants and their care partners (Yeh, 
Truscott & Snyder, 2001; Zarit, 2004; Snyder, 2000).  
Although there is a breadth of clinical and anecdotal testimony that reveals the 
benefits of support groups for persons with mild-to-moderate AD, it has been 
difficult to measure these outcomes with existing mood, mental status, or other 
psychometric instruments (Ishizaki et al. 2000; Morhardt & Johnson 1998; Quayhagen 
et. al; 2000). Many outcome measures have not been normed for people with 
dementia, nor are they specific to the support group dynamics and subjective 
experiences noted in participant testimony.  Logsdon et al. (2005) are currently 
evaluating the effectiveness of a nine-week time-limited didactic support group 
for people with early-stage dementia and their care partners using a variety of 
outcome measures. Preliminary data suggests that some of their study instruments 
may be sensitive to measuring outcomes in quality of life, perceived stress, family 
conflict and self-efficacy for people with mild dementia.  The study will require the 
final analysis of data from a larger cohort of participants to be conclusive.
This paper reports on a survey that was developed and piloted specifically for 
participants with dementia to investigate their subjective experience with a support 
group. Results of this survey provide useful feedback concerning perceived benefits 
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of support groups and can be used to influence the development of more sensitive 
outcome measures to evaluate the effectiveness of support groups for affected 
individuals.
Methods
All survey participants were recruited from eight well-established support groups 
in regions across the United States. All support groups met for at least one and 
one half hours. Six of the groups met weekly, one group met bi-monthly, and one 
group met monthly.  All groups followed an unstructured format whereby topics of 
discussion were initiated by group participants or informally by facilitators, but 
were based on the aforementioned concerns common to people with early-to-
moderate stage AD. A total of 70 people with dementia participated in the survey. 
There were 30 females and 40 males. The mean age was 73. The mean time since 
diagnosis, as reported by the care partner, was 3 years with symptoms having a 
mean duration of 5 years.  The mean time for participation in the support group 
was 22 months.
With growing awareness of the subjective experience of AD, researchers are 
validating that persons into the moderate stages of the disease (ten and above on 
the Mini Mental Status Exam) (Folstein, 1975) can act well as reliable informants 
about a wide range of experiences ranging from quality of life to personal care 
values and preferences (Feinberg, Whitlach & Tucke, 2000; Logsdon, 2002). 
Drawing on these findings, a survey was developed to investigate why participants 
with dementia attend a support group, what they like best about their group, their 
preferences for discussion topics, and any perceived beneficial or detrimental 
outcomes of participation. 
The survey incorporated rating scales and open-ended questions to investigate the 
reasons for support group attendance, degree of interest in various discussion 
topics, and perceived outcomes of attending the group. The survey was administered 
orally by an interviewer who documented the participant’s narrative responses to 
open-ended questions and their ratings on questions that incorporated a structured 
three-point Likert scale. 
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Results
Scale Ratings
The first of three rating scale questions asked participants: “Of the following 
reasons people attend support groups, which are the most important to you?” 
(See Table 4.1).  Friendship and socialization was a very important reason for 70% 
of the participants followed by educational themes including learning to cope 
with AD (65.7%) and learning more about AD (61.4%).  Care partner influence was 
important in over half the participants (55.1%) but having an activity was rated as 
only a somewhat important or not important reason by 62.9% of the participants. 
The value participants placed on learning was also revealed in their ranking of the 
degree of interest in topics commonly discussed during support group sessions. 
(See table 4.2). The topics ranked very important by the largest number of 
participants included strategies for coping with AD (75.4%) and research and 
drug updates (58.6%).  Other topics were far less engaging with over half of the 
participants rating the topics of long-term care and driving as not interesting.
Participants were also asked to evaluate whether attending the support group 
had produced any effect across seven outcomes (See Table 4.3). Most participants 
they had more understanding of Alzheimer’s as a result of support group 
participation (87.9%) and were also better able to cope with changes related to 
Alzheimer’s (82.6%).  A majority of participants also reported that they were better 
able to accept their diagnosis (69.1%), felt less isolated and alone (68.1%), and 
less frightened or anxious (52.9%).  Although 63.6% of participants reported that 
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Table 4.1   Reasons for Support Group Attendance (%)
Very 
important
Somewhat 
important
Not 
important
Friendship/Socialization      70.0 22.9 7.1
To learn to cope with AD 65.7 27.1 7.1
To learn more about AD      61.4 30.0 8.6
Care-partner wants it 55.1 21.7 23.2
To have an activity 37.1 44.3 18.6
AD=Alzheimer’s Disease
60
the support group had no perceived impact on the level of conflict they had with 
their care partner, 27.3% noted decreased conflict while 9.1% noticed an increase.
Spearman-rho correlations revealed some consistency of responses across 
interrelated questions and supported the findings of other previously noted 
researchers that people with mild-moderate dementia can provide reliable and 
valid responses when reporting on their subjective experiences, values, and 
preferences.  Concerning reasons for attending a support group, the shorter the 
time since diagnosis, the more likely the person rated learning about AD (rs= 
-0.294; p<0.05) and learning how to cope with AD as a very important reason for 
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Table 4.2   Rating of discussion topics  (%)
Very 
interesting
Somewhat 
interesting
Not 
interesting
Strategies for coping with AD      75.4 18.8 5.8
Research and drug updates 58.6 27.1 14.3
Planning for future 36.2 24.6 39.1
Reminiscing about past 35.3 35.3 29.4
Effects of AD on relationships     34.3 47.1 18.6
Long-term care 29.9 19.4 50.7
Community resources 29.4 38.2 32.4
Driving 28.4 16.4 55.2
Table 4.3   Results of Participation (%)
Decreased No Change Increased
Understanding of AD 0 12.1 87.9
Ability to cope with AD changes 1.4 15.9 82.6
Ability to accept AD diagnosis 1.5 29.4 69.1
Feelings of isolation 68.1 27.5 4.3
Feelings of fear/anxiety 52.9 44.1 2.9
Depressed feelings 42.6 52.9 4.4
Conflict with caregiver 27.3 63.6 9.1
AD= Alzheimer’s Disease
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attending the group (rs= -0.425; p=0.001).  Those participants who said that 
learning how to cope with AD was a very important reason for support group 
attendance also rated research updates (rs=0.377; p<0.01) and strategies for 
coping (rs=0.649; p<0.001) as being very interesting topics of group discussion. 
These correlations suggest that more newly diagnosed individuals are particularly 
attentive to the learning aspects afforded by group participation.  
On further examination of topic preferences, the degree of time that a person has 
had a diagnosis may impact on which topics of discussion are most interesting. 
The more recent the diagnosis, the more interested the participant was in learning 
about AD (r. = -0.294; p<0.05) and in learning strategies for coping with AD (r.= 
-0.284; p<0.05).  Many newly diagnosed people may come to the group seeking 
information about their disease and are eager to learn ways to manage their 
symptoms. As the disease progresses, it is possible that group participants 
become more familiar with their condition and may rate learning about it as a 
lower priority.  Correlations also suggested that the longer participants had been 
in the group, the less interested they were in the topic of social and family relations 
(rs= -0.275; p<0.05).  The support group experience may quell some of the initial 
isolation experienced by many with the disease and make the need to discuss 
social relations less urgent.  Also of note concerning topics, the small percentage 
of participants who rated planning for the future as a very interesting topic were 
also among the minority who rated community resources and programs (rs=0.485; 
p<0.001), and long-term care planning (rs=0.455; p<0.001) as very important topics 
suggesting consistency in reporting preferences for this group of participants.
Finally, concerning perceived results of participating in a support group, those 
who stated that they were more able to cope with AD also reported that they had 
more acceptance of the diagnosis, (rs=0.443; p<0.001) and felt less frightened or 
anxious (rs=-0.312; p=0.01).  This suggests a relationship between improved 
coping and increased acceptance of the diagnosis and a corresponding reduction 
in fear and anxiety for this cohort of support group participants.  Those who 
reported that they had more understanding of Alzheimer’s as a result of group 
participation also reported that they had more ability to cope with changes related 
to the disease (rs=0.467; p<0.001) supporting a relationship with increased 
knowledge and improved coping.
Narrative Reports
Narrative responses from participants were analyzed separately.  The transcribed 
responses for each open-ended question were content analyzed for recurring 
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themes and clustered into meaningful categories by two of the investigators.  Five 
independent raters (two licensed clinical social workers, one nurse practitioner, 
one neuropsychologist, and one clinical psychologist) validated the themes with 
inter-coder agreement of 0.91. 
When asked, “Why do you come to this group?” 28.5% of participants referred to 
the influence of a spouse, family member, or physician recommendation. One man 
responded. “My wife heard about it. She felt I needed to be in a group. I suppose 
it’s wise.”  Approximately one quarter (21.4%) of the group participants came 
primarily for socialization, companionship, and activity.  Many referred to the 
friendships they had made in the group and the value of social interaction.  One 
participant stated, “I thought I would get some benefit from company and people 
involved.  I live alone.”  Another quarter of participants came to the group to learn 
something and to help them cope with the diagnosis or with memory problems 
(21.4%). One group member replied, “Support for memory – memory enhancement. 
The rest of my body is fine, but my memory is not there.”  Others came to the 
group to be with people who had the same problems related to Alzheimer’s 
(14.2%).  One respondent replied,” To be with a group that feels the same as I do 
and has the same problems.  I don’t feel strange about revealing what is going on 
with me.” The remainder of the respondents (8.5%) provided answers reflecting a 
generalized appreciation or enjoyment of the group experience. 
When asked the open-ended question, “What do you like best about the group?” 
nearly half of the participants’ responses were coded in the theme of social 
contact or socialization with others (48.5%).  References were made to the group 
feeling like a family or to the sense of camaraderie and friendship among the 
group members. One respondent stated, “They’re very congenial and respect 
each other.” Twenty percent of participants stated that verbal sharing or learning 
was the best part of the group.  One participant replied, “When we can share 
things and then that way we might be able to help each other.” The remainder of 
the participants’ responses was coded into the categories of a feeling of mutual 
understanding (10%), the group leaders (8.5%), or laughter (5.7%) as being what 
respondents liked best about their support group.  One participant replied, “ The 
positive attitude. It’s uplifting.  The reason for being here is not funny, but everyone is 
laughing.”
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Discussion
This survey did not attempt to determine who is appropriate for a support group 
or who may or may not benefit. Indeed, the study sample is biased by the sole 
inclusion of those who volunteer to attend a support group and continue 
participation in the group due to some presumed positive experience. This survey 
does, however, provide insight into why participants continue to attend their 
group and what aspects of the experience are most valuable. Although some 
participants reported caregiver influence in getting them to join the group or in 
spurring attendance, this was not ranked among the more important reasons for 
continued participation. Rather, analysis of the survey’s rating scale and narrative 
data reveals the consistent value that participants place on both the social and 
educational components of the support group experience. It is not simply having 
an activity that is of value, but rather the satisfactions inherent in the support 
group experience that were discerned by the participants. 
The survey data supports previously cited published facilitator observations that 
participants seem less isolated as a result of the support group. The self-disclo-
sure, empathy, altruism, and cohesion facilitators have observed early on among 
group participants corresponds with the value of the friendship and socialization 
that participants report in this survey.  Findings in the previously noted published 
case examples are supported in this survey by references the participants make 
to peer group problem solving, the alleviation of symptoms of depression, and 
increased acceptance of the diagnosis.   
There are limitations to this study. This unfunded pilot project relied on the 
volunteer efforts of those support group sites that agreed to participate in the 
survey. Hence, although written instructions on administering the survey and 
recording the data were provided to each data collector, different interviewers 
across sites could have gathered the data with varying degrees of exactness. 
Although the participants’ 3-year mean time since diagnosis suggests a cohort of 
mild-moderately impaired patients, mental status testing was not administered to 
support group participants to determine whether level of cognitive impairment 
correlated with survey responses or affected the ability to answer questions. An 
obvious discrepancy in methodology occurs in the fact that two of the eight 
groups did not meet weekly; rather these sites held bi-monthly or monthly groups. 
With limited numbers in the total analysis, we cannot determine whether reports 
varied significantly between the groups that met weekly and those that did not. 
Also, unlike time-limited 6-10 week psychoeducational support groups that 
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incorporate a more structured weekly curriculum, the model of an ongoing 
open-ended support group is not a standardized intervention; the process and 
content vary across groups and from session to session.  The open-ended group 
model was selected for this survey to allow for a more generalized evaluation of 
the experience of participation in a support group rather than evaluating the 
effectiveness of a distinct model. 
Conclusion
For those currently conducting support groups for people with AD, an administered 
survey instrument can be a useful tool for evaluating the effectiveness of the 
group and providing feedback to facilitators on the benefits or limitations of their 
program. Since the efficacy of support groups has not been well researched, 
findings from this pilot survey could also be used to suggest the development of 
more rigorous outcome measures for evaluating support groups and other early- 
stage educational or socialization programs. The reported themes of educational 
value, positive socialization, and improved ability to cope provide useful categories 
for instrument design. 
Support group participants highlighted the importance of learning about AD and 
learning to cope with AD in both the rating and narrative responses. As one survey 
respondent stated, “For anyone with Alzheimer’s, joining a support group is a 
must to learn coping skills and drug and technology changes. I can’t imagine 
where all those other people are who are not in groups.”  Although support group 
participation may only appeal to a sub group of people with AD, many regions of 
the country (and the world) do not have groups available to meet the needs of this 
ever-growing population. Alzheimer’s Associations and international Societies 
have made some headway in trying to address the educational needs of those 
diagnosed, but there remains a paucity of written materials, workshops, or 
conferences directed specifically to people with mild-moderate AD.  Professionals 
and families may underestimate the social and educational needs of people living 
with dementia. Given the scientific emphasis being placed on earlier detection 
and treatment of AD, much progress can be made in development and delivery of 
services to those living most intimately with the disease.
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Abstract
Objective: To evaluate the feasibility and present preliminary results of a Cognitive 
Behavioural Group Therapy for patients with Mild Cognitive Impairment and their 
significant others.
Design: One group pretest-posttest design 
Subjects: 22 MCI patients and their significant others, running in four group 
programs.
Intervention: The main goal of the Cognitive Behavioural Group Therapy was to 
strengthen adaptive behaviour in ten weekly 2-hour sessions
Main Measures: Distress and mood: The RAND-36, Geriatric Depression 
Scale-short form; Acceptance and Helplessness: Subscales Acceptance and 
Helplessness from the Illness Cognition Questionnaire, Marital satisfaction: 
Maudsley Marital Questionnaire, Alertness to memory failure and behaviour 
changes: Informant Questionnaire on Cognitive Decline in the Elderly and the 
Revised Memory and Behaviour Problems Checklist Burden. The burden of care 
giving reported by the significant others: Sense of competence Questionnaire 
and Behaviour Problems Checklist Burden, Hindrance subscale.
Results: No changes were found on distress and mood measures in both patients 
and their significant others. Patients showed a significant increased level of 
acceptance (p<0.05) and a trend for an increased marital satisfaction (p<0.1). 
The significant others reported an increased awareness of memory and 
behavioural problems (p<0.05). Attendance was high, indicating a high motivation 
for this intervention.
Conclusion: Preliminary results show evidence for positive changes after a 
Cognitive Behavioural Group Therapy for Mild Cognitive Impairment patients and 
their significant others. In addition, the developed  programme is applicable and 
feasible. The programme’s effectiveness should be studied further, with an 
estimated sample size of 70 couples in a controlled study design. 
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Introduction
Over the last few decades, research has focused on the clinically important 
distinction between normal, age-associated forgetfulness and memory impairments 
associated with the (early) development of dementia. In this light, the concept of 
Mild Cognitive Impairment (MCI) is of considerable importance. It refers to a 
syndrome that is thought to represent a transitory state between age-related 
cognitive decline and dementia, often characterised by memory impairment with 
intact everyday functioning (Petersen, 2001). However, patients diagnosed with 
MCI represent a very heterogeneous group as, over time, they may remain stable, 
revert to normal performance levels compared to their age group, or progress to 
a dementia syndrome. Prospective longitudinal studies report annual conversion 
rates from MCI to dementia of 6% up to 25% (Feldman & Jacova, 2005; Panza et 
al., 2005). Early detection of individuals at risk of eventually developing dementia 
may offer clinicians the possibility to offer treatment options.
Only a handful of small-scale descriptive studies have explored how MCI patients 
and their significant others cope with their diagnosis and impairments. Moody 
and Whitehouse (Moody & Whitehouse, 2003), for example, described the 
reactions of four MCI patients shortly after they had received the diagnosis. These 
patients responded with denial and confusion about what MCI entailed and were 
severely distressed. Lingler et al. (Lingler et al., 2006) explored the experiences of 
12 MCI patients and found that although most patients felt relieved after the 
diagnosis, feelings of stress and worries about an uncertain prognosis were also 
prevalent. The analysis of structured interviews in eight MCI patients conducted 
at our department revealed that they encountered profound stress-inducing 
practical, social and psychological difficulties (Joosten-Weyn Banningh et al., 
2008). Moreover, Hwang et al. (Hwang et al., 2004) showed that the incidence of 
mood disorders, such as dysphoria, anxiety, restlessness or irritability, occurred 
more frequently in MCI patients than in a healthy, age-matched control group. 
Also, the significant others of MCI patients (i.e., partners, children or close friends) 
report more symptoms of depression and anxiety (Garand et al., 2005) than 
controls. Thus, patients receiving a diagnosis of MCI, as well as their significant 
others, subsequently not only have to deal with an uncertain prognosis, but also 
face a multitude of everyday changes that may affect their well-being. Apart from 
ethical questions with respect to the use of MCI as a diagnostic label (Moody & 
Whitehouse, 2003; Joosten-Weyn-Banningh et al., 2008a), this illustrates the 
need for adequate psychosocial interventions that help these patients and their 
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significant others contend with the many consequences of the diagnosis. 
However, psychological approaches to enhance well-being in MCI have so far not 
been described in the literature. More studies are available that have investigated 
the effects of psychosocial interventions in patients suffering from dementia 
(Bottino, 2005; Brodaty, Green, Koschera, 2003). Despite the memory and 
communication problems that are central in dementia and that tend to interfere 
with learning and social functioning, group therapies have been developed that 
comprise a mixture of psycho-educational and cognitive-behavioural elements. 
The rationale behind this approach is that the interaction with and support of 
others in similar circumstances, as well as exchanging experiences and coping 
strategies is likely to be beneficial (Cheston, 1998). Finally, Brodathy et al. (Brodaty, 
Green, Koschera, 2003) in their meta-analysis on psychosocial interventions 
aimed at the caregivers of people with dementia concluded that success was 
more likely if both the patients and the caregivers were actively involved in the 
programme. Although there is a great diversity in group interventions, little 
systematic evaluation has been undertaken (Scott & Clare, 2003).
Based on abovementioned findings, we have developed a psychological group 
intervention to support both the MCI patients and their significant others. The 
programme aims to enhance well-being, acceptance of memory failure, reduce 
distress and helplessness, and strengthen the patient-partner relationship. It 
additionally aims to boost the significant others’ sense of competence. In the 
current explorative study, we evaluate the applicability and feasibility of this newly 
developed MCI patient-significant others group intervention. Preliminary results 
on the programme’s effects are described and related to the characteristics of the 
participants, such as age, education level and cognitive status. We will also 
address attendance, dropout rates and reasons for dropping out. 
Methods
Participants 
Between 2005 and 2006 we recruited patients and their significant others from 
three regional outpatient memory clinics in the east of the Netherlands. Inclusion 
criteria were an MCI diagnosis, i.e. amnestic MCI, single non-memory domain 
MCI or multiple domains MCI, age over 50 years, and presence of a partner/
spouse, relative or close friend willing to participate in the study. In all participating 
centres, MCI was diagnosed using a multidisciplinary approach according to 
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criteria established by Petersen (Petersen, 2004), using a thorough clinical 
interview with the patient and significant others, supported by extensive neu-
ropsychological assessment and neuroradiological findings. Performance on the 
neuropsychological tests was rated as either within the normal range, below 
average or impaired based on available age- and education-adjusted normative 
data. Normal performance was defined as between –1 SD and +1 SD below the 
normative mean, below average between –1 SD and –1.65 SD below the normative 
mean and impaired as more than –1.65 SD below the normative mean (van den 
Berg et al., 2005).  To fulfil the criteria for MCI, impairments had to be present in 
one of the cognitive domains, or below-average performances were found on 
more than one cognitive domain, in the absence of a decline in activities of daily 
living or dementia. Participants were excluded if they showed signs of moderate 
to severe overall cognitive decline as measured with the Mini-Mental State 
Examination (i.e., MMSE<24) (Folstein, Folstein, McHugh, 1974). Other exclusion 
criteria were absence of informed consent, psychiatric co-morbidity, co-existing 
somatic disorders if dominant to the MCI, severe concentration difficulties 
impeding communication, unable to communicate fluently in the Dutch language, 
lack of motivation to share experiences in a group, and evidence of severe, pre- 
existing partner relationship problems unrelated to the cognitive impairments. 
Procedure and assessment instruments 
Initial interviews were conducted at the hospital by a psychotherapist.  Information 
was given about the aims and topics of the group programme. Expectations from 
patients and their significant others were explored and unrealistic expectations 
were corrected if necessary. The interviews allowed the psychotherapist to 
determine the potential participants’ capability and interest in the group 
programme. At baseline (i.e., within two weeks before the start of the intervention) 
and within two weeks after the final tenth session, pre- and post-intervention 
assessment was carried out in the hospital. All participants completed self-report 
questionnaires, administered by a psychological assistant. The MCI patients also 
performed a neuropsychological screening. 
Cognitive impairment was estimated in the patients with the Mini-Mental State 
Examination (MMSE) (Folstein, Folstein, McHugh, 1974), which gives an overall 
impression of cognitive impairment. The Dutch version of the Rey Auditory Verbal 
Learning Test (van der Elst et al., 2005), was administered to assess verbal word- 
list learning. It consists of 5 trials in which 15 words are presented, followed by 
immediate recall. After a 20-minute delay, a delayed recall trial followed, as well 
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as a recognition trial in which the 15 words were presented among 15 distracter items..  
Distress was evaluated with the 15-item Geriatric Depression Scale (Hermann & 
Mittmann, 1996), which is rated on a 15-point scale and has a cut-off score of 5, 
with higher scores reflecting more depressive symptoms. The Dutch version of 
the RAND-36 health survey (VanderZee, 1996) was applied to assess general 
well-being including physical, social en emotional dimensions. We used five of 
the eight scales, i.e. Social Functioning, Role-Emotional, Mental Health, Vitality, 
and General Health. Each scale ranges from 0 to 100, higher scores reflect higher 
level of perceived health or well-being.
Acceptance and helplessness were measured with the Illness Cognition 
Questionnaire (Evers et al., 2001), which gauges the way patients cognitively 
adjust to their chronic condition. We used two of its three scales, i.e. Helplessness, 
the six items of which focus on the adverse aspects of the disease and generalizes 
them to daily functioning, and Acceptance, the six items of which assess the 
patients’ recognition of the need to adapt to their chronic disease and their ability 
to tolerate and manage its adverse consequences. The subscales range from 6 
to 24 with higher scores on Acceptance implying higher levels of acceptance, 
and higher scores on Helplessness reflecting more feelings of helplessness. 
Satisfaction with the partner relationship was assessed in the 21 spousal 
dyads with the Maudsley Marital Questionnaire (Arrindell 1983; Arrindell, 1985). 
We used one of its three subscales: the 10-item Emotional Satisfaction scale, 
which is an index of the respondents’ satisfaction with the emotional and 
communication aspects of their relationships. The subscale ranges from 0 to 80 
with higher scores implying higher levels of dissatisfaction.  
Alertness to memory failure and other changes was evaluated using the Dutch 
version of the Informant Questionnaire on Cognitive Decline in the Elderly – Short 
Form (Jorm & Jacomb, 1989; de Jonghe et al., 1997a). This 16-item list invites the 
significant other to rate the patient’s decline in memory as observed in their daily 
functioning. The partners and significant others also completed the Revised 
Memory and Behaviour Symptoms Checklist (Teri et al., 1992) reflecting their 
perception of the patient’s memory problems, depressive behaviour and 
behavioural problems. We also used the Informant Questionnaire on Cognitive 
Decline in the Elderly – Short Form as a self-assessment questionnaire for the 
patients, for which we adjusted the instructions slightly. 
The burden of care giving was assessed with the Sense of Competence 
Questionnaire (Vernooij-Dassen, Persoon, Freling, 1996). This questionnaire consist 
of three subscales: satisfaction with the MCI partner as the recipient of the care 
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(12 items), satisfaction with one’s own performance as a caregiver (7 items) and 
the implications of the involvement in the patient’s care for the caregiver’s 
personal life (8 items). In addition, the Hindrance scale of the Revised Memory 
and Behaviour Symptoms Checklist was used to measure to what extent the 
patients were affected by the observed behavioural problems (0 = not at all, 1 = 
a little, 2 = rather, 3 = very much).
Description of the intervention
Goals and principles 
The main goal of the current intervention was to elicit or strengthen adaptive 
behaviours in patients diagnosed with MCI and was based on principles from 
cognitive-behavioural therapy combined with psycho-educational elements. The 
programme included 10 weekly, 2-hour sessions with the group comprising 5 to 
8 patients, each with their accompanying significant other (i.e., partner, child or 
close friend). The focus of the programme was the acquisition of knowledge of 
and skills to adequately cope with MCI-associated symptoms and their 
consequences, learning to recognize memory problems in daily life and to explore 
explanations and attributions, communication with partner and others, and self-
regulation skills. Also, topics such as diagnostic uncertainty, dependency on 
others and stigmatization were discussed in relation to each theme. Appendix 1 
lists the themes and goals for each of the programme’s ten sessions. 
Structure 
To promote mutual support among the participating patients and between the 
patient and his/her significant others, we implemented the procedure described 
by Snyder (Snyder, 1995) in that in each 2-hour session the patients and their 
significant others were first assigned to two separate groups (a patient group and 
a significant others group), each with its own therapist. During the first 90 minutes 
of each session both groups explored the same topics and received similar (oral 
and written) information with relevant home assignments. For the remaining 30 
minutes the two groups were merged and the key issues from the preceding 
session were summarized and highlighted. Therapists in both groups were 
registered psychologists who were trained and supervised by the first author. 
Procedure of the intervention
Sessions began with a discussion of topical questions, problems or experiences 
the patients or their significant others put forward. In most cases it was possible 
to relate these topics to past, present or upcoming themes of the programme. 
Subsequently, the therapist introduced the theme of the current session.
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The participants were instructed to prepare the sessions with relevant texts 
selected from a patient handbook on coping with memory impairment that was 
specifically developed for this purpose (Joosten-Weyn Banningh, 2007). Each 
section was accompanied by questions about the session’s theme and self- 
monitoring tasks. Patients and partners were asked to monitor their thoughts, 
feelings and behaviour in situations of cognitive failure or stress, with the aim to 
reduce or prevent irrational and stress-inducing cognitions. 
The following topics were discussed: memory function in general, MCI as a clinical 
diagnosis, therapeutic possibilities, strategies to improve memory performance 
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Table 5.1   Goals and themes for each session of the MCI group intervention
Session Therapeutic aims Topics
1 · Introducing the programme and 
getting acquainted with each 
participant
· Preliminary explanations
· Getting to know each other
· Initial inventory of themes, 
key problems, cognitions and 
experiences 
2 · Improving knowledge about MCI 
and its symptoms 
· Acknowledging memory problems 
· Modifying invalid attributions 
· What does MCI mean?
· Naming the other symptoms 
besides memory deficits
· Exploring and modifying 
attributions
3 · Optimizing memory performance 
by changing memory behaviour. 
· How does memory work?
· Memory-enhancing strategies like 
the “errorless learning method”, 
internal and external strategies. 
4
5
6 · Recognizing and/or preventing 
stress 
· Adaptive, cognitive stress-coping 
and relaxation techniques (role 
playing)
7 · Recognizing alterations in 
recreational activities and
· Preventing the loss of these
· The importance of recreational 
activities in daily life 
8 · Acknowledging social conflicts
· Improving communication abilities
· Normalising disagreements 
· Managing disagreements and 
social conflicts (role-playing) 
9 · Decreasing worrying/rumination 
and anxiety
· Strategic problem solving 
10 · Evaluation of the attained goals · What did I learn and how should I 
proceed now that the programme 
has ended?
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(such as note taking and using a memory book), ways to recognize strain, learning 
to relax, the importance of pleasant everyday activities, and dealing with social 
conflicts and worrying. The participants were encouraged to recognize and 
cognitively restructure dysfunctional self-evaluations and negative social and 
unduly anxious cognitions. Special attention was paid to the acquisition or 
improvement of social skills; via role-playing patients learned how to discuss their 
memory problems and how to seek assistance in order to minimize the adverse 
social consequences of their symptoms. Pleasant activities were encouraged 
and patients learned to restructure their goals consistent with their new cognitive 
attributions. By sharing their reactions and thoughts, the participants learned that 
others in similar situations may show different and perhaps more adequate 
behaviour. Subsequently, the participants were asked how they felt about their 
responses. When they were satisfied, this sentiment was reinforced. If not, 
alternative responses were explored and practised via role playing. The separate 
sessions ended with an evaluation of the most important issues discussed and a 
summary of the thoughts and behaviours the participants decided to change. 
In the plenary part of the session, the respective therapists itemized the major 
topics and experiences from the separate sessions, after which the patients and 
significant others were invited to add their points. At the end of the plenary session 
the therapists briefly explained the theme of the subsequent session and the 
associated home assignments and handed the participants the relevant material. 
Statistical analyses
With respect to the differences between pre- and post-treatment outcome 
variables, we expected an improvement in both the patients and their significant 
others. All analyses on the primary outcome measures were thus performed 
using one-tailed Students’ paired t-tests. For the measures assessing the severity 
of the memory impairment we did not have any a-priori expectations with respect 
to the direction of change. Here, two-tailed paired-sample t-tests were applied. 
Comparisons between patients and significant others were performed using 
two-tailed independent t-tests.
As an index of post-intervention change, effect sizes (Cohen’s d) were computed 
based on the difference between the pre- and post-intervention means and the 
pooled variance (Cohen,1988). Post-intervention change was correlated with the 
characteristics of the participants (i.e., age, education level, sex, as well as 
cognitive status for the patients) using Pearson product moment correlation 
coefficients (two tailed). 
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Results
Participants
Thirty-two patients and their significant others were informed about the MCI 
group intervention by their consultant geriatricians or neurologists after they 
received the diagnosis; they were contacted by phone and invited to our research 
centre for an intake interview. Twenty-three patients (13 women; 10 men) were 
willing to participate. Often mentioned reasons for non-participation were: I have 
no partner who can accompany me; I do not want to ask anybody to do this for 
me; I do not want to be in a group; I do not want to be confronted with my memory 
problems; I do not experience many problems other than my memory impairment; 
It is part of getting older, and It’s too much of a burden right now.
Four intervention groups were composed including 7, 5, 5 and 6 patients and their 
significant others, respectively. Of the 23 patient-significant others pairs 21 were 
husband-and-wife dyads, one patient was accompanied by her sister and one by 
a close friend. The groups totalled 25 women and 21 men. The average age of the 
participants was 69.5 years (sd=7.3; age range 52- 84 years). Mean educational 
level as rated on a 7-point scale (Verhage, 1964; Hochstenbach, 1998), with 1 
being the lowest, i.e. less than primary school (< 6 years of education), and 7 the 
highest, i.e. a university degree (> 13 years of education) was 4.7 (sd=1.0) with 
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Table 5.2   Sociodemographic and clinical characteristics of all participants 
to the MCI group intervention
MCI patients
(n=23)
Significant others
(n=23)
Age (yrs) 68.7 (7.9) 70.4 (6.8)
Education level (1-7) 4.7 (1.0) 4.4 (1.0)
Sex
Female N (%)
Male N (%)
13 (56)
10 (44)
12 (52)
11 (48)
Married N (%) 21 (91) 21 (91)
MMSE 26.7 (2.2)
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levels 5 and 6 being more prevalent (n=27) than the levels 2 and 3 (n=4). 
Pre-treatment group comparison
Pre-treatment comparisons of characteristics of the patients and their significant 
others outcomes showed that patients rated their health lower than their significant 
others (t(42) =-2.383 p<0.05). Compared to the significant others, trends were 
found for lower patient ratings on acceptance (Illness Cognition Questionnaire; 
acceptance, t(42) =-1.821 p=0.08) and memory changes (Informant Questionnaire 
on Cognitive Decline in the Elderly – Short Form, t(42)= -1.761 p=0.09).  
Attendance and dropout rates
One couple dropped out after the fourth session because of medical complications 
(i.e., the patient had suffered a severe cerebral vascular accident). Of the 
remaining 42 participants, 30 participants attended all sessions, 7 participants 
failed to attend one session and 6 participants missed two or more sessions. 
Post-treatment outcomes 
The effects of the intervention are presented in Table 5.3. Neither for the MCI 
group nor for the significant others group did we find any significant pre-post-
treatment changes on the distress measures. With respect to illness cognition, 
the MCI group showed a significant change on the Acceptance subscale of the 
Illness Cognition Questionnaire, whereas the significant others group showed no 
pre-post-treatment improvement. The effect size (0.30) reflects a moderate 
difference (Cohen, 1988). The Maudsley Marital Questionnaire revealed a trend 
for an increased satisfaction with their marital relationship compared to the 
pre-treatment measurement. The effect size (0.24) reflects a small change 
(Cohen, 1988). The significant others’ ratings showed no significant changes. On 
the Informant Questionnaire on Cognitive Decline in the Elderly - Short Form 
patients reported a decrease in the alertness to their symptoms after therapy 
(effect size: 0.48) with a reverse, yet small effect for the significant others (effect 
size: IQCODE: -0.19, RMBPC frequency of memory problems: -0.31). This 
indicates that the patients experienced less memory problems after the 
intervention than before treatment, while the significant others reported an 
increase in the patient’s memory and behavioural problems. The pre-post 
comparisons of the MMSE and the Rey Auditory Verbal Learning Test did not yield 
any changes for memory impairments. In addition, no significant differences were 
found on the Sense of Competence Questionnaire and the subscale Hindrance of 
the Revised Memory and Behaviour Symptoms Checklist. 
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Table 5.3   Means (+ SD) and effect sizes (Cohen’s d) for the MCI group and 
their significant others
Patients  (n=23) Significant others  (n=23)
Variable Pre Post d Pre Post d
MMSE 26.7 (2.2) 26.7 (1.9) 0.00
RAVLT
Total score 29.2 (7.1) 28.4 (7.1) 0.11
Delayed recall 3.4 (2.7) 4.5 (3.6) -0.29
GDS-15 3.6 (2.8) 4.5 (3.6) -0.28 2.4 (2.5) 2.5 (3.1) 0.04
RAND-36 
Social functioning 79.8 (18.7) 75.6 (18.7) 0.22 80.7 (22.7) 82.4 (17.1) -0.08
Role-emotional 63.6 (41.0) 66.7 (37.1) -0.08 89.4 (29.8) 83.3 (30.4) 0.20
Mental Health 70.7 (14.7) 69.8 (14.2) 0.06 72.9 (18.0) 71.1 (21.9) 0.1
Vitality 58.0 (19.1) 56.4 (18.3) 0.09 64.3 (19.2) 62.0 (21.3) 0.2
General health 61.8 (13.4) 66.1 (17.2) -0.28 70.2 (17.0) 64.3 (17.9) 0.34
ICQ
Helplessness 10.5 (2.4) 10.3 (2.5) 0.08 9.7 (2.7) 9.9 (3.0) -0.07
Acceptance 14.0 (4.6) 15.4 (4.6)** -0.30 18.1 (5.1) 17.8 (4.7) 0.05
MMQ Marital 
satisfaction
12.0 (9.2) 10.0 (7.9)* 0.24 16.3 (12.4) 16.5 (14.3) -0.01
IQCODE-N 58.9 (6.2) 55.2 (8.8)** 0.48 62.9 (8.8) 64.6 (9.1)** -0.19
RMBPC
Memory - Frequency 13.1 (4.6) 14.6 (5.1)** -0.31
Memory Hindrance 5.8 (3.8) 5.4 (3.3) 0.11
Problem - Frequency 3.3 (2.4) 4.3 (3.0)** -0.37
Problem Hindrance 2.5 (2.2) 3.3 (2.9) -0.28
Depression Frequency 7.5 (4.6) 7.8 (4.3) -0.05
Depression Hindrance 6.6 (5.5) 6.5 (5.8) 0.016
SCQ
Self 40.1 (9.9) 41.6 (9.5) 0.09
Patient 20.05 (5.1) 19.5 (7.3) -0.15
Personal life 23.7 (12.5) 26.9 (7.37) -0.31
MMSE = Mini Mental State Examination; RAVLT = Rey Auditory Verbal Learning Test; GDS-15 = 
Geriatric Depression Scale; RAND-36 = RAND Health Survey; ICQ = Illness Cognition Questionnaire; 
IQCODE-N = Informant Questionnaire on Cognitive Decline in the Elderly - Dutch version; RMBPC = 
Revised Memory and Behavioural Problems Checklist; SCQ = Sense of Competence Questionnaire
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Correlations between participant characteristics and the change 
measures 
In the patient group, a significant negative correlation was found between the 
Acceptance scale of the Illness Cognition Questionnaire and educational level 
(r=-0.50; p=0.018, two-tailed), indicating that lower levels of education were 
related to higher levels of acceptance. We also found a trend for a negative 
correlation between the subscale Acceptance and the delayed free recall score 
on the Rey Auditory Verbal Learning Test (r=-0.37; p=0.09). This indicated that 
higher post-treatment acceptance levels were related to a lower memory 
performance. Finally, the increase in the significant others’ perceptions of the 
patients’ memory problems was associated with lower pre-treatment memory 
performance (Rey Auditory Verbal Learning Test -delayed recall) in the patient 
group (r=0.38, p=0.02). 
Discussion
The preliminary results of our programme in a total cohort of 23 patients and their 
significant others, showed various beneficial effects in the patients. Most notable 
were the effects on acceptance of their memory problems and the positive trend 
for marital satisfaction in the MCI group. The acceptance effect proved related to 
the patients’ educational level and their pre-treatment memory performance: 
lower education level and lower baseline memory scores were associated with 
more positive change in acceptance. The finding that our intervention helped 
patients to accept the symptoms of their condition better is crucial in the light of 
optimizing everyday adaptation to their memory impairment. It can be 
hypothesized that acceptance of memory problems is only possible if patients 
are aware of the memory problems. Awareness has been found to be an important 
predictive variable of treatment success in patients with dementia undergoing 
various types of therapy (Clare et al., 2005; Bahro, Silber and Sunderland, 1995). 
For many patients, MCI signifies the very early stages of dementia in which they 
are still able to learn to adapt to their current disabilities as well as prepare for the 
impending aggravation of their symptoms. The distress and helplessness 
measures showed no changes after treatment, neither for the patients nor for their 
significant others. However, scores on both Helplessness and the GDS distress 
measure were already at a floor level before treatment, indicating that further 
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reduction was not possible.
In line with our expectations, we found an increase in the significant others’ 
alertness of their partners’ mnemonic and behavioural problems, while the 
patients’ objective memory performance outcomes had not changed. Since a 
measurable decline of the memory performance was not expected during the 
three-month period of the intervention, the increased awareness by the significant 
others of memory problems in the patients may reflect a change in the perception 
of the significant others.  During the sessions they have learned to observe the 
changes in their partners’ memory performance in more detail by means of 
monitoring exercises, raising their alertness of existing problems. Consequently, 
they may recognize memory failure or behavioural changes in the MCI patient 
sooner or better. On the basis of the effects sizes we have found in the current 
study, and a power of 0.8, we estimate the number to treat in a case-control study 
at approximately 70 patients and controls (Dupont and Plummer, 1988). 
The fact that distress was never mentioned as a motive for participation may 
explain the low overall levels of distress we have found in our sample. The low 
dropout rate indicates that all participants were highly motivated to attend our 
psychotherapeutic programme, and the high compliance rates reflects their 
eagerness to adhere to the conditions and ingredients of the programme. The 
lack of additional changes in the significant others may indicate that the 
programme was perhaps not optimally adjusted to their situation. The current 
MCI group was made up of different subtypes, contributing to its heterogeneous 
features and resulting in different symptoms (Alladi et al., 2006). Apart from 
memory deficits, impairments in executive or language functions are likely to be 
prevalent in some MCI patients and may have different consequences, which are 
not explicitly taken in account in the programme. The relationships between 
treatment effects and patient characteristics should therefore be explored in a 
larger sample. Longer-term follow-up assessments are also recommended, 
because with its preventive features, any beneficial effects of the present 
intervention may especially be expected to occur in the long term. Finally, we 
must emphasize the explorative character of the study and the lack of a control 
group. In conclusion, the cognitive behavioural group therapy we have developed 
for patients with mild cognitive impairments and their significant others is 
promising, in that we found a moderate increase in the patients’ acceptance of 
their condition and a positive trend for increase of marital satisfaction. These 
preliminary findings justify the continuation and further implementation of the 
intervention, as well as a formal case-control evaluation.
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Part III  Efficacy of the intervention
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Abstract
Background: Patients with Mild Cognitive Impairment (MCI) have to deal with an 
uncertain prognosis and also face a multitude of memory related problems and 
psychosocial consequences. A newly developed group programme proved to be 
feasible, however, it needed confirmation by a controlled study. 
Aim: This controlled study evaluates this group therapy for MCI patients aimed to 
help them accept and manage the memory problems and the psychosocial 
consequences. The programme combines elements from psychoeducation, 
cognitive rehabilitation and cognitive behavioural therapy.
Participants and methods: Ninety-three MCI patients received treatment, with 
30 patients being first assigned to a waiting list, thus serving as their own control 
group. Pre- and post-treatment acceptance and helplessness were assessed 
using subscales of the Illness Cognition Questionnaire (ICQ), while distress and 
general well-being were gauged with the Geriatric Depression Scale (GDS) and 
subscales of the RAND-36. 
Results: Linear mixed model analyses showed that, relative to the controls, 
acceptance had increased more in the intervention group compared to the 
waiting-list period (p=0.034). Distress and general well-being showed no 
changes. Treatment responders demonstrating a clinically significant effect on 
acceptance and two of three secondary outcome measures had higher baseline 
levels of helplessness and fewer self-reported memory complaints in daily life 
than patients who did not improve. 
Conclusion: The intervention helped the patients deal better with their uncertain 
future in that they were overall better able to accept their condition, with especially 
the female patients showing a decrease in helplessness cognitions, although the 
effects were relatively small. 
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Introduction
Mild cognitive impairment (MCI) is characterized by cognitive deficits in the 
context of normal daily functioning (Petersen, 2004; Petersen & Negash, 2008). It is a 
known risk factor for the development of dementia, with prospective longitudinal 
studies reporting annual MCI-dementia conversion rates of 6% to up to 25% 
(Panza et al., 2005; Feldman & Jacova, 2005). These rates also imply that for a 
large proportion of MCI patients the progression of their illness is uncertain, and 
that the diagnosis may, rather than diminish their feelings of uncertainty, even 
exacerbate them. Although MCI patients can by definition still function independently 
in everyday life, they do encounter a multitude of difficulties because of the mild 
cognitive changes, inducing profound stress, which, in turn, causes more 
practical, social and psychological problems (Joosten-Weyn Banningh et al., 
2008a; Lingler et al., 2006). In line with these findings, Hwang et al. (Hwang et al., 
2004) showed that the incidence of mood disorders, such as dysphoria, anxiety, 
restlessness or irritability, was higher in MCI patients than in healthy age-matched 
controls. To date, there is no targeted pharmacological treatment for MCI, but 
there is increasing evidence supporting an important role of non-pharmacologi-
cal interventions in diminishing distress or disturbed behaviour in early dementia. 
Such interventions commonly combine elements from cognitive training, neuro-
psychological rehabilitation with occupational therapy, psychoeducation and 
psychotherapy (Spijker et al., 2008). While psychoeducation and psychotherapy 
are predominantly offered to the patients’ caregivers, recent studies in patients 
with early dementia have shown that these therapeutic interventions are also 
feasible and effective in the patients themselves (Joosten-Weyn Banningh et al., 
2008b). Furthermore, in a meta-analysis of psychosocial interventions for 
dementia, Brodaty et al. (Brodaty et al., 2003) found that success was more likely 
if both the patients and the caregivers were actively involved in the programme. 
Since MCI typically is a chronic condition, for some reflecting the early stage of 
dementia, it is crucial to support the patients in the actual problems they encounter 
in daily life and to prepare them for future difficulties. Although an earlier Cochrane 
Review (Clare et al., 2003) did not find support for the use of cognitive rehabilitation 
and training interventions in patients with MCI, a recent review (Belleville, 2008) 
reported positive findings for such programmes in six of the seven studies 
evaluated. In this review, it was recommended to combine cognitive training with 
interventions addressing psychosocial, attributional or self-regulatory factors. 
Although dedicated psychotherapeutic interventions for MCI are lacking, equipping 
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patients with strategies to cope with the demands of the condition in an early 
stage of a chronic disease are thought to lie at the heart of self-management 
(Mountain, 2006; Vernooij-Dassen & Moniz-Cook, 2005). In a study on the 
adaptation process in patients after the onset of Alzheimer’s disease, a balanced 
struggle with acceptance in order to integrate the changes with the patients’ 
identities was reported (Clare L., 2002). Here, illness acceptance was described 
as the outcome of a gradual process in which denial of the symptoms and facing 
them are interchanged in order to keep the previous “sense of self”. In patients 
with chronic conditions, illness acceptance can be described as the acceptance 
of loss, the ability to tolerate the unpredictable and uncontrollable nature of the 
disorder, and coping with the aversive consequences (Evers et al., 2001). A 
growing body of studies highlight the role of illness cognitions in the adaptation 
process and provide evidence that acceptance is related to increased 
psychological well-being and higher quality of life. In addition, acceptance can 
be increased by psychoeducation  about the illness and the adaptations to the 
consequences of the illness in the personal life (Karademas et al., 2009).
In a previous pilot study on 22 MCI patients, we introduced and tested the 
feasibility of a newly developed psychotherapeutic intervention for MCI patients 
and their partners (Joosten-Weyn Banningh et al., 2008b). We based our 
intervention on principles from cognitive-behavioural therapy (CBT) and combined 
these with psychoeducational and memory-rehabilitation elements. We choose 
CBT as the psychotherapeutic method, because CBT has been found feasible for 
MCI patients (Kipling et al., 1927) and has been successfully applied in other 
cognitively impaired patient groups (Kraus et al., 2008) (Teri et al., 1997). The pilot 
study showed the programme to be applicable in this population, yielding 
promising results, with the programme contributing to the patients’ acceptance of 
their memory impairment and showing a trend for increased marital satisfaction. 
The acceptance effect was related to the patients’ educational level and their 
pre-treatment memory performance: lower levels of education were associated 
with a greater positive change in acceptance. Moreover, the high attendance 
rates suggested that the intervention clearly fulfilled a need for assistance and 
information felt by many MCI patients. However, the study lacked a control group, 
limiting the value of our findings. Also, the intervention had not diminished the 
level of self-reported distress, although we suggested this was because of the 
already low pre-treatment levels. 
The main aim of the current study was to demonstrate the effectiveness of our 
group CBT programme for MCI patients and their partners/caregivers in a 
CHAPTER 6
87
controlled design and in a larger patient sample. Based on our pilot data and 
other empirical evidence suggesting that acceptance plays a crucial role in 
coping with chronic medical conditions, we adopted ‘acceptance’ as the primary 
outcome measure in the current trial. We hypothesised that this variable would 
increase significantly more after the intervention compared to a waiting-list 
period. Since patient characteristics such as age, sex, and educational level may 
sometimes be more important than disease-related variables (Heijmans, 2004), 
we also explored the changes in acceptance in relation to six pertinent patient 
factors, i.e. age, sex, educational level, cognitive status, coping behaviour, and 
perceived social support. In addition, we evaluated well-being, distress and 
feelings of helplessness, expecting helplessness to be reduced due to the psy-
choeducation and coping strategies offered in the programme. Since the primary 
outcome measures, the nature of the experienced difficulties with the MCI 
diagnosis and the expected coping mechanisms differ between the patients 
themselves and the significant others, we report the findings of the latter group in 
a separate paper. 
Methods
Patients 
Between September 2003 and December 2007 eligible MCI patients and their 
significant others from four regional outpatient memory clinics in the east of the 
Netherlands offering the treatment were recruited (i.e., Radboud University 
Nijmegen Medical Centre and three general hospitals, viz. ‘Maasziekenhuis 
Pantein’ in Boxmeer, ‘Rijnstate’ in Arnhem and ‘Slingeland’ in Doetinchem). 
Inclusion criteria were an MCI diagnosis, that is, amnestic MCI, non-memory 
single-domain MCI or multiple-domains MCI (Petersen & Negash, 2008), age 
over 50 years, and the availability of a partner/spouse, relative, or close friend 
willing to participate in the study. In all four participating centres MCI was 
diagnosed using a multidisciplinary approach supervised by a geriatrician or 
neurologist, according to generally accepted criteria described by Petersen 
(Petersen, 2004; Petersen & Negash, 2008). This approach consisted of a 
thorough clinical interview with the patient dyads, supported by an extensive 
 neuropsychological assessment, neurological and radiological findings and 
assessment of activities of daily living. Performance on the neuropsychological 
tests was rated as falling within the normal range, below average, or impaired as 
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based on available age- and education-adjusted normative data, with performance 
between 1 SD below or above the normative mean being defined as normal, 
between –1 SD and –1.65 SD below the normative mean as below average, and 
more than –1.65 SD below the normative mean as impaired (Berg van den et al., 
2005). The MCI criteria were met if a patient’s performance was impaired in one 
of the cognitive domains, or if more than one cognitive domain showed his/her 
performance to be below-average, all in the absence of a decline in activities of 
daily living or dementia. Instrumental activities of daily living were assessed using 
validated rating scales (such as the Lawton Instrumental Activities of Daily Living 
Scale (Lawton & Brody, 1969) and/or by structured observation of daily-life 
activities by an occupational therapists (either in the patient’s home environment 
or in the outpatient clinic). The clinical diagnosis was decisive in cases in which 
the neuropsychological performance outcomes did not correspond with the 
clinical impression. Participants were excluded if they fulfilled the criteria for 
dementia. Other exclusion criteria were the absence of informed consent, the 
presence of psychiatric comorbidity, co-existing somatic disorders if dominant to 
MCI, severe concentration difficulties impeding communication, inability to 
communicate fluently in Dutch, lack of motivation to share experiences in a group, 
and evidence of severe, pre-existing partner relationship problems unrelated to 
the cognitive impairments. 
Study design and procedure
The study had a naturalistic, non-randomized, waiting-list controlled design, with 
all eligible patients receiving the group treatment either within eight weeks of their 
recruitment or after having first spent eight weeks or more on a waiting list (waiting 
for a new intervention group to begin). The patients receiving treatment within 
eight weeks of the intake interview, the ‘intervention-only’ group, were first 
assessed in the two weeks prior to their treatment (T1) and within two weeks after 
treatment completion (T2). When the time to the start of the next group intervention 
was more than eight weeks, patients were assigned to a waiting list, serving as 
our control group, at the start of which period they took a baseline assessment 
(T0), with their pre-treatment (T1) test also scheduled within two weeks before the 
start of their group and the post-treatment test within two weeks after treatment 
completion (T2). To maximize the statistical power, the total intervention group we 
report here is hence composed of patients having received ‘immediate’ treatment 
and those having received treatment after a waiting-list period. 
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The patients meeting the inclusion criteria were informed about the group 
intervention programme by their geriatricians or neurologists. Interested patients 
were subsequently invited with their significant others for an interview with a psy-
chotherapist at their local hospital, who explained them the aims and content of 
the group programme and obtained their written, informed consent. By exploring 
the expectations the patients and their significant others had of the programme, 
which were corrected when these were unrealistic, the therapist estimated the 
participants’ potential capability and interest in the group programme. All 
subsequent assessments were conducted by trained psychology (research) 
assistants of the hospital delivering the intervention. Patients received no other 
psychosocial or medical intervention for their cognitive impairment during the 
waiting list or intervention interval. 
Demographic variables and patient characteristics
Demographic variables, such as age, sex, marital status and education level, 
were assessed with a general checklist. Participants rated their educational level 
on a 7-point scale with 1 reflecting less than primary school (<6 years of 
education), and 7 a university degree (Bachelor degree and up: >14 years of 
education) (Verhage, 1964; Hochstenbach , 1998).
In the patients overall cognitive impairment was estimated with the Mini-Mental 
State Examination (MMSE) (Folstein et al., 1975), which gives an overall impression 
of the cognitive decline. Memory function was assessed with the Dutch version of 
the Rey Auditory Verbal Learning Test (Elst van der et al., 2005), which requires 
the participant to recall 15 orally presented words in 5 trials, immediately after 
their presentation and after a 20-minute delay, followed by a recognition trial in 
which the 15 words are presented among 15 distracter items. Since the delayed 
recall measure is an early predictor of cognitive decline (Salmon & Bondi, 2009; 
Salmon & Lange, 2001; Welsh et al., 1991), we used this measure as an index of 
episodic memory performance.  
Coping was assessed with two subscales of the Utrecht Coping List (UCL) 
(Scheurs et al., 1993) gauging active and passive coping strategies when dealing 
with everyday problems. The 7-item Active Coping subscale evaluates cognitive 
and behavioural efforts to apply goal-oriented problem solving strategies and the 
8-item Avoidance subscale cognitive and behavioural attempts to avoid, escape 
from and acquiesce when facing everyday problems. 
Subjective memory decline was investigated by having the patients complete the 
16-item Dutch patient version of the Informant Questionnaire on Cognitive Decline 
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in the Elderly (IQCODE-N-Pt) (Jonghe de & Schmand, 1997b; Clare et al., 2005; 
Isella et al., 2006; Jorm & Jacomb, 1989) whose instructions were slightly adjusted 
(Joosten-Weyn Banningh et al., 2008). The respondent rates his/her memory 
decline in daily life relative to his/her daily memory functioning about ten years 
before, on a 5-point scale ranging from ‘Much improved’, (1 point) to ‘Much worse’ 
(5 points) with a score of 3 reflecting ‘No change’. 
Social support in the past two weeks was evaluated with the 12-item Social 
Support List, Interaction version (SSLI-12), an inventory designed for use in elderly 
people, which consists of three 4-item subscales: Everyday social support 
(SSLI-EV), Social support in problem situations (SSLI-PR), and Esteem support 
(SSLI-EST) (van Eijk et al., 1994).
Outcome measures
Acceptance was the primary outcome measure and assessed with the Illness 
Cognition Questionnaire (ICQ) (Evers, 2001), which assesses the way patients 
cognitively adjust to their chronic condition. Acceptance is one of its three 
subscales and has six items that assess the patients’ recognition of the need to 
adapt to their chronic disease and their ability to tolerate and manage its adverse 
consequences. (e.g., ‘I have learned to live with my memory problems’; ‘I think I 
can handle the problems related to the memory problems, even if they get worse’.) 
The subscale scores can range from 6 to 24 with higher scores reflecting more 
cognitions of acceptance. 
Distress was evaluated as one of three secondary outcome measures by means 
of the 15-item Geriatric Depression Scale – Short Form (GDS-15) (Hermann & 
Mittmann, 1996), with higher scores reflecting more depressive symptoms (with 5 
being the cut-off score for depressive symptoms). 
General well-being was assessed using the Dutch version of the RAND-36 
Health Survey (van der Zee et al., 1996), which measures physical, social and 
emotional dimensions. We used four of the eight scales, i.e. Social Functioning, 
Role-Emotional, Mental Health, and Vitality. Each scale ranges from 0 to 100, with 
higher scores reflecting higher levels of perceived health or well-being.
Helplessness was evaluated with the same-named subscale of the Illness 
Cognition Questionnaire (ICQ) (Evers et al., 2001), which focuses on the adverse 
aspects of the disease and generalizes them to daily functioning. The 6-item 
subscale ranges from 6 to 24, with higher scores reflecting more feelings of 
helplessness.
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Intervention
The intervention consisted of ten weekly 2-hour group sessions and was based 
on CBT principles combined with psychoeducational and memory rehabilitation 
elements. The programme and procedures have been extensively described 
elsewhere (Joosten-Weyn Banningh et al., 2008b). Each group comprised 5 to 8 
patients all accompanied by a significant other, i.e., a partner, adult child, relative 
or close friend. The focus of the programme was the acquisition of knowledge of 
and skills to adequately cope with MCI-associated symptoms and their 
consequences. Slight adjustments in the CBT method, like shortening of verbal or 
written instructions, repeating important information or personal goals and using 
of reminder cues, requiring the patient to make notes, or simply repeating the 
on-going discussion, were made because of the cognitive impairments of the 
patients (Kraus et al., 2008; Kinney, 2001). The therapists delivering the treatment 
were all registered psychologists trained and supervised by the first author. 
To promote mutual support among the participating patients and between the 
patients and their significant others, we implemented the procedure described by 
Snyder (Snyder et al., 1995) in that the first 90 minutes of each 2-hour session the 
patients and their partners participated in separate groups, that is, a patient and 
a ‘partner’ group, each with its own therapist, both groups exploring the same 
topics and receiving similar (oral and written) information with relevant home 
assignments. For the remaining 30 minutes the two groups came together and 
the key issues from the preceding session were summarized and highlighted. 
Participants learned to optimize internal and external memory strategies, to 
recognize memory problems in daily life and to explore their explanations and 
attributions, improve the communication with their partner and others and train 
self-regulation skills. Topics such as diagnostic uncertainty, dependency on 
others and stigmatization were discussed in relation to each theme. All participants 
were instructed to prepare each session with relevant texts and self-monitoring 
tasks. The patients were asked to monitor their thoughts, feelings and behaviour 
in situations of cognitive failure or stress, with the aim to reduce or prevent 
irrational and stress inducing cognitions. The following topics were addressed: 
memory function in general, MCI as a clinical diagnosis, therapeutic possibilities, 
strategies to improve memory performance (such as note taking, errorless 
learning and using a memory book), ways to recognize strain, learning to relax, 
the importance of pleasant everyday activities, and dealing with social conflicts 
and worrying.  
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Statistical analyses
Baseline differences between the waiting-list group and the intervention only 
group were analysed by independent-samples t-tests. To analyse changes in the 
two dependent distress variables and the two illness cognition outcomes following 
the waiting-list and intervention interval, we applied a linear mixed model (LMM) 
for repeated measurements. We opted for LMM because this approach, in 
comparison to repeated-measures analysis of variance, does not require data to 
be present at each assessment time point for a participant to be included in the 
statistical analysis whilst at the same time accommodating the dependency 
caused by repeated measurements. In the outcome variables, differences 
between T0 and T1 (change after waiting-list interval), and between T1 and T2 
(change in intervention interval) were calculated and used as repeated measures 
with interval (2 levels), group (17 levels), sex (2 levels) and their first-order 
interactions as fixed factors. We included sex as a fixed factor because we 
assumed it might be an important factor, influencing outcome. To correct for 
potential group effects, we introduced Group as a fixed factor into the analysis. 
Interval (T0-T1 vs. T1-T2) was entered as a within-subject variable. We used the 
procedure MIXED from the SPSS package (version 14).
The power calculation we ran in our pilot study had indicated that approximately 
70 patients were required to reach a power of 0.8, with a significance level of 0.05 
(Joosten-Weyn Banningh et al., 2008) 
Finally, we performed an exploratory responder analysis to describe the charac-
teristics of the patients who had benefited (most) from the intervention. To this 
end, patients were categorized as responders when we obtained an effect size > 
0.2 in the intervention interval on ICQ Acceptance, the primary outcome, and an 
effect size of at least > 0.2 on two of the other three secondary outcome measures 
(GDS-15 Distress, RAND-36 General well-being and ICQ Helplessness). Effect 
sizes (Cohen’s d) were computed based on the differences between pre- and 
post-intervention means and the pooled variance (Cohen, 1988). Following 
Cohen, we took an effect size of 0.2 to reflect a small but significant clinical effect. 
The participants not meeting these criteria were categorized as non-responders. 
Differences between the effect sizes of the two conditions, were tested with 
Students t-test. For the group comparison of the patient characteristics obtained 
at T1 (pretreatment) we used an ANOVA in which responder group is the grouping 
variable and the patient characteristics data the dependent variables.
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Results
Ninety-six MCI patients expressed an interest to participate in our trial and were 
included (see Figure 6.1 for a trial overview). 
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Figure 6.1   Trial overview 
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The intake of 33 dyads took place more than 9 weeks before the start of a new 
intervention group and they were hence first placed on the waiting list, constituting 
our control group, with three dyads dropping out after the baseline (T0) 
assessment because of medical illness (1) or lack of time (2). The other 63 
patients started treatment within 8 weeks of their intake interview, accordingly 
constituting the ‘intervention only’ group. Thus, a total of 93 patients, viz. 30 
patients from the waiting-list group and 63 patients from the ‘intervention only’ 
group, were assessed at T1 (pretreatment). The intervention only group was twice 
the size of the control group due to the variability in the flow of referrals in the four 
participating hospital and the study schedule. Of the final intervention group 
(n=93) no post-treatment (T2) data were available for 6 patients who left the 
treatment prematurely. Reasons for discontinuation were the occurrence of 
serious medical problems unrelated to the MCI (n=4) and loss of motivation 
(n=2). The patients dropping out did not differ from the completers with respect 
to the patient characteristics and baseline outcomes, although relatively more 
dropouts lived alone. Thus, the data of 87 patients entered the LMM analyses.
Baseline patient characteristics
Table 6.1 lists the patients’ baseline data for the two study groups (T0 and T1, 
respectively). Between-group comparisons revealed no significant differences 
in their demographics (age, education, relationship to study partner), main 
 characteristics (MMSE, coping style, social support, and subjective memory 
deterioration) nor primary or secondary outcomes, measured at baseline.
Treatment effects
Table 6.2 shows the means of the outcome measures at pre and post treatment 
assessments and the effect sizes for the patients in the waiting-list and the 
intervention intervals. 
The LMM analysis revealed a significant difference between the two conditions 
for our primary outcome measure of Acceptance (F(1, 63.8) = 4.7, p=0.034) with 
an estimated difference between the two conditions of 3.49 and a 95% confidence 
interval ranging from -6.21 to -.73 (df=73.1, p=0.014).  Estimated mean changes 
for Acceptance are  -0.99 (SE=0.9) in the waiting-list interval and 1.2 (SE=0.4) in 
the intervention interval.
This reflects an increase in pre-to-post Acceptance during the intervention interval 
relative to the values obtained during the waiting-list interval, with effect sizes 
of at least 0.2 being obtained for 51% of the patients. As to the secondary 
chapter 6
95
measures, Helplessness showed an interaction effect between intervention and 
sex (F(1, 80.9) = 4.95, p=0.029), while no main effects were found for Distress 
(F(1, 45.3)=0.93, p=0.34) and General well-being (F(1, 44.6)=0.08, p=0.78).  
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Table 6.1   Baseline characteristics of the patients in the two study groups 
Waiting-list group
n = 30
Intervention only 
group
n = 63
p
Demographics
Age 69.4 (7.2) 70.5 (7.0) 0.51
Education (1=low,  7=high) 4.9 (1.2) 5.0 (1.1) 0.78
Sex*
Male
Female 
             14 (47%)
             16 (53%)
             34 (53%) 
             29 (47%)
MMSE 25.8 (3.9)           25.6 (3.2) 0.86
Type of partner*
Married / living together
Living apart
Daugther / sister
             27 (90.0%)
               3 (10.0%)
               0
             57 (90.4%)
               1 (1.6%)
               5 (8.0%)
0.65**
Patient characteristics
RAVLT - Delayed recall
SSLI- EV
SSLI- PR
SSLI- EST
UCL- active coping
UCL- passive coping
IQCODE-N-Pt
2.9 (3.5)
10.3 (1.8)
9.6 (2.5)
9.4 (2.7)
15.6 (4.7)
16.7 (3.7)
58.1 (7.2)
2.7 (2.2)
10.8 (1.9)
9.1 (2.8)
9.5 (2.9)
16.8 (3.4)
17.0 (3.3)
57.2 (8.5)
0.79
0.29
0.41
0.88
0.17
0.70
0.63
Dependent variables  
GDS-15 (cut-off = 5)
GDS-15 > 5 (%)
RAND-36
ICQ Acceptance
ICQ Helplessness
3.6 (2.8)
16.7%
261.7 (73.3)
13.4 (4.0)
10.2 (2.2)
3.0 (2.2)
14.5%
287.0 (65.4)
13.5 (4.0)
11.2 (3.1)
0.27
0.10
0.90
0.12
Note: MMSE=Mini Mental State examination; RAVLT=Rey Auditory Verbal Learning Test; SSLI=Social 
Support List Interaction version, EV=everyday social support; PR=social support in problem situations; 
EST=esteem support; UCL=Utrecht Coping List; IQCODE-N-Pt= Informant Questionnaire on Cognitive 
decline in the Elderly-Dutch patient version; GDS-15= Geriatric Depression Scale–Short Form; 
ICQ=Illness Cognition Questionnaire Acceptance and Helplessness scale. Data represent means (sd) 
or * numbers of patients; All p-values refer to student t-tests, except ** Mann Whitney U test
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Table 6.2   Effect sizes (ES) with standard deviations (SD) and means with 
standard deviations (SD) in the outcome measures 
Outcome 
measure
Mean ES
waiting-list
interval 
(SD)
Mean ES 
intervention 
interval
(SD)
T=0
N=30
T=1
N=93
T=2
N=87
GDS-15 0.16 (0.9) -0.04 (1.0) 3.57 (2,8) 3.05 (2.3) 3.11 (2.6)
RAND 0.14 (0.7) 0.12 (0.3) 261.7 (73.3) 281.6 (68.2) 282.2 (75.9) 
Acceptance 0.08 (0.8) 0.34 (0.9) 13.40 (4.0) 13.62 (4.3) 15.25 (4.7)
Helplessness 0.03 (0.8) 0.23 (0.9) 10.20 (2.2) 10.89 (2.9) 10.29 (2.9)
GDS-15: Geriatric Depression Scale–Short Form
Figure 6.2   Mean acceptance score (+ SEM), for the waitinglist and the 
intervention only group 
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To explore the possible confounding effect of the waiting-list interval on the 
subsequent intervention, the means of the acceptance at the three assessment 
moments for the waiting-list group and the intervention only group are shown 
separately in Figure 6.2. No statistical differences were found between the inter-
vention-only group and the waiting-list plus intervention group at either T1 
t(89)=1.09, p=0.91 or T2 t(86)=1.33, p=0.19, indicating that the effect in the 
participants who were assigned to the waiting-list interval before receiving the 
actual intervention did not show a differential effect compared to the group who 
received the intervention immediately after recruitment.  
Table 6.3 lists the mean change in Helplessness as a function of sex, revealing an 
inverse direction for the two intervals for the female patients, reflecting a decrease 
in helplessness following the intervention. No such direction of change was found 
for the male patients. 
Responder analysis
Comparing the patient characteristics and baseline scores on the outcome 
measures of the treatment responders (n=24, 36.2 %) and the non-responders 
(n=63; see Table 6.4), we found a difference for Helplessness (F(1, 85)=4.9, 
p=0.029), with the responders showing higher levels of helplessness, than the 
non-responders. Perceived memory problems (IQCODE-N-Pt) and education 
level both showed a trend (F(1, 83)=2.9, p=0.089 and F(1, 85)=3.0, p=0.092 
respectively), with responders reporting slightly fewer memory problems and 
lower levels of education than the non-responders. 
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Table 6.3   Estimated marginal means (and standard errors) for changes  
in Helplessness as a function of sex for the waiting-list and the 
intervention interval 
Helplessness Change
waiting-list 
interval
 df Change
intervention 
interval
 df
Women 0.77 (0.72) 97.4 -1.06  (0.82) 91.32
Men -1.10 (0.46) 94.9 -0.27  (0.40) 93.48
Negative means indicate that helplessness cognitions decreased, while positive means reflect an 
increase.
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Discussion
In this first controlled study of a comprehensive group therapy for patients with 
mild cognitive impairment and their significant others we confirmed the hypothesis 
we formulated on the basis of our pilot study (Joosten-Weyn Banningh et al., 
2008b) that following our dedicated treatment patients would be more accepting 
of their condition (as assessed with the ICQ) than their counterparts awaiting 
treatment. Improving the patients’ acceptance is crucial since MCI comes with a 
relatively high degree of uncontrollability and unpredictability and acceptance 
allows an optimal adaptation to this uncertain condition. In their validation study 
of the Illness Cognition Questionnaire (ICQ) Evers et al. (Evers et al., 2001) 
postulated that acceptance reflects a cognitive evaluation of the perceived ability 
to live with and master the aversive consequences of a condition and they indeed 
found that higher levels of acceptance were related to superior psychological 
health and coping skills. With respect to coping behaviour, recent studies have 
indicated that the onset of dementia places major demands on a person’s coping 
resources, (Robinson et al., 2005) and it can be argued that the same holds for 
MCI patients. 
Another interesting aspect of acceptance is that it implies an awareness of the 
current memory problems, underscoring its relevance in therapy given that 
awareness has been found to be an important predictive factor of treatment 
success in patients with dementia undergoing various types of therapy. (Clare et 
al., 2005; Aalten et al., 2005; Bahro et al., 1995). As also in MCI the patients’ 
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Table 6.4   Means and standard deviations (SD) for the main differences in 
pre-treatment variables for the treatment responders and non 
responders (full patient sample) 
Responders
n= 24
Non-responders
n= 63
p
Education 4.7 (1.0) 5.1 (1.0) 0.087
Helplessness 12.0 (3.4) 10.4 (2.6) 0.029
IQCODE-N-Pt 55.3 (9.0) 58.4 (7.1) 0.092
IQCODE-N-Pt: Informant Questionnaire on Cognitive Decline in the Elderly  Dutch patient version
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awareness of their condition has been found to be diminished (M.Dekkers et al., 
2009; Tabert et al., 2002), increasing their acceptance necessarily raises their 
awareness and thus the chance of a favourable treatment outcome. 
Despite the relevance of the findings supporting our pilot study (Joosten-Weyn 
Banningh et al., 2008b) and thus a non-pharmacological treatment of MCI, we 
found again no changes on the subjective measures of general well-being 
(RAND-36) or distress (GDS-15). With respect to distress, scores on the GDS-15 
distress measure were already at a floor level before treatment, indicating that 
further reduction was not possible. These normal levels of general well-being and 
distress are in agreement with the study of McIlvane (McIlvane et al., 2008). 
Another explanation for the lack of change may be the relatively short intervention 
period (10 weeks). Reporting on a cognitive-motor intervention for patients 
diagnosed with MCI and mild-to-moderate Alzheimer disease, Olazaran et al. 
(Olazaran et al., 2004) found that after twelve months of treatment, the affective 
status of the patients was maintained or improved compared to the control group. 
In conclusion, it is, not unlikely that we might have obtained larger effects if the 
intervention had lasted longer or if we had re-assessed the patients after a certain 
follow-up interval. Additionally or alternatively, our 10-week intervention not only 
aims to help the patients and their partners/caregivers cope with the current 
problems resulting from the MCI, but also, or perhaps even more so, with any 
future consequences. Hence, changes in coping strategies and subsequent 
changes in perceptions of well-being may not become apparent until after one or 
two years. Still, the reported increase in acceptance correlated significantly with 
an increase in well-being (r=0.41, p=0.003). This is in agreement with findings in 
several studies indicating that acceptance plays a mediating role in adaptation to 
(chronic) illness resulting a higher well-being (Karademas et al., 2009). As far as 
we know no other studies exist on the effect of a psychotherapy group for patients 
with MCI or early dementia aimed at improving acceptance. However, previous 
findings in patients with mild to moderate dementia after group psychotherapy 
(Cheston et al., 2003; Cheston & Jones, 2009) showed a decrease in depression, 
and a trend for a decrease in anxiety. It is suggested that psychotherapy can be 
more effective on reducing levels of depression compared to psycho-education. 
Moreover, a systematic review of cognitive rehabilitation programs for individuals 
with MCI shows only in 3 of 9 studies an amelioration of the mood, anxiety of 
quality of life (Jean et al., 2010a). Consequently, it can be hypothesised that both 
psychotherapeutic and cognitive rehabilitation programs have effects on distress 
and/or well-being. With regard to our programme, combining psychoeducation, 
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cognitive rehabilitation and psychotherapeutic elements, each part lasted only 3 
sessions, which may have resulted in smaller changes.
We further found a significant interaction effect between the intervention and sex 
on ICQ helplessness in that the attribute had decreased more in the female 
patients. As sex-specific coping strategies and self-reported stress have been 
described before in chronically ill patients (Moos, 1982; Heijmans et al., 2004), 
our results were not surprising, but do provide some insight into the sex-specific 
coping patterns in MCI patients, which merit further investigation to allow us to 
adapt and optimize psychosocial interventions to these specific styles. 
We also sought to delineate typical characteristics in the patients that responded 
to our programme. We defined responders as those patients for whom we 
obtained an effect size larger than 0.2 on ‘acceptance’ and an effect size of at 
least 0.2 for two other outcome measures. Our analysis revealed differences on 
‘helplessness’, with the responders having higher pre-treatment levels of 
helplessness. We additionally found trends for subjective memory problems (as 
measured with the patient-rated IQCODE-N) and level of education, with the 
treatment responders reporting fewer memory problems in daily life and a lower 
educational level. Reported memory problems were not related to the level of 
memory impairment (r=-0.11, p=0.39) which is in accordance with the findings of 
Jungwirth (Jungwirth et al., 2004). Based on these results we recommend using 
these easily assessed factors for the selection of patients most eligible for 
treatment. 
Furthermore, the programme addressed topics known to pose serious problems 
in MCI patients (Joosten-Weyn Banningh et al., 2008b). However, individual 
differences during the intervention were considerable, which may explain why two 
of the three secondary outcome measures failed to show a change. The session 
on the theme of worrying, for example, triggered very diverse reactions: about 
one third of the participants confirmed they worried a lot, while one third said not 
to worry much or not at all. This could be a result of inter-individual differences 
between participants combined with the nature of the coping process in individual 
MCI patients in which denial is interchanged with facing the problem and 
accepting it and gradually will be diminished (Clare, 2002). Other topics, among 
which shame, stress management, social consequences, or perceived social 
support, showed very diverse interests too. Clearly, the format of our current 
group intervention was not designed to address individual problems. Tailoring the 
intervention by having patients with similar profiles participate in targeted 
programme modules, with each module lasting several sessions, may improve 
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treatment outcome. For example, after an introductory psychoeducational module 
about MCI, memory and memory-enhancing behaviour, subsequent modules 
could either address the themes of the current programme, or could adopt a strict 
psychotherapeutic or cognitive rehabilitation approach. Possibly, patients with 
lower levels of acceptance and/or helplessness may benefit from a strict psycho-
therapeutic approach which focuses explicitly on sharing experiences of memory 
loss, reflecting on the emotional significance of participants’ views on changing 
relationships with other people and working with behavioural experiments. 
Obviously, organising such a tailored programme would be a challenge because 
of the co-existing partner group and the aim to offer both patients and partners 
the same topics in order to stimulate sharing and working together. 
Several methodological considerations are in order: Although not a fully 
randomized trial, in our study the patient dyads were pseudo-randomly assigned 
to the waiting-list condition on the basis of the pseudo-random moment the 
patients were referred for treatment. Moreover, the criterion for randomization was 
met, because the two groups did not differ in the baseline outcome measures 
and patient characteristics. A limitation of this study design may be that the 
assessment of the effectiveness of the intervention was based on patients who 
received the intervention after a waiting list period and patients who received the 
intervention immediately after recruitment. Consequently, the waiting-list plus 
intervention group received an extra assessment (i.e., before the waiting-list 
period). Also, the waiting-list period itself may have affected the intervention 
outcome differentially. However, direct comparison of the two groups with respect 
to the intervention effect did not reveal a different pattern with respect to the main 
outcome variable, suggesting that our results can be interpreted validly. Also, 
dedicated outcome measures that evaluate the specific therapeutic goals should 
then be used rather than generic measures. Recently, outcome measures that 
specifically address areas of saliency to patient education and self-management 
programmes have been developed which may more accurately reflect the impact 
of this type of intervention (Nolte et al., 2007).The Goal Attainment Scaling (GAS) 
proved to be useful in evaluating important aspects of psychogeriatric patients 
with cognitive disorders (Bouwens, van Heugten, Verhey, 2008) and could be 
recommended in the evaluation of our programme. 
In conclusion, our comprehensive psychotherapeutic group programme for MCI 
patients and their significant others yielded small, yet promising results by 
increasing the patients’ acceptance of their condition and by decreasing feelings 
of helplessness in the female patients, with a third of all patients meeting 
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conservative responder criteria for at least three of the four outcome measures. 
Based on the current results we venture that the efficacy of our intervention may 
be improved by tailoring the content to patients sharing particular pertinent char-
acteristics and by incorporating more sex-specific themes and training.
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Abstract
Background: The partner of a loved one with Mild Cognitive Impairment (MCI) 
faces an uncertain prognosis and a multitude of memory-related and psycho - 
social consequences. This study examines the efficacy of a newly developed 
comprehensive group programme aimed at MCI patients and their significant 
others that comprises elements of psychoeducation, cognitive rehabilitation and 
cognitive behavioural therapy. 
The aim is to quantitatively and qualitatively evaluate the effects of this MCI group 
programme in the significant others using a controlled design. 
Methods: In a mixed-method design pre- and post-treatment quantitative and 
qualitative data were collected in the significant others of 84 MCI patients, with 27 
dyads having first been assigned to a waiting list, thus serving as their own control 
group. Besides evaluating the programme, the significant others assessed burden 
of caregiving, well-being, distress, acceptance, helplessness and awareness. 
Results: Analyses yielded discrepant findings. Whereas the linear mixed-model 
analyses of the quantitative data did not reveal statistically significant differences 
between the control and intervention condition, the qualitative results indicated 
that at programme completion the significant others reported significant gains in 
knowledge, insight, acceptance and coping skills. 
Conclusion: Although no statistically significant changes were found on the 
measures of well-being, distress, burden and illness cognitions, the qualitative 
data suggest that the MCI programme facilitated the process of learning to live 
with or care for a loved one with MCI. Suggestions for programme adjustments 
and alternative outcome measures are discussed. 
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Introduction
Mild cognitive impairment (MCI) is a syndrome characterized by cognitive deficits 
in the context of normal daily functioning (Petersen, 2004). It is a known risk factor 
for the development of dementia, with prospective longitudinal studies reporting 
annual MCI-dementia conversion rates of 2 to up to 31% (Bruscoli and Lovestone, 
2004). These rates imply that for a large proportion of MCI patients the progression 
of their illness is uncertain, and that the diagnosis, rather than diminishing their 
feelings of uncertainty, may even exacerbate them (Joosten et al., 2008a).  As a 
result of the increasing awareness of potentially effective pharmaceutical 
interventions for dementia, more people are being diagnosed with MCI, resulting 
in an estimated increase of 6 to 40% in the memory clinic population (Visser et al., 
2000).
Having a partner or loved one with MCI may be quite unsettling and finding ways 
to support the changing partner or relative is difficult. The transition from being a 
partner to being a carer of a person with MCI gives rise to ambiguous feelings 
and behaviour, distress, and interpretations of the changes observed (Adams 
2006; Blieszner et al., 2007; Bruce et al., 2008a; Garand et al., 2005). Interestingly, 
caregiver well-being and distress were found not to be associated with symptom 
severity, but correlated with the occurrence of or changes in symptoms. These 
changes may be most frequent and most fundamental in the early stages, 
requiring more adjustment (Perren et al. 2006). In several studies both the MCI 
patients and their (care) partners expressed a need for more information and 
support. (Garand et al., 2005; Adams 2006; Ryan et al., 2010; Blieszner et al., 
2010; Davies 2010), indicating the call for a psychosocial intervention that would 
provide them with the relevant information and support as well as help them 
develop effective coping techniques. 
Based on the available reviews of interventions for early-stage dementia (Acton 
and Kang, 2001; Brodaty et al., 2003) we designed a multi-component programme 
in which MCI patients and their partners or primary caregivers participate. The 
intervention combines principles from cognitive behavioural therapy (CBT) with 
psychoeducational and memory-rehabilitation elements (Joosten et al., 2008b). 
A pilot study showed the intervention to be applicable in this population and 
yielded promising first results, with the programme contributing to the patients’ 
acceptance. Gains for the significant others were, however, limited to an increase 
in alertness for memory impairments (Joosten et al., 2008b). Their post-treatment 
levels of distress and burden were not diminished, which could be attributed to 
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the already low pre-treatment distress levels in our pilot sample. This was in line 
with the low levels of distress and burden Blieszner et al. (2007) reported for their 
MCI care-partner sample. However their qualitative analyses showed evidence 
for distress in some carepartners. This discrepancy shows that combining 
qualitative and quantitative measures may reveal the significant others’ responses 
in more detail. In this light, the two-fold aim of the current study was to quantitatively 
evaluate the effects of our MCI intervention programme in MCI significant others 
and to provide additional qualitative information on the post-intervention effects 
as perceived by the patients’ significant others (O’Cathian et al., 2010). We 
hypothesized that after programme completion the significant others’ sense of 
well-being would be increased and their sense of distress and burden reduced. 
We furthermore expected the degree of acceptance of their partners’ condition 
and awareness to the changes to have increased and the level of helplessness to 
have reduced.
Methods
The quantitative and qualitative data were collected in the same participants. We 
used the model of complementarities, using the strengths of one method to 
enhance the other (Morgan, 1998; Mofatt et al., 2006). With the quantitative study 
we aimed to evaluate intervention effects on well-being, distress, acceptance, 
helplessness and alertness to MCI-related changes. For the qualitative study we 
used the self-reports completed in the tenth session to explore the respondents’ 
views on the intervention and its outcome. Both datasets were analysed separately 
and not compared until both analyses were completed. 
Sample  
Between September 2003 and December 2007 we recruited eligible MCI patients 
and their significant others from four regional outpatient memory clinics in the 
east of the Netherlands offering the treatment (the Radboud University Nijmegen 
Medical Centre and three general hospitals: ‘Maasziekenhuis Pantein’ in Boxmeer, 
‘Rijnstate’ hospital in Arnhem and ‘Slingeland’ hospital in Doetinchem).
Inclusion criteria were an MCI diagnosis, more specifically amnestic MCI, 
non-memory single-domain MCI or multiple-domains MCI (Petersen, 2004), age 
over 50 years, and the availability of a partner, spouse, relative, or close friend 
willing to participate in the group programme. In all four participating centres MCI 
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was diagnosed using a multidisciplinary approach supervised by a geriatrician or 
neurologist in accordance with generally accepted criteria as described by 
Petersen. The procedure consisted of a thorough clinical interview with the patient 
dyads, supported by an extensive neuropsychological assessment, neurological 
and radiological findings, and a performance assessment of activities of daily 
living (ADL). The MCI criteria were met if a patient’s performance was impaired in 
one of the cognitive domains, or if more than one cognitive domain showed a 
below-average performance, compared to available normative data and in the 
absence of a decline in ADL performance or dementia. The performance of 
instrumental ADL was assessed using validated rating scales (among which the 
Lawton Instrumental Activities of Daily Living Scale (Lawton and Brody, 1969) 
and/or by structured observation of ADL performance by an occupational 
therapist (either in the patient’s home environment or in the outpatient clinic). 
Exclusion criteria were the absence of informed consent, the presence of 
psychiatric comorbidity, coexisting somatic disorders if dominant to MCI, severe 
concentration difficulties impeding communication, inability to communicate 
fluently in Dutch, lack of motivation to share experiences in a group, and evidence 
of severe, pre-existing (care) partner relationship problems unrelated to the 
cognitive impairments. All dyads were extensively informed about the study, after 
which written informed consent was obtained from both the patient and the care 
partner. Ethical approval was obtained from the regional (Arnhem-Nijmegen) 
Medical Ethics Committee. 
Quantitative study
Study design and procedure
The quantitative study had a pragmatic, naturalistic, non-randomized, waiting-list 
controlled design, with all eligible patient-partner dyads receiving the group 
treatment either within eight weeks of their recruitment or after eight weeks or 
more on a waiting list (waiting for a new intervention group to begin). The ‘inter-
vention-only’ group (dyads receiving treatment within eight weeks of the intake 
interview) was first assessed in the two weeks prior to the start of the intervention 
(T1) and within two weeks following programme completion (T2). When the time 
to the start of the next intervention was more than eight weeks, dyads were 
assigned to a waiting list, serving as our control group, at the start of which period 
they took a baseline assessment (T0). Their pre- and post-treatment (T1 and T2) 
tests were scheduled as in the intervention-only group. Waiting-list intervals 
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(T0-T1) ranged from 8 to 16 weeks. To maximize the statistical power, the total 
intervention group we report on here is hence composed of significant others 
having received ‘immediate’ treatment and those having received treatment after 
having spent at least 8 weeks on a waiting list (Joosten et al., 2011).
The patients and their significant others fulfilling the inclusion criteria were 
informed about the group programme by their geriatricians or neurologists. 
Interested dyads were subsequently invited for an interview with a psychothera-
pist at their local hospital, who explained them the aims and content of the 
intervention and its evaluation, and, if relevant, obtained their written  informed 
consent. The expectations, which the patients and their significant others had of 
the programme were explored and corrected if these were unrealistic. By doing 
so, the therapist estimated the participants’ potential capability and interest in the 
programme. All subsequent assessments were conducted by trained psychology 
(research) assistants of the hospital delivering the intervention. Both during the 
waiting period and the intervention participants received no other psychosocial or 
medical intervention for their cognitive complaints. 
Demographic variables and participant characteristics
Demographic data, such as age, sex, marital status and education, were collected 
with a general checklist. Educational level was rated on a 7-point scale with 1 
reflecting less than primary school (<6 years of education), and 7 a university 
degree (Bachelor degree and up: >14 years of education) (Verhage, 1964).
In the patients overall cognitive impairment was measured with the Mini-Mental 
State Examination (MMSE; Folstein, 1976). Memory function was assessed with 
the Dutch version of the Rey Auditory Verbal Learning Test (Van der Elst et al., 
2005), which requires the participant to recall 15 auditory presented words across 
five trials, immediately after their presentation and after a 20-minute delay, 
followed by a recognition trial in which the 15 words are presented among 15 
distracter items. Since the delayed recall measure is an early predictor of cognitive 
decline (Salmon and Lange, 2001) we used this measure as an index of episodic 
memory performance.  
Coping was assessed with two subscales of the Utrecht Coping List (UCL; 
Scheurs et al., 1993) gauging active and passive coping strategies when dealing 
with everyday problems. The 7-item Active Coping subscale evaluates cognitive 
and behavioural efforts to apply goal-oriented problem-solving strategies and the 
8-item Avoidance subscale measures cognitive and behavioural attempts to 
avoid, escape from and acquiesce when facing everyday problems. 
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Social support in the past two weeks was evaluated with the 12-item Social 
Support List, Interaction version (SSLI-12), an inventory designed for use in elderly 
people, which consists of three 4-item subscales: Everyday Social Support 
(SSLI-EV), Social Support in Problem Situations (SSLI-PR), and Esteem Support 
(SSLI-EST) (van Eijk et al., 1994).
Satisfaction with the partner relationship was assessed with the Maudsley Marital 
Questionnaire (MMQ) (Arrindel, 1983). We used one of its three subscales: the 
10-item Emotional Satisfaction scale, which is an index of the respondents’ 
satisfaction with the emotional and communicational aspects of the relationship. 
The subscale ranges from 0 to 80 with higher scores implying higher levels of 
dissatisfaction. 
Outcome measures 
The primary outcome variable burden of caregiving was assessed with the Sense of 
Competence Questionnaire (Vernooij-Dassen et al., 1996). The inventory has three 
subscales: satisfaction with the MCI partner as the recipient of the care (12 items), 
satisfaction with one’s own performance as a significant other/caregiver (7 items) and 
the implications of the involvement in the patient’s care for the care partner’s personal 
life (8 items). The total scale score ranges from 27 to 135, with higher scores reflecting 
a lower sense of competence. In addition, the Hindrance scale of the Revised Memory 
and Behavior Problems Checklist (RMBPC; Teri et al., 1992) was used to measure 
to what extent the significant others were affected by the observed behavioural 
problems (0 = not at all, 1 = a little, 2 = rather, 3 = very much).  
The secondary outcome measures (and their scales) were as follows: 
Distress was evaluated by means of the 15-item Geriatric Depression Scale – 
Short Form (GDS-15; Hermann et al., 1996), where higher scores reflect more 
depressive symptoms (with 5 being the cut-off score for depressive symptoms). 
General well-being was assessed using the Dutch version of the RAND-36 Health 
Survey (Zee and Sanderman, 1993), which gauges physical, social and emotional 
dimensions. We used four of the eight scales, i.e. Social Functioning, Role-
Emotional, Mental Health, and Vitality. Each scale ranges from 0 to 100, with 
higher scores reflecting higher levels of perceived health or well-being.
Acceptance was assessed with the Illness Cognition Questionnaire (ICQ; Evers et 
al., 2001), which charts the way in which significant others adjust their beliefs and 
thoughts to the patient’s chronic condition. Acceptance is one of its three 
subscales and has six items that assess the significant others’ recognition of the 
need to adapt to their partners’ chronic disease and their ability to tolerate and 
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manage its adverse consequences. (e.g., ‘I have learned to live with my partner’s 
memory problems’; ‘I think I can handle the consequences of my partner’s 
memory problems, even if they get worse’.) The subscale scores can range from 
6 to 24, with higher scores reflecting more acceptance. 
Helplessness was evaluated with the same-named subscale of the Illness 
Cognition Questionnaire (ICQ; Evers et al., 2001), which focuses on the adverse 
aspects of the disease and generalizes them to daily functioning. The 6-item 
subscale ranges from 6 to 24, with higher scores reflecting a greater sense of 
helplessness.
Awareness of memory failure and other changes of cognitive abilities was 
evaluated using the Dutch version of the Informant Questionnaire on Cognitive 
Decline in the Elderly – Short Form (de Jonghe et al., 1997a). This 16-item list 
invites the care partner to rate the patient’s decline in memory as observed in 
their daily functioning. The significant others also completed the Revised Memory 
and Behavioral Problems Checklist (RMBPC; Teri et al., 1992) reflecting their 
awareness of the patient’s memory problems, depressive behaviour and 
behavioural problems. 
Intervention
The intervention consisted of ten weekly 2-hour group sessions and was based 
on CBT principles combined with psychoeducational and memory-rehabilitation 
elements. The programme and procedures have been extensively described 
elsewhere (Joosten et al., 2008b) Each group comprised five to eight patients all 
accompanied by their primary caregiver, i.e., a partner/spouse, adult child, 
relative or close friend. The focus of the programme was the acquisition of 
knowledge of and skills to adequately cope with MCI-associated symptoms and 
their consequences. The therapists delivering the treatment were all registered 
psychologists trained and supervised by the first author. 
To promote mutual support among the participating significant others and 
between the significant others and their affected partners, we implemented the 
procedure described by Snyder et al. (1995) in that during the first 90 minutes of 
each 2-hour session the patients and significant others participated in separate 
groups, i.e. a patient and a care partner group each with its own therapist, with 
both groups exploring the same topics and receiving similar (oral and written) 
information with relevant home assignments. For the remaining 30 minutes the 
two groups came together and the key issues from the preceding session were 
summarized and highlighted. 
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The significant others learned how to support their MCI partners in optimizing 
internal and external memory strategies, to recognize memory problems in daily 
life and to explore their explanations and attributions, improve the communication 
with their partner and others, and train self-regulation skills. Topics such as 
diagnostic uncertainty, changes in the spousal-caregiver role, and stigmatization 
were discussed in relation to each theme. 
Interaction and support, as well as exchanging experiences and coping strategies 
are commonly known beneficial elements in group therapies. All participants 
were instructed to prepare each session with relevant texts and self-monitoring 
tasks. The participants were asked to monitor and record their thoughts, feelings 
and behaviour in situations of conflicts or stress. These personal logs were 
discussed and explored in the group with the aim to reduce or prevent stress-in-
ducing cognitions. The following topics were addressed: memory function in 
general, MCI as a clinical diagnosis, therapeutic possibilities, strategies to 
improve memory performance (such as note taking, errorless learning, and using 
a memory book), ways to recognize strain, learning to relax, the importance of 
pleasurable everyday activities, and dealing with social conflicts and worrying.
Statistical analyses
Baseline differences between the waiting-list group and the intervention-only 
group were analyzed by independent-samples t-tests. To analyze changes in the 
two dependent distress variables and the two illness-cognition outcomes 
following the waiting-list and intervention intervals, we applied a linear mixed 
model (LMM) for repeated measurements (Joosten, 2011). We opted for LMM 
because, as opposed to repeated-measures analysis of variance, this model 
does not require data to be present at each assessment for a participant to be 
included in the statistical analysis, whilst at the same time accommodating the 
dependency caused by repeated measurements. In the outcome variables, 
differences between T0 and T1 (change after waiting period), and between T1 
and T2 (pre-post-treatment change) were calculated and used as repeated 
measures with Interval (2 levels), Group (17 levels), Sex (2 levels) and their 
first-order interactions as fixed factors. We included Sex as a fixed factor because 
we assumed it might be an important aspect, influencing outcome. To correct for 
potential group effects, we introduced Group as a fixed factor into the analysis. 
Interval (T0-T1 vs. T1-T2) was entered as a within-subject variable. We used the 
MIXED procedure from the SPSS package (version 14).
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The power calculation we ran in our pilot study had shown that approximately 70 
significant others were required to reach a power of 0.8 on the primary outcome 
measure, with an effect size of 0.2 and a significance level of 0.05 (Joosten et al., 
2008). 
Finally, to give an indication of the individual changes, the percentages of 
significant others showing beneficial changes were calculated for all outcome 
measures both in the control and intervention condition. Change was indicated 
by effect size (Cohen’s d), which was calculated by computing the difference 
between the post- en pre-treatment measurements divided by the standard 
deviation (SD) at baseline (Cohen, 1988). In accordance with Cohen, an effect 
size larger than 0.2 was taken to reflect a small positive change.
Qualitative study
Data collection and analysis
The qualitative data were analyzed using the interpretative phenomenological 
analysis method, which involves a constant comparative analysis to identify 
common themes and issues (Corbin and Strauss, 1990; Smith, 2004). Well-trained 
master-level psychology students assisted in and monitored each group, noting 
the statements the participants made during the sessions. For the qualitative 
analysis we made use of the anonymous transcripts of the final (tenth) sessions 
in which the intervention was evaluated. We adhered to the following interview 
guide: 1. Which of the programme themes was or were the most helpful? 2. What 
are the main benefits of the group programme? 3. Which of the issues we dealt 
with still need your attention? 4. How did both you and your partner experience the 
group? 5. Do you have suggestions to improve the programme? After the 
participants had given their personal evaluations, they were specifically 
encouraged to broach negative aspects or topics they had missed in the 
programme. The transcripts of their evaluations were independently read and 
analyzed by two researchers (MVD and LJ-WB), using the open-coding procedure, 
an interpretive process by which data are broken down analytically and 
conceptually labelled, generating a comprehensive understanding of themes and 
patterns in the data. Its purpose is to give the analyst new insights by breaking 
through standard ways of thinking about or interpreting phenomena reflected in 
the data (Smith, 2004). The sequence was as follows: codes were assigned that 
were closely related to the quotations. For example, the quotations: “I have to 
take care that my alertness to changes in my husband’s memory problems will 
not stress me out too much” and “I will take care not to worry too much” were both 
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coded as: alertness for negative consequences to the self. Codes referring to the 
same phenomenon were grouped into categories and categories grouped into 
themes. Consensus among researchers about codes, categories and themes 
was reached by peer-group discussion conducted by a clinical neuropsycholo-
gist and psychotherapist (LJ-WB), a senior medical sociologist (MVD) experienced 
in qualitative end-of-life research and a Master’s level psychology student (MVD) 
experienced in gerontology issues and research. All three researchers are 
knowledgeable about spousal care giving in dementia and MCI. Care-partner 
evaluations were included until the saturation point of qualitative data was 
reached. Finally, using a grounded theory approach, hypotheses were derived 
from the data. ATLAS.ti (computer software Berlin, Germany: ATLAS.ti Scientific 
Software Development GmbH) was used to manage the dataset and to allow for 
systematic searching and cross-referencing.
Results
Quantitative results 
Eighty-eight MCI patients and their significant others expressed an interest to 
participate in our study and were included (for a trial overview see Fig 7.1). 
The intake procedure for 30 dyads took place more than 9 weeks before the start 
of a new group intervention programme and they were hence initially assigned to 
our waiting list, thus constituting the control group, with three dyads dropping out 
after the baseline assessment (T0) because of somatic disease unrelated to MCI 
(n=1) or lack of time (n=2). The other 58 dyads started treatment within 8 weeks 
of their intake interview, accordingly constituting the intervention only group. 
Thus, a total of 85 dyads, that is to say 27 from the waiting-list control group and 
58 from the intervention-only group, were assessed at T1 (pre-treatment). The 
intervention-only group was twice the size of the control group due to the variability 
in the flow of referrals in the four participating hospitals and the study schedule 
(Joosten et al., 2011). For one care partner in the final intervention group (n=84) 
no post-treatment (T2) data were available because of loss of motivation. Thus, 
the data of 84 significant others were entered into the LMM analyses. 
LEARNING TO LIVE WITH A LOVED ONE WITH MCI: A WAITING-LIST CONTROLLED TRIAL ON GROUP THERAPY 
7
116
CHAPTER 7
Figure 7.1   Trial overview 
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Table 7.1   Baseline characteristics of the significant others for the two  
study groups 
Waiting-list 
control group
(T0; n = 27)
  Intervention 
only group
n = 58
p
Demographics
Age 67.00 (8.15) 69.83 (8.20) 0.22
Education (1=low,  7=high) 5.07 (0.92) 4.93 (0.98) 0.98
Sex*
Male
Female 
            14 (51.9%)
            13 (48.1%)
            22 (38%)
            36 (62%)
MMSE (patient) 25.91 (3.9) 25.36 (3.2) 0.50
Type of partner*
Married / living together
Living apart
Daugther / sister
            24 (88.9%)
              1 (3.7%)
              2 (7.4%)
            53 (91.4%)
              0
              5 (8.6%)
0.70
Care-partner characteristics
Social support
Everyday support
Support in problem situations
Esteem support
Active coping
Passive coping
MMQ es
10.81 (1.90)
9.26 (1.83)
10.52 (2.06)
19.33 (3.49)
15.19 (2.87)
15.57 (11.33)
10.72 (1.7)
9.65 (2.6)
10.47 (2.3)
17.79 (3.5)
16.70 (3.1)
17.30 (13.3)
0.83
0.49
0.96
0.17
0.04
0.59
Dependent variables  
SCQtot
Personal life
Patient
Self
Mood / GDS-15
GDS-15 > 5 (%)
Well-being (RANDtot)
Acceptance
Helplessness
MCI-related problems (RMBPC)
Frequency
Hindrance
IQCODE
89.65 (20.44)
27.85 (7.71)
20.37 (7.38)
41.23 (11.26)
1.48 (1.58)
3.7%
305.38 (71.54)
18.30 (3.77)
9.95 (3.28)
12.04 (8.14)
22.00 (8.76)
62.56 (7.42)
87.48 (19.7)
26.45 (8.1)
19.57 (7.6)
41.04 (9.0)
2.26 (2.4)
10.9%
293.56 (66.9)
15.91 (3.1)
10.27 (3.1)
15.01 (9.2)
25.51 (10.0)
62.55 (6.8)
0.83
0.49
0.14
0.94
0.21
0.47
0.05
0.53
0.14
0.17
0.99
Note: MMSE=Mini Mental State Examination total score of the MCI patient; MMQ es= Maudsley Marital 
Questionnaire, emotional satisfaction; SCQtot=Sense of Competence Questionnaire total score; 
RMBPC=Revised Memory and Behavioural Problems Checklist. Differences were tested by student 
t-tests except for the following variables: social support esteem, active coping, sense of competence 
patient, mood, helplessness and hindrance.  *Differences were tested with Chi-square tests.
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Baseline characteristics significant others
Table 7.1 lists the significant others’ baseline data for the two study groups (T0 
and T1, respectively). Between-group comparisons revealed no significant 
differences in their demographics (age, education, relationship to study partner), 
main characteristics (MMSE, coping style, social support, and subjective memory 
deterioration) or the primary outcomes at baseline. The only factor revealing a 
group difference was Acceptance, with the waiting-list control group reporting a 
slightly higher level of acceptance than the intervention-only group. 
Treatment effects
Table 7.2 shows the means of the baseline, pre- and post-treatment outcomes 
and the effect sizes for the significant others in the two study conditions. The 
LMM analysis revealed no significant difference between the two conditions for 
our primary outcome measure of Burden(F(1, 87.1) =0.45, p=0.50), nor for any of 
the secondary outcome measures (all F-values<1.79).
Visual inspection of the effect size for Acceptance following the waiting-list 
interval (T0-T1: d=0.24) reflected a small clinical increase, while for the intervention 
interval the effect size was small (T1-T2: d=0.10). The effect size for the Frequency 
variable of Alertness to memory problems showed no change after the waiting 
period (T0-T1: d=0.04), but indicates a moderate change after the intervention 
(T1-T2: d=0.34). The effect sizes for Hindrance showed the opposite pattern: in 
the waiting-list condition the mean effect size reflected an increase (T0-T1: 
d=0.37), while in the intervention condition it had remained unaltered (T1-T2: 
d=-0.02). 
Qualitative results 
The saturation point was reached after the programme evaluations of 70 significant 
others had been coded and refined. Their sociodemographic characteristics and 
those of their MCI partners were similar to the data recorded for the full study 
sample: the mean age was 68.8 years (SD =6.8), the significant others’ mean 
educational level 4.8 (SD=1.0) and 61.4% were women, while 90% lived together 
as partners. The MCI patients’ mean MMSE was 25.3 (SD=2.8). 
Analyses of the transcripts of the tenth session of 12 intervention groups resulted 
in 355 quotations from 70 caregivers. These were translated into 33 codes and 17 
final categories. Table 7.3 lists the final five common themes: Valuation of the 
programme, Knowledge, Insight, Acceptance, Coping and Emotional changes. 
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We have added the 17 categories and some representative quotations to elucidate 
the scale results.  
Valuation of the programme 
In their evaluations of the intervention the significant others described positive 
emotional experiences only. Some sessions had evoked sad emotions, but the 
beneficial aspect of sharing these feelings was stressed. The social gains derived 
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Table 7.2   Means with (SDs) for the primary and secondary outcome 
measures, and effect sizes in the waitinglist and intervention 
intervals 
T0
n=27
T1
n=85
T2
n=84
Mean ES
waiting 
list
n=27
Mean ES
intervention
n=84
Primary 
outcome measure
SCQ
Total
Self
Patiënt
Personal life
89.65 (20.4)
41.23 (11.3)
20.37 (7.4)
27.85 (7.7)
88.53 (21.0)
41.69 (9.8)
20.08 (7.0)
26.49 (9.2)
88.04 (21.7)
42.73 (10.2)
19.31 (7.4)
25.81 (8.6)
0.04 
0.15
0.12
-0.11
-0.02
0.10
-0.11
-0.07
RMBPC 
Hindrance total 12.04 (8.1) 14.26 (9.5) 13.74 (9.2) 0.06 -0.05 
Secondary 
outcome measure
GDS-15    1.48 (1.6) 2.01 (2.2) 2.10 (2.8) 0.00 0.04 
RANDtot 4 305.38 (71.5) 299.40 (67.8) 288.10 (78.9)      
0.07 
     -0.17 
ICQ 
Acceptance
Helplessness
18.30 (3.8)
9.95 (3.3)
16.96 (4.7)
10.00 (2.9)
17.14 (4.3)
10.16 (3.2)
0.10
-0.21
0.04 
0.06
RMBPC 
Frequence total
IQCODE-N
22.00 (8.8)
62.65 (7.4)
24.32 (9.9)
62.39 (7.4)
26.12 (10.5)
63.02 (8.7)
0.00 
-0.07
0.18
-0.06
Note: GDS-15=Geriatric Depression Scale; RAND-36=36 item RAND Health Survey; ICQ=Illness 
Cognition Questionnaire; IQCODE-N=Informant Questionnaire on Cognitive Decline in the Elderly-Dutch 
version; RMBPC=Revised Memory and Behavioural Problems Checklist; SCQ=Sense of Competence 
Questionnaire
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from the intervention were expressed as relief from sharing worries and 
experiences, knowing not to be the only one to feel irritated at times, and the 
compassion conveyed by their group peers. Also the comments on the methods 
employed by the therapists were all positive. The background information and 
instructions handed out to help the participants prepare for the next session at 
home or to read over afterwards was much appreciated. The views on the number of 
sessions (10) were diverse: some were positive because they now felt sufficiently 
equipped to cope (better) on their own, while many expressed the wish for this 
support group to be continued given that their partner’s condition would deteriorate, 
creating new problems. 
Knowledge 
The significant others described knowledge gains in four categories: they were 
now familiar with MCI as a diagnostic entity and the function of memory, had 
learned techniques to help optimize their partner’s memory functions, as well as 
ways to deal with their own negative reactions and present and future relational 
changes. These categories largely corresponded to the main programme themes. 
Some significant others reported that the information had generated new questions 
and added to the uncertainty. We also detected that some had occasionally 
misinterpreted the information provided. Thus, one participant harboured the 
thought that MCI was not the same as dementia, on the basis of which he had 
concluded that his partner’s problems would not progress like they do in 
dementia. 
Insight 
The caregivers reported an increased insight with respect to several domains: 
they had gained more insight into their own coping and grieving process, into the 
coping and the emotional responses of their MCI partners, and into their present 
and future situation, as well as gained awareness of the problems that could 
emerge in the future. They were thus prepared for problematic changes in their 
own and in their MCI partner’s functioning and for the consequences for their 
relationship. 
Acceptance 
Acceptance of MCI-associated changes was often mentioned to have increased, 
although some caregivers reported that the process of acceptance had only just 
begun. Still, some of the programme evaluations revealed a lack of acceptance, 
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Table 7.3   Overview of themes and sub-themes: 
Themes and categories Quotations
1. Valuation of the programme
category 1a: Emotional 
aspects
category 1b: Social 
aspects
category 1c: Quality
of intervention
“My partner enjoyed the sessions.” 
“Some sessions were very emotional.”
“ I cherished the sympathy the other group members 
expressed.”
“ I appreciated the written background information.” 
“ I will miss the group because my partner’s condition 
will progress and I will need similar support then too.”
2. Knowledge 
category 2a: MCI and 
memory
category 2b: Memory-
enhancing techniques
category 2c: Dealing with 
own negative responses
category 2d: Dealing with 
relational changes
“ My understanding of how memory works has 
increased.”
 
“ I still have questions about the precise type of MCI my 
husband is suffering from.” 
“ We cannot solve the memory problem itself, but you 
can make use of memory aids.”
“ I’ve learned the importance of talking with other 
people about it.” 
“ I’ve learned a lot from the session, about 
disagreements and social conflicts.”
3. Insight
category 3a: Coping with 
self-relevant implications
category 3b: Problems 
due to MCI related changes
category 3c: Keeping alert 
with respect to changes in 
memory functioning
category 3d: Keeping alert 
with respect to negative 
consequences to the self
“ I’m now better aware of the coping process we’re 
both going through, of which the shifts in denial and 
defiance and acceptance are part.” 
“ I realize that my husband and I should keep up our 
leisure activities. Until now we had become too 
passive in this respect.”
“ I became aware that my wife has difficulties managing 
some situations. I now think differently about this.”
“ I intend to be more alert that my partner does not 
become too passive. I will not take over her tasks 
too quickly but will assist my wife in performing them 
herself.”   
“ I’ll try not to get worried too much about the daily 
hazards.”
“ I’ll try to deal with my growing sense of loneliness.”
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Table 7.3   Continued 
Themes and categories Quotations
category 3e: Keeping alert 
with respect to relational 
changes
“ I intend to spend one-on-one time with my partner.” 
“ I have to check my criticizing attitude.” 
“ I have to mind not to be devaluing when supporting 
my partner.” 
4. Acceptance
category 4a: MCI
category 4b: Relational 
changes
“ Thanks to the therapy I’ve become more accepting of 
my wife’s MCI.”
“ I hope my wife will recover from her memory 
problems.”
“ We can’t discuss it in the way I would like to do, but 
I’m now more accepting because my husband used 
to be like this before.”
5. Coping 
category 5a: Instrumental 
coping - Applying memory 
strategies
category 5b: Emotional 
coping 
category 5c: Coping with 
relational changes
          
“ I repeatedly refer him to our agenda when he asks me 
about our appointments.”
“ I feel less guilty now of leaving him on his own when 
I’m feeling stressed. I know this is a good way to deal 
with stress”
“ I’m talking about our situation with others, even 
though my partner doesn’t want me to do so. It isn’t 
easy, but it helps me a lot.” 
“ My partner has changed in that he is more open 
towards me. The memory problems are a common 
theme of our talks now.” 
“ I’ve learned to agree with my partner even when I 
know he’s wrong, but only with unimportant subjects.”
“ We still have difficulties discussing the problems 
together.”
6. Emotional changes “ I feel more relaxed and confident now” 
“ I now have more faith in that what I do is right.”
“ I now am less often annoyed when my husband has 
forgotten something.”
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whether in the care partner or in the MCI partner. These participants were, for 
instance, still looking for ways to cure the memory problems. It was also reported 
that gains in acceptance in MCI partners had led to their refusing assistance from 
others less. Caregivers indicated that their acceptance had increased due to the 
realization that they could not change (some of) the problems. 
Coping 
The significant others’ coping skills had been augmented. Instrumental coping 
had improved in that they now applied memory-enhancing strategies: they 
encouraged their MCI partners to apply these to enhance their memory capacities 
and reminded them to keep using them. They made use of practical memory aids 
ranging from calendars to satellite navigation systems (GPS). Emotional coping 
had likewise improved: most significant others reported to have learned to deal 
with their own negative reactions and with relational changes better. They 
explained how they had changed their behaviour after having reframed their 
beliefs and thoughts. One caregiver, for instance, was now sharing her problems 
with others despite her husband’s explicit wish not to do so. She derived support 
from sharing her worries and had concluded that she did not harm her husband 
by doing so, a thought which prevented her earlier. Finally, many concluded that 
since the intervention their MCI partners had also become more open in 
discussing their memory problems with others. 
Emotional changes
The significant others described a sense of relief, felt more comfortable in social 
contexts and expressed an overall improved sense of relaxation and inner calm. The 
absence of any mention of mounting stress or negative emotions was most striking. 
In summary, the qualitative analyses revealed that similar categories arose in the 
themes Knowledge, Insight, Acceptance and Coping. These categories all 
concern MCI or memory-related issues and relational aspects, but had different 
connotations depending on the theme in whose context they were discussed. 
When Knowledge was the theme debated, the memory aspects referred to the 
information provided about a memory model, and about what can be done to 
support the MCI partners, i.e. helping them to optimize their memory performance 
in each new stage of their condition. Memory aspects discussed in relation to 
Insight concerned the significant others’ awareness of and insight into the 
memory changes in the MCI partner, while with the theme Acceptance the 
memory aspects all had emotional and processing connotations. 
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Comparing the quantitative and qualitative outcomes
Analysis of the quantitative and qualitative datasets revealed a discrepancy in the 
findings. With our quantitative evaluation we found no evidence of treatment 
efficacy in the significant others. The outcome measures burden, well-being, 
distress, acceptance, helplessness and alertness to MCI-related problems 
showed no statistically significant changes. Based on effect sizes, alertness to 
memory problems did show a positive trend and burden, (i.e. level of hindrance) 
had remained stable while this had increased in the waiting-list condition. The 
qualitative study on the other hand suggests stress levels to have lowered, based 
on the augmented levels of acceptance and alertness to MCI-related problems, 
while also gains in knowledge, insight and coping skills were reported. 
Discussion
This is the first controlled study investigating the efficacy of a multi-component 
group therapy for individuals with MCI and their significant others in this latter 
group. In contrast to our findings on acceptance in the MCI patients themselves 
(Joosten et al., 2011), in their significant others we found no statistically significant 
beneficial effects of the intervention on burden, our primary outcome measure, 
nor on the secondary measures of well-being, distress and illness cognitions and 
alertness to memory changes. In a previous uncontrolled pilot study we reported 
an increase in alertness to memory changes in the caregivers (Joosten et al., 
2008b). With the current controlled design we were unable to replicate this finding. 
Possibly, our sample of 84 significant others may have been too small to show a 
statistically significant effect, even though a power analysis of the ‘burden’ data 
obtained in the pilot study estimated the optimal sample size at 70 to achieve 
adequate power. A recent study comparing the effects of a group intervention for 
(early) dementia patients and their caregivers on quality of life (96 dyads) to a 
waiting-list condition (46 dyads) also could not establish significant post-treatment 
changes in the significant others (Logsdon et al., 2010). In contrast to the 
outcomes of our quantitative analyses, the qualitative data suggest favourable 
effects on distress, knowledge, insight, and coping. 
We will discuss several explanations for this discrepancy. First, an explanation 
may be found in the dual-process theory on coping with loss (Leventhal, 2001; 
Stroebe and Schut, 1999). In an early phase of adaptation to loss or serious 
illness, partners or caregivers have to first appraise the stressor before they can 
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formulate adaptations to it. Adaptations are categorized as loss-oriented or res-
toration-oriented adaptation tasks, with increased levels of distress and anxiety 
accompanying the early stages of appraisal and adaptation. The dual-process 
theory proposes that adaptation to a chronic or life-threatening illness is 
characterized by oscillations between two domains, i.e. addressing emotional 
issues within the loss-oriented context and handling practical adaptations within 
the restoration-oriented framework. This process is characterized by a gradual 
interplay of accepting, denying and trivializing. When this process is stimulated, 
well-being is expected to increase, but it is unclear how long this first adaptation 
phase lasts. The ambiguity of the MCI label (Blieszner et al., 2007) may prolong 
in this early phase. Our qualitative data clearly illustrate this early adaptation 
process. The caregivers gave numerous examples illustrating adapted behaviour 
and (re)appraisals of stressors. We consequently hypothesize that the moment of 
evaluation may have been too early to reliably measure quantitative effects in 
burden, well-being, distress, acceptance, helplessness or alertness to memory 
changes. 
A second factor that may explain the absence of beneficial effects on the outcome 
measures is the heterogeneity of the MCI concept. In our sample all three 
subtypes were present (Petersen, 2004) and different clinical patterns for 
amnestic and non-amnestic patients have been reported (Rozzini et al., 2008). 
Possibly, the significant others of amnestic MCI patients may face different 
problems than the caregivers of non-amnestic MCI patients. Consequently, the 
inclusion of patients with different MCI subtypes may have increased the diversity 
in the problems faced by their caregivers. Future studies on interventions for MCI 
patients and their primary caregivers should include larger samples of the 
different MCI subtypes to facilitate more detailed subgroup analyses. 
Thirdly, the outcome measures we opted for may, in retrospect, not have been 
optimal for determining post-intervention changes in our trial, as they may have 
been too general (i.e. not specific for MCI). The qualitative data provided 
information that is useful for selecting more appropriate outcome measures. 
Specifically, in their programme evaluations the significant others gave numerous 
examples of augmented instrumental and emotional coping skills. The categories 
in the coping theme reflected improved coping with the main stressors, i.e. 
memory and relational problems and negative reactions like feeling guilty or 
feeling alone. These descriptions reflect a change in attitude, which has been 
suggested as one of the most crucial achievements for caregivers, enabling them 
to cope with the MCI-related changes (Blieszner and Roberto, 2010). More 
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specifically, instruments assessing coping skills such as the capacity and 
willingness to take care of one’s own health, openness to respite care, and 
communication skills aimed at communication with a loved one with memory or 
other cognitive problems may be more sensitive to change and thus more 
appropriate outcome measures (Blieszner and Roberto, 2010). As far as we know, 
such a syndrome-specific coping inventory has not yet been developed for MCI, 
but our findings again illustrate the need for  instruments more dedicated to the 
intervention aims, for instance to measure seeing more and new options (Ver-
nooij-Dassen and Mittelman, 2011). 
Although promising, we should take into account the limitations of the present 
study. First, ours was not a fully randomized trial: the patient-caregiver dyads 
were pseudo-randomly assigned to the waiting-list condition on the basis of the 
pseudo-random moment they were referred for treatment. However, the criterion 
for successful randomization seemed to be met, because the treatment and 
control groups did not differ in their baseline outcome measures and patient 
characteristics. Also, the waiting period itself may have affected the intervention 
outcome differentially. Furthermore, the participants we enrolled (estimated at 
approximately 50% of all MCI couples diagnosed in the four participating memory 
clinics) represent only a subgroup of all newly diagnosed MCI patients and their 
significant others. We were unable to directly compare our sample with the dyads 
that were not enrolled, although it is clear that the reasons for not participating 
were very diverse (Joosten et al., 2008b). It is possible that our sample 
predominantly included highly motivated people, who may be more open to 
support and possibly had adequate coping yet. 
In conclusion, our psychotherapeutic intervention for individuals with MCI and 
their primary caregivers is feasible and appears to be beneficial for some – but 
not all – significant others. Although no statistically significant effects on 
well-being, distress, burden or illness cognitions were found after the intervention 
relative to the waiting-list control condition, the qualitative analysis showed that 
the programme facilitated the learning process of the significant others, enabling 
them to take better care of their MCI-affected partner or loved one by helping 
them to change their insight into and attitude toward the MCI-related problems 
and discover new ways to cope with these. 
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Abstract
The present study examines the long-term effects of a 10-session cognitive 
behavioural group therapy for patients with mild cognitive impairment (MCI) and 
their significant others 6 to 8 months after completion of the intervention. 
Forty-seven MCI patients participated in the follow-up assessment and 47 
significant others. Results of the RAND-36, Illness Cognition Questionnaire, 
IQCODE, GDS-15 and Sense of Competence Questionnaire at follow-up were 
compared with the post-intervention assessment. Our findings showed that the 
increased level of acceptance in the MCI patients was maintained at follow-up, 
with an increased insight into their cognitive decline compared to post-interven-
tion assessment (p<0.001). In both the patients and the significant others, 
helplessness and wellbeing were worse at follow up (p<0.05), and burden of 
caregiving increased in the significant others (p<0.05). These results indicate a 
need for extension of the support after completion of the program, for example by 
providing regular booster sessions.    
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Introduction 
Patients with Mild Cognitive Impairment (MCI) experience subjective cognitive 
losses that can be objectively assessed using neuropsychological tests, but that 
do not yet impair daily functioning (Petersen et al, 2001). There is increasing 
evidence that MCI can be considered a transitional phase between healthy 
ageing and dementia, and different MCI subtypes have been identified, i.e. 
amnestic MCI, multiple-domain MCI and single non-memory MCI (Petersen, 
2004). However, as a diagnostic entity MCI is still under discussion (Whitehouse 
& Moody, 2006). For example, annual conversion rates vary greatly from 2 to 31% 
(Bruscoli & Lovestone, 2004). In addition, it is clear that not all patients diagnosed 
with MCI in the end will develop a dementia syndrome (Panza et al., 2005). 
Consequently, patients with MCI and their partners, children or friends not only 
have to deal with an uncertain prognosis, but the diagnostic label and the related 
cognitive changes may also affect their wellbeing (Joosten-Weyn Banningh, 
 Vernooij-Dassen, Olde-Rikkert & Teunisse, 2008a). Therapeutic interventions aimed 
at psycho-education, cognitive rehabilitation and/or psychological distress may be 
effective in ameliorating the changes experienced by patients and their significant 
others.
A recent study demonstrated that a rehabilitation programme aimed at teaching 
MCI patients practical strategies resulted in improvements in processing speed, 
quality of life and daily functioning (Jean et al., 2010b). Results of other studies on 
cognitive rehabilitation in MCI, however, are inconclusive (Kinsella et al., 2009; 
Rapp, Brenes & Marsch, 2002; Troyer, Murphy, Anderson, Moscovitch, & Craik, 
2008). Although the findings with respect to the efficacy of cognitive rehabilitation 
in MCI are mixed, it is likely that compensatory strategies, which are acquired 
before cognitive functioning declines, may be most relevant for daily life. 
Furthermore, previous findings have demonstrated the need for information in 
MCI patients and their partners (Joostenet al., 2008a). Based on a meta-analysis 
on psychosocial interventions in (early) dementia (Brodathy, Green, & Ko, 2003), 
a therapeutic programme for MCI may be more beneficial if the patients’ significant 
others actively participate as well. Moreover, a recent study by Ryan and 
colleagues (2010) highlights that already in the MCI stage partners express a 
need towards coping strategies aimed at the patients’ neurobehavioral symptoms. 
We developed an intervention for MCI patients and their significant others aimed 
at increasing the use of memory strategies and external aids, increasing wellbeing, 
the diminishing of feelings of distress and helplessness, acceptance of memory 
LONG-TERM EFFECTS OF A GROUP THERAPY FOR PATIENTS WITH MCI AND THEIR SIGNIFICANT OTHERS 
8
132
loss, and the strengthening of the partner relation (Joosten et al, 2008b). A pilot 
study demonstrated a heightened level of acceptance and a trend towards a 
higher marriage satisfaction in participants of the group intervention (Joosten et 
al., 2008b). Moreover, a subsequent controlled study in a larger sample showed 
increased levels of acceptance in the MCI patients and lower levels of helplessness 
after the intervention period compared to a waiting-list period (Joosten et al., 
2011). After completion of the programme, the patients’ significant others reported 
that their knowledge of MCI had improved and that they feel equipped to apply 
this knowledge and insight in daily practice. However, no significant differences 
were reported on level of acceptance, burden wellbeing or distress after 
completion of the intervention compared to the waiting-list control period (Joosten 
et al., submitted).    
It was the aim of the present study to investigate the long-term effects 6 to 8 
months after completion of the intervention. We examined the long-term effects 
for both the patients and their significant others. Main research question was to 
investigate whether the beneficial effects of the intervention on acceptance in the 
patients were still present at follow-up. With respect to the significant others, a 
belated effect of the intervention could have occurred, resulting in increased 
levels of acceptance and a decreased burden of care-giving at follow-up 
compared to the assessment after completion of the intervention. In addition, we 
explored whether levels of helplessness, wellbeing and mood at follow-up differed 
from the post-intervention assessment. 
Methods
Patients
Patients and their significant others were recruited through the memory clinics of 
four hospitals in the Nijmegen region in the Netherlands. Patients and significant 
others were asked to participate in the intervention between 2003 and 2007. 
Inclusion criteria were 1) a diagnosis of MCI, 2) age over 50, and an available 
significant other who was able to participate as well (this could be a partner, child 
or good friend). The diagnosis MCI was based on the criteria described by 
Petersen et al. (2004), that is, having self-reported cognitive complaints, intact 
overall cognitive function and no deficits in activities of daily living and an objective 
deficit in one cognitive domain or if more than one cognitive domain showed his/
her performance below average, on neuropsychological tests corrected for age 
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and education level. The clinical diagnosis was determined in a multidisciplinary 
team, supported by neuroimaging, extensive neuropsychological testing, the 
patient’s medical history and an interview with the patient and significant other 
(Joosten et al., 2011). 
After the patient and their significant other gave written informed consent, both 
were asked to complete a number of questionnaires and cognitive tests before 
the start of the treatment and after the intervention. Patients that were assigned to 
a waiting list because of logistic reasons served as controls and completed the 
intervention programme after the waiting-list period because of logistic reasons. 
All participants were invited by letter to participate in a follow-up assessment 6 to 
8 months after the post-intervention assessment. After giving consent, the 
participants completed the questionnaires that were sent and returned through 
postal service. No cognitive tests could be administered at follow-up. 
Materials and Procedure
Baseline characteristics
At baseline, overall cognitive performance was assessed using the Mini-Mental 
State Examination (MMSE) (Folstein, Folstein, & McHigh, 1975). Episodic memory 
was measured using the Dutch version of the Rey Auditory Verbal Learning Test 
(RAVLT; Van der Elst, Van Boxtel, van Breukelen, & Jolles, 2005). Education level 
was classified using a 7-point scale based on the Dutch educational system 
(1=less than primary school; 7=university degree). The Dutch version of the 
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE; De Jonghe, 
Schmand, Ooms & Ribbe, 1997a) was used as a subjective rating of cognitive 
deterioration over the last 10 years, both completed by the patient with MCI 
(IQCODE-patient) and by the patient’s significant other (IQCODE-other). 
Outcome measures
For the present study, only the data of the post-intervention assessment (T2) and 
the 6- to 8- month follow-up assessment (T3) were taken into account. The 
following outcome measures were used: the 15-item Geriatric Depression Scale 
(GDS-15; Herman et al., 1996) to assess depressive symptoms, the Dutch version 
of the RAND-36 (short form, subscales Social Functioning, Role-Emotional, 
Mental Health, and Vitality; Van der Zee & Sanderman, 1993) as a measure of 
general wellbeing and quality of life and the subscales Acceptance and 
Helplessness of the Illness Cognition Questionnaire (ICQ; Evers, Kraaimaat, van 
Lankveld, Jongen, Jacobs, & Bijlsma, 2001). The Sense of Competence 
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Questionnaire (SCQ; Vernooij-Dassen, Persoon, & Felling, 1996) was administered 
in the significant others as a measure of burden of care-giving. The total scale 
score ranges from 27 to 135, with higher scores reflecting a lower burden. The 
IQCODE (completed by the patients and the significant others) was also 
administered at T2 and T3, with questions aimed at the cognitive changes during 
the intervention period and follow-up period respectively. All outcome measures 
were administered to the patients as well as to the significant others. 
Intervention
The intervention was based on cognitive behavioural therapeutic principles 
combined with elements of psychoeducation and memory rehabilitation, and 
consisted of ten weekly 2-hour group sessions, described in detail elsewhere 
(Joosten et al., 2008a). Each group consisted of five to eight patients all 
accompanied by a significant other, i.e. a partner, adult child, relative or close 
friend. The focus of the intervention was the acquisition of knowledge of and skills 
to adequately cope with MCI-associated symptoms and their sequelae. All 
therapists were psychologists who were trained and supervised by the first author. 
The procedure described by Snyder, Quayhagen, Shepherd, and Boweret (1995) 
was applied in that the first 90 minutes of each 2-hour session the patients and 
their significant others participated in separate groups, each with its own therapist, 
both groups exploring the same topics and receiving similar (oral and written) 
information with relevant home assignments. In the last 30 minutes of each 
session, the two groups came together and the main issues from the preceding 
session were summarized and highlighted. 
Statistical analyses
Differences on the baseline assessment (T1) between the participants who took 
part in the follow-up assessment at T3 and those who did not participate in the 
follow-up assessment were compared using independent-sample t-tests. In order 
to analyze the changes in the outcome measures between T2 and T3, a doubly 
multivariate repeated measure analysis (general linear model) was performed 
with Time as within-subject factor (two levels: T2 and T3) for the outcome 
measures listed above. These analyses were performed for the MCI-patients and 
the significant others separately and effect sizes were computed (Cohen’s d) that 
were interpreted as small, moderate or large using convention (Cohen, 1988).
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Results
Ninety-three patients with MCI and 89 significant others have participated in the 
intervention (for details see Joosten-Weyn Banningh et al., 2010, 2011). Six of 
these patients and five significant others dropped out during the intervention 
because of somatic problems unrelated to the MCI or lack of motivation. In total, 
87 MCI patients and 84 significant others completed the intervention. Of these, 47 
MCI patients (50.5%) and 47 significant others (52.8%) were willing to participate 
in the follow-up assessment (T3). Table 8.1 shows the baseline characteristics of 
the MCI patients who completed the follow-up assessment at T3 (MCI participants) 
LONG-TERM EFFECTS OF A GROUP THERAPY FOR PATIENTS WITH MCI AND THEIR SIGNIFICANT OTHERS 
8
Table 8.1   Baseline characteristics at T1 (means+SD or distribution/
percentages) of the MCI patients who participated in the follow-up 
assessment and those who did not 
T3 MCI
 
participants
(N=47)
T3 MCI 
non
participants
(N=40)
Statistical test p-value
Demographic variables
Age 69.9 (7.3) 71.1 (6.7) t(85) = .78 0.441
Education level 5.3 (0.9) 4.7 (1.1) t(85) = -2.73 0.008**
Sex distribution (m:f) 27:20 15:25 U=752.5, Z= -1.85 0.065
Cognitive measures
MMSE 25.7 (3.2) 25.1 (3.8) t(73) = -.81 0.421
RAVLT total score 27.1 (8.8) 24.0 (5.5) t(58.2) = -1.68 0.098
RAVLT delayed recall 3.2 (2.9) 2.3 (1.5) t(51.5) = -1.39 0.172
IQCODE-patient 58.4 (7.9) 57.1 (7.9) t(83) = -.72 0.473
Outcome measures
GDS-15 3.2 (2.6) 3.2 (2.0) t(85) = .10 0.920
GDS-15 > 5 (%) 14.9 % 15.0 %  U=939.0, Z= -0.14 0.989
RAND-36 short form 295.4 (65.7) 267.7 (68.7) t(77) = -1.81 0.074
ICQ Acceptance 15.0 (4.4) 12.6 (3.9) t(84) = -2.72 0.008**
ICQ Helplessness 10.4 (2.7) 11.5 (3.2) t(84) = 1.72 0.089
* p ≤ .05, ** p  ≤ .01
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and the MCI participants who did not participate in the follow-up. Significant 
differences were found on education level and the Acceptance subscale of the 
ICQ, with the nonparticipants having a lower education and lower levels of 
acceptance than the participants. Table 8.2 shows the baseline characteristics of 
the significant others who participated in the follow-up assessment (significant 
other participants) and those who refused to participate after T2 (significant other 
nonparticipants). The follow-up nonparticipants had higher levels of Acceptance 
and Helplessness on the ICQ than the participants. 
Table 8.3 shows the results for the outcome measures of the MCI participants on 
the post-intervention assessment (T2) and the follow-up assessment (T3). 
Patients had lower scores on the short form of the RAND-36 at T3 compared to 
T2 (F(1,46)=4.2, p=0.045), the effect size (d=-0.20) reflecting a small change 
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Table 8.2   Baseline characteristics at T1 (means+SD or distribution/
percentages) of the significant others who participated in the 
follow-up assessment and those who did not 
T3 MCI
 
participants
(N=47)
T3 MCI 
non
participants
(N=40)
Statistical test p-value
Demographic variables
Age 68.5 (7.6) 68.5 (9.3) t(83) = .02 0.982
Education level 5.0 (1.0) 5.0 (1.0) t(83) = .00 1.00
Sex distribution (m:f) 16:31 19:19 U=750.5, Z=-1.48  0.140
Cognitive rating
IQCODE-other 61.7 (7.2) 63.8 (7.5) t(83) = 1.32 0.189
Outcome measures
GDS-15 2.2 (2.2) 1.9 (2.3) t(82) = -.62 0.538
GDS-15 > 5 (%) 10.6 %   7.9 %  U=847.5, Z=-0.39 0.697
RAND-36 short form 289.0 (68.3) 311.5 (64.5) t(76) = 1.45 0.151
SCQ total 85.5 (22.1) 92.9 (18.9) t(75) = 1.47 0.147
ICQ Acceptance 16.0 (4.8) 18.8 (4.0) t(68) = 2.50 0.015*
ICQ Helplessness 10.5 (3.1) 8.8 (2.3) t(68) = -2.43 0.018*
* p ≤ .05
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(Cohen, 1988). Subsequent analyses per subscale only demonstrated a small 
(d=-0.24), but significant difference on the subscale Mental Health (F(1,46)=4.2, 
p=0.047). A marginally significant higher score (d= 0.35) on the ICQ subscale 
Helplessness was found at T3 compared to T2 (F(1,46)=4.0, p=0.05). A moderate 
increase (d=0.56) in reported cognitive deterioration was found on the 
IQCODE-patient at T3 compared to T2 (F(1,46)=13.5, p=0.001). No significant 
differences were found on any of the other outcome measures in the MCI patients 
(all F-values<3.6). The outcome measures for the significant others are displayed 
in Table 4. A small, yet significant change was found on the GDS-15, on which the 
significant others reported higher levels of depressive symptoms at T3 than at T2 
(F(1,46)=5.0, p=0.031). Moreover, the significant others had slightly lower scores 
on the overall measure of the short form of the RAND-36 at T3 compared to T2 
(F(1,46)=4.6, p=0.038) and on the SCQ (F(1,46)=4.3, p=0.045.). No significant 
differences were found on any of the other measures in the significant others (all 
F-values<3.1).      
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Table 8.3   Outcome measures (means, SD and effect size) for the MCI 
participants at post-intervention assessment (T2) and at 6- to 
8-months follow-up (T3) 
Outcome measure T2 T3 Cohen’s d
GDS-15 3.2 (3.1) 3.5 (3.2) 0.10
RAND-36 short form  287.99 (73.3) 273.3 (74.0) -0.20*
RAND-36 Social Functioning 77.7 (21.2) 72.8 (20.1) -0.23
RAND-36 Vitality 63.7 (17.4) 59.8 (17.4) -0.22
RAND-36 Role-Emotional 73.8 (37.4) 71.6 (39.9) -0.06
RAND-36 Mental Health 72.9 (15.0) 69.3 (13.2) -0.24*
ICQ Acceptance 15.7 (4.6) 15.2 (4.5) -0.11
ICQ Helplessness 10.2 (2.6) 11.1 (2.7) 0.35*
IQCODE-patient 55.4 (10.7) 61.4 (8.6) 0.56**
* p ≤ .05, ** p ≤ .001
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Discussion
It was the aim of the present study to investigate changes in acceptance, 
helplessness, mood, wellbeing and sense of competence 6 to 8 months after a 
psychotherapeutic group intervention in MCI patients and their significant others. 
With respect to the findings in the MCI patients, no significant follow-up differences 
were found on acceptance compared to the post-intervention assessment. As we 
previously reported an increase in levels of acceptance in the MCI patients after 
the intervention compared to baseline (Joosten et al., 2011), the present findings 
indicate that the patients are able to maintain the beneficial effect of the 
intervention with respect to acceptance up to 8 month after the treatment has 
been completed. With respect to helplessness, patients reported slightly higher 
levels of helplessness at follow-up compared to post-intervention. Moreover, 
patients reported a lower quality of life at follow-up, specifically with respect to 
their mental health status, and rated their own cognitive performance as worse 
compared to the post-intervention assessment. These findings may be interpreted 
in the light of the progressive cognitive decline that is expected in MCI. An 
important finding is that the patients showed more insight into their cognitive 
problems, as their subjective ratings are more in agreement with those of the 
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Table 8.4   Outcome measures (means, SD and effect size) for the significant 
others at post-intervention assessment (T2) and at 6- to 8-months 
follow-up (T3) 
Outcome measure T2 T3 Cohen’s d
GDS-15 2.0 (2.6) 2.5 (3.0) 0.19*
RAND-36 short form 287.6 (76.7) 271.9 (83.7) -0.20*
RAND-36 Social Functioning 78.5 (20.8) 73.9 (21.8) -0.22
RAND-36 Vitality 61.8 (17.9) 61.8 (21.8) 0.00
RAND-36 Role-Emotional 75.9 (38.5) 66.7 (42.3) -0.23
RAND-36 Mental Health 71.5 (17.6) 69.4 (17.9) -0.12
SCQ Total 88.0 (23.0) 81.0 (27.6) -0.30*
ICQ Acceptance 16.2 (4.2) 16.4 (4.0) 0.05
ICQ Helplessness 10.3 (3.1) 10.5 (3.3) 0.06
IQCODE-patient 63.8 (8.7) 63.5 (10.5) -0.03
* p ≤ .05
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significant others than at baseline (Dekkers, Joosten-Weyn Banningh, & Eling, 
2008). Insight is a prerequisite for successful psychotherapeutic intervention 
(Clare, 2004b; Koltai, Welsh-Bohmer, & Schmechel, 2001) and lack of insight may 
result in unreliable ratings of quality of life in MCI (Berwig, Leicht, & Gertz, 2009). 
This improved insight may have resulted in more reliable subjective ratings by the 
patients with respect to mood and helplessness (cf. Bruce et al., 2008b). It should 
be stressed, however, that the lower wellbeing as reported on the RAND-36 is not 
reflected on the GDS-15 using the widely-used cut-off score of 5, which is 
regarded as indicative for the presence of a clinical depression. With respect to 
the changes reported in the significant others, no differences were found with 
respect to acceptance and helplessness at follow-up. Here, it should be noted 
that feelings of helplessness were already very low at baseline, i.e. before the 
start of the intervention, and levels of acceptance were already high at this point 
(Joosten et al., 2011). As a result, it may have been difficult to improve these 
further during the intervention period. Mood, wellbeing and sense of competence 
worsened in the 6 to 8 months after the intervention, although effect sizes can be 
regarded as small. Still, in order to strengthen the caregivers’ competence in 
caring or reduce the burden of caregiving, this might be the optimal period to 
support caregivers. This is in agreement with a qualitative post-intervention (T2) 
analysis of the evaluations of the significant others who took part in the study 
(Joosten et al., submitted). Here, the significant others reported a need for a 
longer group programme or follow-up interventions. 
Several limitations of the present study should be highlighted. First, a selection 
bias is present. Although the drop-out rate during the intervention was low, 
indicating a high motivation to participate in the intervention, only 50.5% of the 
patients and 52.8% of the significant others participated in the long-term follow-up 
assessment. The MCI nonparticipants at follow-up were characterized by having 
a lower education level and lower levels of acceptance. Participants with lower 
education levels are generally more likely to drop out in behaviour therapy studies 
(Keijsers et al, 2001), but we cannot conclude anything with respect to the 
long-term effects of the intervention in these nonparticipants. As the MCI nonpar-
ticipants appeared to have profited most from the intervention with respect to 
acceptance, it is still unclear whether this benefit is maintained over a longer time 
period in this group. In this light, it is remarkable that of the significant others, 
those who had higher levels of acceptance and more feelings of helplessness 
refused to participate in the follow-up assessment. Future studies should make 
an effort of recruiting more participants for such a follow-up assessment. 
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Second, we could not include objective measures of cognitive deterioration at 
follow-up. Although the significant others did not report a statistically significant 
cognitive decline in the follow-up period, it would have been interesting to examine 
the neuropsychological test performance in our sample at T3. Possibly, some 
patients may have converted to a clinical dementia at follow-up. In turn, it is likely 
that inclusion of neuropsychological tests at T3 would have resulted in even 
higher drop-out rates, as this would have required all participants to visit the 
hospital and participate in cognitive testing which may be confronting. 
A third limitation is the lack of a control group for the comparison of the follow-up 
assessment (T3) with the post-intervention assessment (T2). While the 
intervention’s effectiveness itself (T2 versus T1) was studied in a controlled design 
using a waiting-list period of 8 weeks or more before the intervention, it would 
have been unethical to extend this waiting-list period with another 6 to 8 months 
without any treatment. Finally, the selection of outcome measures could be 
debated. That is, previously reported qualitative analyses of the evaluations by 
the participants after completion of the intervention already showed beneficial 
effects that were reported by many, but which were not reflected on the 
standardized questionnaires. As it is clear that quantitative and qualitative 
analyses may result in discrepancies (Moffat et al, 2006), it would be interesting 
to perform a qualitative study on the long-term effects as well.
In all, the present study extends previous findings showing that a group 
intervention for MCI patients and their significant others results in beneficial 
effects on acceptance, which are maintained for up to 8 months after completion 
of the treatment. However, feelings of helplessness were slightly higher in the MCI 
patients at follow-up, but the patients’ insight improved over this period. General 
wellbeing was worse at follow-up in both the MCI patients and the significant 
others. An extension of the current intervention is recommended which facilitates 
support during the uncertain period in which a patient has the diagnosis MCI, 
aimed at the needs of patients and their partners, children or friends. Regular (i.e. 
monthly) booster sessions could be aimed at improving feelings of control (self 
efficacy) in order to lower feelings of helplessness and improve wellbeing. For the 
significant others, support aimed at coping with the consequences of MCI in their 
loved one is required, which may also improve their wellbeing and lower the 
burden of care-giving.
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Summary
As a result of the possibilities to diagnose neurodegenerative diseases in 
increasingly earlier stages a growing group of individuals with cognitive 
impairment due to neurodegenerative disease exists that does not yet fulfil the 
criteria for dementia. Persons in this transitional stage who have impairment in 
one or more cognitive domains can be classified with the label Mild Cognitive 
Impairment (MCI) or as having preclinical or prodromal (Sperling, 2011). 
Individuals with MCI are at greater risk to develop dementia in the following years, 
but many also stay stable for a long period of time. By definition, persons with 
MCI function independently, in that the cognitive impairment does not affect their 
daily functioning. Incidence of mood disorders, such as dysphoria, anxiety, 
restlessness or irritability, is however higher in persons with MCI than in healthy 
age-matched controls, although to a lesser extent than reported in patients 
diagnosed with dementia (Hwang et al. 2004; Apostolova and Cummings, 2007). 
The same holds for the significant others of persons with MCI, in whom heightened 
depressive symptoms have been reported (Yueh-Feng 2007; Garand 2005; 
Bruce, 2008a; Blieszner, 2010). These increased distress levels in both persons 
with MCI and their significant others may reflect their coping behaviour, as part of 
the adaptation process. (Early) dementia is strongly related to psychiatric 
comorbidity and behaviour problems in patients, resulting in high burden levels in 
caregivers. (Schulz 2004.) Caregivers of persons with MCI also express the need 
for support services at a similar level as reported by caregivers of patients with 
Alzheimer’s dementia (Ryan 2010). Thus, coping strategies should already be 
strengthened in patients and their caregivers in the MCI stage. 
The main aim of the present thesis was to develop and evaluate an intervention 
programme for persons with MCI and their partners that supports them and 
improves their coping in order to enhance well-being. First, an introduction in 
which MCI was defined and an overview of some general consequences of MCI 
for patients and their significant others was given (chapter 1). Next, in Part I, I 
investigated how MCI patients experience and cope with their cognitive decline 
(chapter 2). In Chapter 3, awareness of memory impairment in MCI patients was 
studied. In part II the development of the intervention is described (chapters 4 
and 5). Finally, in Part III (chapters 6,7,8) we present the results of the studies on 
the efficacy of our comprehensive group intervention for both the MCI patients 
and their significant others. In this chapter, firstly the overall findings are briefly 
summarized and their limitations are addressed, followed by methodological 
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considerations. Practical implications for improving the intervention are discussed, 
and suggestions for future studies are presented. 
Part I: Consequences of MCI for patients
The primary aim of the study in Chapter 2 was to investigate how patients fulfilling 
MCI criteria experience and cope with their cognitive decline with the secondary 
aim to derive key themes for a prospective MCI support-group programme. 
Based on the procedure of the grounded theory, the verbatim of guided interviews 
with eight MCI patients were analyzed. Related to the cognitive impairment, 
patients reported changes in mobility, affect, vitality and somatic complaints. The 
patients reported a wide range of consequences that affected their personal and 
interpersonal wellbeing. Many of them tended to disagree and argue with their 
spouses about the nature of their memory failure. Initially the label MCI gave 
relief, but in many persons this was mixed with worrying and pondering on causes 
for the changes they experience. Etiologies, such as personality traits (like 
laziness); overload of information or a fearsome explanation such as a brain 
tumor, are considered by many patients. This study confirmed the information 
need and provided key themes for the MCI support-group programme. 
In all, the intervention should focus on providing information about the syndrome’s 
causes, course, concomitant symptoms, social consequences, and available 
treatments and strategies to enhance or support the cognitive functioning. The 
patient’s cognitions and attributions should be explored to identify and modify 
inappropriate attributions and thoughts that educe a negative mood. Additionally, 
to prevent social isolation, interactions between the patients and their partners 
and social environment should be encouraged and enhanced. 
The main limitation in this study is that we only interviewed patients and did not 
include their proxies. As a result, the results we obtained could be incomplete or 
biased. Despite this limitation, the extensive interviews resulted in important 
insight that helped us to set up our therapeutic programme. 
In Chapter 3 awareness of memory impairment in MCI patients was examined. 
Discrepancies between MCI patients’ subjective reports on their cognitive decline 
and the corresponding reports of their caregivers were analysed. The results of 
this study with 61 MCI ‘patient-significant other’ couples and 40 age- and educa-
tion-matched healthy couples suggest a diminished awareness in 60% of the MCI 
patients. Impaired awareness is related to higher levels of cognitive impairment. 
To conclude, considering the influence of awareness on treatment success and 
social interactions, the information of this study was of importance in diagnosing 
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and supporting MCI patients and their significant others. In MCI, awareness 
should be examined followed by psychoeducation for the patient and his or her 
significant other.  Increasing insight may positively influence treatment compliance 
and enhance therapeutic effects. 
Although discrepancy scores between ratings of cognitive changes by patients 
and significant others are widely used to validly measure awareness, there is 
some evidence that the awareness of the significant others of patients with MCI 
can be affected in this early stage as well. This may have resulted in an under-
estimation of the lack of awareness in patients in our study. Future studies 
using awareness measures that include more objective ratings, e.g. structured 
interviews that can be completed by the clinician (Prigatano, 1998), can take this 
underestimation into account.
Part II:  The development of the intervention 
At the start of this research project, no information on MCI support groups was 
available. Therefore, we evaluated an ongoing support group for persons with 
mild to moderate Alzheimer disease in the United States in Chapter 4. Main aim 
was to evaluate the efficacy of these support groups based on the participants’ 
feedback. This survey offered also insight into the valued aspects and themes of 
support groups that, in addition to those reported in chapter 2, define key themes 
for setting up an intervention for persons with MCI. A survey questionnaire was 
administered in 70 support-group participants with Alzheimer’s dementia who 
participated in one of eight well-established group programmes across the United 
States. Participants reported on the educational value, positive socialization, and 
improved ability to cope with symptoms and to accept the diagnosis as a result 
of participating in a support group. Interestingly, those persons who reported to 
accept the diagnosis also expressed to have a better understanding of AD and 
felt less frightened or anxious. These findings emphasize the relationship between 
higher levels of acceptance, increased knowledge and improved coping.  
The reported findings also stressed the importance of creating more sensitive 
measures for evaluating the effects of support groups for persons with (early) 
dementia, especially focusing on disorder-specific coping, stress and acceptance. 
This study again showed that that even patients with early to mild dementia are 
able to validly report their experiences and evaluations.  
However, as this study was performed in the USA, it could be argued that the needs 
of dementia patients in the USA differ from those in the Netherlands. Furthermore, 
differences in access to health-care services between the US and the Netherlands 
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may have resulted in a selection bias that make the results less easy to translate to 
(early) dementia patients in general. Finally, the study was aimed at dementia patients, 
whereas our group programme is aimed at people with MCI.  
Chapter 5 described and evaluated the group intervention in a pilot study. The 
focus of the programme was the acquisition of knowledge and skills to adequately 
cope with MCI-associated symptoms and their consequences, learning to 
recognize memory problems in daily life and to explore explanations and 
attributions, communication with partner and others, and self-regulation skills. 
Also, topics such as diagnostic uncertainty, dependency on others and 
stigmatization were discussed in relation to each theme. The intervention was 
multi-factorial and consisted of ten weekly sessions of two hours. The intervention 
comprised several cognitive rehabilitation, psychoeducation and psychothera-
peutic components. In this chapter, the components, the structure of each 
session and the methods were described in detail. An important aspect of our 
intervention was that a significant other participated in the intervention. At the 
beginning of each session patients and their significant others were first separated 
into two separate groups (a patient group and a significant others group), each 
with its own therapist. During the first 90 minutes of each session both groups 
explored the same topics and received similar (oral and written) information with 
relevant home assignments. For the remaining 30 minutes the two groups were 
merged and the key issues from the preceding session were summarized and 
highlighted. 
Next, the applicability and feasibility of the intervention were evaluated in a pilot study. 
The preliminary results of our programme showed various beneficial effects in the 
patients. Most important were the beneficial effects on the acceptance of their 
memory problems and a positive trend for improved marital satisfaction in the MCI 
group. The acceptance effect was related to the patients’ educational level and their 
pretreatment memory performance: lower education level and lower baseline 
memory scores were associated with more positive change in acceptance. In the 
significant others, the alertness towards their partners’ mnemonic and behavioral 
problems increased. No significant changes were found on measures for distress 
and well-being. The relatively low levels of distress and normal levels of well-being at 
baseline could explain this. The attendance rate was high and only one couple 
dropped out because of a serious medical illness. On the basis of the effects sizes 
we found in this study, we estimated the number to treat in a case–control study on 
approximately seventy patients and controls. 
To conclude, this pilot was the first study that described and evaluated a psycho-
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therapeutic intervention for MCI patients and their significant others. Our group 
program is a feasible intervention for patients with MCI and their significant 
others. The programme contributes to acceptance of the memory impairment 
and alertness to the everyday changes in the patients by the significant others. 
High attendance rates suggest that the intervention fulfils a need for assistance 
and information in MCI patients and their significant others. The main limitation of 
this pilot study is that it lacked a control condition, which we took into account in 
the larger study (Chapters 6 and 7). 
Part III: The efficacy of the intervention 
In Chapter 6, we investigated the efficacy of the intervention for the MCI patients using 
a controlled design. Ninety-three patients participated in the intervention, thirty of 
whom being first assigned to a waiting list condition, thus serving as their own control 
group. Based on our pilot data and other empirical evidence suggesting that 
acceptance plays a crucial role in coping with chronic medical conditions, 
‘acceptance’ was included as the primary outcome measure in this trial. In addition, 
we evaluated well-being, distress and feelings of helplessness, expecting 
helplessness to be reduced due to the psychoeducation and coping strategies 
offered in the programme. Compared to the waiting-list period, the intervention was 
effective in enhancing the acceptance level after completing the intervention. The 
intervention did not alter the level of distress and general well-being. Female patients 
showed a decrease in feelings of helplessness. Comparing the patients who profited 
with those who did not, showed that the first group was characterized with higher 
levels of helplessness at baseline. 
The results of this chapter demonstrate that our comprehensive psychotherapeutic 
group programme for MCI patients and their significant others yielded significant, 
yet small results on the primary and secondary outcome measures. The 
programme increased the patients’ acceptance of their condition and decreased 
feelings of helplessness in the female patients specifically. Based on the current 
results we venture that the efficacy of our intervention may be improved by 
tailoring the content to patients sharing particular pertinent characteristics and by 
incorporating more gender-specific themes.
Main limitation of this study is that the patient dyads were assigned to the 
waiting-list condition based on the (pseudo-random) moment the patients were 
referred for treatment, making it not a fully randomized trial. Yet, the criterion for 
randomization was met, as the two groups did not differ in the baseline outcome 
measures and patient characteristics. 
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In Chapter 7 the efficacy of the intervention for the significant others was explored 
using the same controlled design. We used both quantitative and qualitative 
analyses to evaluate the intervention. Combining quantitative with qualitative 
measures may reveal the responses of significant others in more detail. Compared 
with the waiting-list control period, the intervention did neither show significant 
quantitative effects on burden, distress and well-being, nor on illness cognitions 
and alertness to memory changes. In contrast to the results of these quantitative 
analyses, the qualitative data point towards favourable effects on distress, 
knowledge, insight, and coping in the significant others. Specifically, these 
qualitative results indicated that the intervention facilitated the process of learning 
to live with or care for a loved one with MCI. Caregivers also expressed an overall 
improved sense of relaxation and inner calm. 
Again, this study was not fully randomised; the patient-caregiver dyads were 
pseudo-randomly assigned to the waiting-list condition on the basis of the 
pseudo-random moment they were referred for treatment. Furthermore, we 
included only motivated dyads and could not compare our participants with the 
nonparticipants.  
Finally, in Chapter 8 we investigated whether the beneficial effects of the 
intervention on acceptance in the patients were still present after a follow-up 
assessment. Comparison of follow-up assessment, six to eight months after 
completion of the intervention, with the assessment directly after completion of 
the intervention showed a stable acceptance level in the patients. In addition, 
patients reported more memory impairment in daily life compared to the 
post-treatment level. However, the significant others did not report such a 
deterioration. Thus, the discrepancy between patients and care partners that we 
reported in chapter 3 has decreased, indicating improved awareness. Furthermore, 
the sense of competence of the significant others decreased during this follow-up 
interval. Finally, the levels of helplessness increased and well-being decreased in 
both MCI patients and their caregivers. 
Clearly, our programme shows some belated beneficial effects in the significant 
others, as the increased level of acceptance could be maintained by the MCI 
patients. However, well-being decreased and feelings of helplessness increased, 
which stresses the need for follow-up interventions. Therefore, an extension of the 
current intervention period is recommended that continues to facilitate support 
during this uncertain period, aimed at the needs of patients and their partners, 
children or friends.
A few limitations could be identified in this follow-up study. First, we could not 
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include a control group for this follow-up study because of the waiting-list 
controlled design. Second, a large drop out rate was present. That is, only about 
half of the patients and significant others participated in the long-term follow-up 
assessment. Moreover, the persons who participated in the follow up study 
differed from those who did not. The non-participating MCI patients were 
characterized by lower levels of acceptance and lower education levels, whereas 
the non-participating significant others showed higher levels of acceptance and 
helplessness. 
The results of the studies reported in chapters 2 to 8 show that an intervention 
including elements if psychoeducation, cognitive behavioural therapy and 
cognitive rehabilitation is feasible and effective in MCI patients and their significant 
others. The participants appraised the intervention and the significant others 
reported that their knowledge, insight and coping behaviour has benefited from 
the intervention. They reported the MCI patients profited from a heightened 
acceptance that was still present at the long–term follow-up. A positive effect on 
awareness of their memory problems was found in the MCI patients at follow up. 
Unfortunately, over time well-being decreased and helplessness increased in the 
MCI patients. Caregivers did not show statistically significant changes on the 
outcome measures immediately after the intervention, but we found evidence for 
enhanced levels of competence in caregiving at follow up.  As the patients with 
MCI, the significant others also showed a decrease in wellbeing 6-8 months after 
the intervention was completed. 
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General discussion
In this final section the findings will be evaluated, discussed and recommenda-
tions for improving this psychotherapeutic intervention and its evaluation are 
presented. First, I will address the participants and their selection, second the 
intervention content and methods, and finally the outcome measures. 
Participants
In 2003 we started this research project with a literature study. At the time, there 
was some evidence that distress levels where heightened in MCI patients. This 
was confirmed by the qualitative study on experiences and consequences of MCI 
in patients recently diagnosed with this label. However, results from our pilot 
study showed that the distress levels of our participants were at floor levels, as 
measured with the Geriatric Depression Scale and RAND-36 subscales. As a 
result, a beneficial effect could only be demonstrated on these outcome measures 
if the control group would show an increase in distress compared to a stable 
distress level in the intervention group. In the controlled study we did not find 
evidence for this. Possibly, patients characterized by higher levels of distress 
might show to have better treatment outcomes. Recruiting these patients in the 
future may optimize the treatment’s efficacy. 
Another explanation for our relatively small effects may come from the recruitment 
procedure. MCI patients were informed about the studies both by oral and written 
information given by their geriatricians or neurologists in four different memory 
clinics, immediately after diagnostic disclosure. Only persons who immediately 
expressed their interest then entered the recruitment procedure. The drop out rate 
(4 to 5%) during the intervention period itself was very low. Serious medical illness 
was the major reason to stop, so the recruited couples were very motivated. 
Unfortunately, we have no information on the characteristics of the group that was 
not interested in participating. A post-hoc estimation is that about 30-40% of the 
MCI persons and their significant others were not interested or not able to 
participate in this study. Possibly, the relatively low distress levels in the selected, 
highly interested group may be the result of already adequate coping with the 
MCI diagnosis. In turn, the non-responder group might have had more problems 
with awareness or accepting the MCI. Because we found some indications that 
patients with lower insight levels and lower education profited more from the 
intervention, it is recommended that clinicians should try to motivate patients and 
transform their negative expectations about group programme’s such as this into 
positive ones. 
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Finally, the type of MCI patients may be relevant. In this thesis, MCI refers to three 
subtypes of patients: Patients with amnestic impairments, patients with 
impairments in multiple domains or patients with impairment in a non-amnestic 
domain. To our knowledge, no study exists on differences in patients’ character-
istics such as distress levels, awareness or coping styles between these three 
subtypes. It can be hypothesized that the intervention programme had differential 
effects on the subgroups. Because of the relatively small subgroup sizes we 
could not perform more detailed analyses at a subgroup level. The programme’s 
efficacy, however, could have been affected by heterogeneous reactions due to 
different aetiologies. 
Of interest here are the recently published research criteria for ‘MCI due to Alzheimer’s’ 
disease’ (Albert, 2011). Selection of patients according to these criteria may result in 
more homogeneous groups for studying effects of non-pharmacological interventions. 
However, we feel that our treatment should also be offered to MCI patients not fulfilling 
the criteria for Alzheimer’s disease, as many of these will experience the same 
uncertainty and everyday problems as the Alzheimer-type MCI patients. However 
differences between MCI subtypes should be taken into account in future studies. 
Moreover, because of the growing accuracy to diagnose neurodegenerative diseases 
in early non-dementia stages, the MCI concept may become less relevant in the 
future. As a result, the clinical and often arbitrary distinction between MCI and (early) 
dementia may become less of an issue. Treatments such as ours could then be 
offered to all patients in the early stages of Alzheimer’s disease, irrespective of the 
dementia label. It would be of interest to examine the differential effects of the 
intervention related to disease stage.  
Evaluation of the multi components and therapeutic methods
The programme consisted of elements of psychoeducation, cognitive rehabilitation 
and cognitive behavioural therapy. We intended to increase knowledge about the 
origin of the cognitive changes, and we have taught skills to increase memory 
strategies and MCI-specific coping behaviour. Attributions and appraisals were 
explored and, if not helpful, altered into beneficial cognitions. Apart from 
MCI-specific information and behaviour adaptations, generic chronic-disease 
themes were incorporated into the program as well. Specifically, themes such as 
recognising and dealing with stress, difficult social situations and misunderstand-
ing, and worrying were addressed. These themes make it possible that patients 
or partners can bring in all kinds of personal themes, which is characteristic for 
individualized interventions. (Spijker, 2008)
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There is increasing evidence for the beneficial effects of self-management 
programs for patients with chronic diseases. These programs show some overlap 
in components and themes compared to our program. The beneficial self-man-
agement program developed by Lorig (Lorig, 1999) used trained peers as 
therapists, which might be an essential therapeutic component. Still, the presence 
of cognitive deficits makes it crucial to adapt standard therapy programmes for 
chronic diseases for use in MCI patients. 
Our intervention methods are appealing largely to communicative, social and 
cognitive abilities. Other elements, such as physical exercise, may be incorporated 
as complementary methods (Burgener, 2008; Scherder, 2010). Still, the beneficial 
effects of exercise have to be determined in MCI patients and (early) dementia 
(Scherder, 2010; Lautenschlager, 2008). 
Psychoeducation in both the patients and their significant others groups 
concerned the same topics and both groups received similar (oral and written) 
information with relevant home assignments. We deliberately applied uniformity 
in themes to promote mutual support and collaboration between the participating 
dyads. Nevertheless, differences between the most valued themes were found 
between patients and significant others. That is, the significant others discussed 
more about changing in roles, while the MCI patients spend more time on 
questions about memory-related coping strategies and information. Although 
both groups evaluated working on the same topics as a positive aspect of the 
programme, it could be considered to adjust the programme with some specific 
themes aimed at the specific needs of the MCI patients or the significant others. 
Studies on cognitive rehabilitation programs for patients with MCI have recently 
shown to be promising (Jean, 2010a,b; Clare, 2003). The most frequently reported 
approach in fifteen studies reviewed by Jean (2010b) is cognitive training, 
involving practice on standard tasks designed to address specific aspects of 
cognitive functioning, principally targeting episodic memory. Mnemonic 
techniques included errorless learning, spaced retrieval, mind mapping, 
categorization, method of loci, chunking and cuing (Jean, 2010b). Half of the 
studies performed the training in a group format. Although some studies 
demonstrate modest improvements in performance on trained tasks, it is yet 
unclear whether these improvements are clinically significant or that they 
generalize to everyday functioning (Clare, 2003). Also, it must be taken in account 
that one third of these fifteen studies had a randomized and controlled design. 
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Because of these recent promising results, the time spent on cognitive 
rehabilitation methods could be extended in our intervention and evaluated in a 
future study. 
To date, cognitive behavioural therapy (CBT) based multi-component treatment 
programmes have not been examined yet in MCI. Currently, a controlled study is 
being performed by Forstmeier (Forstmeier, 2011) aimed at mild Alzheimer’s 
disease patients and their caregivers using 20 individual sessions. Furthermore, 
an early-stage dementia group therapy with CBT was evaluated and showed to 
be feasible. This intervention, however, had a high intensity, that is bi-weekly CBT 
sessions during 40 weeks, alternating with physical exercise (Burgerer 2008), 
making it less feasible in the Dutch elderly-care system. 
In CBT, homework or self-help assignments are an important component that was 
included in our intervention as well. Homework helps to promote changes in 
patient behaviour and to support therapeutic gains between sessions. In a 
meta-analysis on the effects of CBT in general, homework compliance proved to 
be a significant predictor of positive therapy outcome (Kazantzis, 2000).  A later 
study showed this to be true also for depressed older adults who were being 
treated with CBT (Coon, 2003). In our study, a large group of the participants 
however, had difficulties with performing the homework assignments. It is 
recommended to emphasise the importance of the homework assignments and 
to adapt the instructions and information to the specific patient sample. 
Compliance may be increased by explicitly exploring barriers or reasons for not 
performing the assignments and by making adaptations such as simplifying and 
limiting the number of concepts used, shortening the information and tasks or 
working on homework at fixed moments together with the significant other. (Coon, 
2002; Coon, 2007)
The evaluation of the number of sessions (10) was mixed: some participants felt 
sufficiently equipped to cope (better) on their own after 10 sessions, while many 
expressed their wishes for continued support as the patient’s condition would 
deteriorate, possibly creating new problems. Evidence on the optimal length of 
supportive programmes for progressive chronic conditions such as dementia are 
lacking. Compared to our study, Burgerer (2008) showed long lasting beneficial 
effects after a 20-week combined intervention that included CBT, support and 
exercises. This may suggest that an extension of the intervention period should 
be considered. 
Although group therapy has proven its strength (Yalom, 1995), tailoring psycho - 
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therapy to the participants’ individual problems is more difficult compared to 
interventions aimed at individual couples. Individual therapy in couples facing 
early dementia also has been found to be beneficial (Quayhagen, 2001). Clearly, 
individual therapy and support may still be essential for many patient-significant 
other couples not willing to participate in group therapy. 
Outcome measures
At the start of our study in 2003, the main aim of our intervention was to strengthen 
patients with MCI and their significant others to cope with this condition. 
Strengthening coping may reduce distress and increase well-being in both 
patients with MCI and in their significant others. The Geriatric Depression Scale 
(GDS) was found to be a useful screening tool for affective (dys)function in 
persons with mild to moderate cognitive impairment (Lyness, 1997), and its 
reliability and validity for measuring changes in distress has been established 
(Burke, 1992). The studies in this thesis show that the overall distress levels are 
very low and we concluded that the GDS was not sensitive enough for measuring 
low levels of distress. Still, in our qualitative study on caregivers’ evaluations of 
the intervention, stress reduction showed to be an important result. Therefore, 
future studies should use an instrument that measures a broader spectrum of 
distress levels. Possibly generic instruments such as the SCL-90-R (Derogatis, 
1977) or the OQ-45 (Lambert, 1996; Jong, 2004) that have been developed to 
specifically monitor changes in distress level over time, also in non psychiatric 
samples are more sensitive measures for distress in MCI patients. 
Related to this, well-being was measured with a generic self-report questionnaire, 
subscales from the RAND-36. No differences were found on this measure in the 
intervention interval compared to the waiting list interval for both groups (chapter 
5 and 6). Small, but significant changes were found on the RAND-36 in the 
follow-up interval, 6 to 8 months after completing the therapy. In addition, changes 
in acceptance correlated with changes in well-being, which support recent 
notions that these variables are interrelated (Evers, 2001).  As a result, the 
RAND-36 has been a useful instrument for monitoring changes in well-being as a 
result of our intervention. 
Acceptance of the MCI condition was heightened by our intervention in the MCI 
patients. In patients with chronic conditions, illness acceptance can be described 
as the acceptance of loss, the ability to tolerate the unpredictable and 
uncontrollable nature of the disorder, and coping with the aversive consequences 
(Evers, 2001). A growing body of studies highlight the role of illness cognitions in 
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the adaptation process and provide evidence that adequate acceptance is 
related to increased psychological well-being and higher quality of life. Moreover, 
acceptance requires awareness of the current memory problems, underscoring 
its relevance in therapy (Clare, 2004a). Many MCI patients display a lack of 
awareness of their condition. Increasing their acceptance levels necessarily 
improves their awareness, which may contribute to a favourable treatment 
outcome (chapter 6). Future research is recommended to study on the relationship 
between changes in acceptance and awareness. With respect to the caregivers, 
there is evidence that acceptance is considered part of the final phase of 
emotional adjustment to dementia in caregivers (Kaplan, 1996). Thus, we believe 
that our findings on acceptance of the memory deficits in both the patients and 
the significant others is a promising result of our treatment programme.
We did not evaluate changes in coping because of the lack of validated disease-
specific coping questionnaires at the start of the project. However, instruments 
such as the Meta Memory Questionnaire (Ponds, 1996) that investigates the use 
of memory strategies might have been a suitable instrument for measuring 
changes in everyday memory behaviour. To our knowledge, no instruments exist 
that measures the support of the patients’ memory strategies by the significant 
other.  An individualised outcome method, such as Goal Attainment Scaling 
might fill this gap in future studies (chapters 6 and 7) 
Finally, the Sense of Competence Questionnaire was included as a primary 
outcome measure in the significant others, because we assumed that our 
intervention would heighten their sense of competence by means of psycho-
education and reframing of less beneficial thoughts. This questionnaire has been 
shown to be sensitive to change in dementia caregivers after nonpharmacologi-
cal interventions (Graff, 2006). Sense of competence is closely related to 
perceived self-efficacy. Studies in the field of coping with chronic illness address 
the importance of perceived self-efficacy in understanding experiences and 
health-related outcomes of patients and their family caregivers. Perceived 
self-efficacy refers to the belief that one can assume personal control over health 
problems by learning about key aspects of care (Bandura, 1977). Higher levels of 
self-efficacy are expected to lead to health-promoting behaviors and improved 
measures of physical and mental health. Fortinsky (Fortinsky, 2002) described 
and evaluated an instrument on efficacy in dementia caregivers based on the self 
efficacy questionnaire developed by Lorig et al. (Lorig, 1989) for patients with 
arthritis. This instrument could be a valuable extension to the outcome measures 
used in our study. Although some items show overlap with the Sense of 
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Competence Questionnaire, it is interesting to investigate the additional value of 
this short instrument in future nonpharmacological studies in (early) Alzheimer’s 
disease.  
Clinical implications and implementation
The intervention programme described in this thesis has been already 
implemented in a number of hospitals and community mental-health services in 
the Netherlands, and many clinicians show an interest to implement it in the 
post-diagnoses trajectory. It is included in care programmes of mental health 
services for elderly with cognitive decline aimed at the prevention of comorbid 
psychopathology. In hospitals, the programme is offered in the context of a post-
diagnostic care trajectory. The setup of our programme resembles trajectories of 
self-management programs, which have been proven beneficial and shown to be 
cost effective (Lorig, 1999). The cost-effectiveness of our programme, however, 
should be determined in the future. 
In all, there is a clear need for evidence-based psychosocial interventions for 
persons with dementia and their significant others (Vasse, 2011). The studies in 
this thesis contribute to this need studying the development, feasibility and 
efficacy of a newly developed psychosocial intervention aimed at MCI patients 
and their significant others. This thesis shows that living with MCI means living 
with an uncertain label, which has psychological and social adverse consequences 
in daily life. Our multicomponent psychological intervention showed positive 
effects addressed a need in both patients and their significant others. It supports 
coping with this uncertain condition, managing stress and preparing the couples 
for the future. Finally, based on the results in this thesis, the programme is 
recommended specifically to MCI patients with heightened levels of helplessness, 
lack of insight, avoidant behaviour, increasing social conflicts or changes in 
mood. 
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Samenvatting
Naarmate mensen ouder worden neemt de kans op een dementie toe. Dementie 
is een verzamelnaam voor ziektes die gemeen hebben dat de hersenen niet meer 
goed functioneren. Hierdoor is er veelal een falend geheugen maar zijn ook de 
intellectuele vaardigheden aangetast. Mensen met een dementie zijn afhankelijk 
van de hulp van anderen en hebben de regie over het eigen leven verloren. 
Kenmerkend voor de meeste vormen van dementie is het sluipende begin. Om 
mensen met klachten in een vroege pre-dementiële fase te beschrijven is de term 
Lichte Cognitieve Stoornis ontwikkeld. Deze term is een vertaling van de 
Amerikaanse term Mild Cognitive Impairment (MCI), beschreven in 1999 door 
Ronald Petersen. MCI wordt gedefinieerd als een syndroom om mensen te 
beschrijven met klachten over het geheugen of van een andere denkvaardigheid 
zoals concentratie, taal of planning. Hierbij kan ofwel de betreffende persoon zelf 
ofwel een naaste de klachten rapporteren. Deze klachten worden geobjectiveerd 
middels een neuropsychologisch onderzoek, maar leiden in principe niet tot 
belemmeringen in het algemeen dagelijks functioneren (er is dus geen sprake 
van een dementie). De kans om binnen enkele jaren een dementie te ontwikkelen 
is bij mensen met een MCI-diagnose aanzienlijk en veel hoger dan bij leeftijdsge-
noten zonder klachten. De groep mensen met MCI is echter wel een heterogene 
groep, omdat er naast de mensen die een dementie ontwikkelen ook een groep 
mensen met de diagnose MCI is die langere tijd stabiel blijft. Een klein deel van 
de mensen met een MCI, herstelt weer naar een leeftijdsconform niveau van 
cognitief functioneren. Ook blijken er subtypes van MCI te onderscheiden kunnen 
worden die gerelateerd zijn aan welke denkvaardigheid is verminderd. Zo is er de 
amnestische MCI met geheugenstoornissen en de niet-amnestische MCI met een 
stoornis van een andere denkvaardigheid dan het geheugen, bijvoorbeeld de taal 
of de planningsvaardigheid. Tot slot is er de MCI in meerdere domeinen. Hierbij 
zijn er lichte stoornissen van meerdere denkvaardigheden tegelijkertijd. Zoals 
gezegd is het algemeen dagelijks functioneren van mensen met MCI niet 
gestoord. Toch heeft MCI wel degelijk gevolgen voor het dagelijkse leven van 
zowel de persoon zelf als ook de naast betrokkenen. Dit komt onder meer naar 
voren uit de verhoogde niveaus van angst en stress. Farmacologische 
behandelingen voor MCI zijn tot dusver niet effectief gebleken. Ook waren er bij 
aanvang van dit onderzoeksproject nog geen psychologische behandelingen 
beschreven voor patiënten met MCI. Omdat de cognitieve klachten licht zijn en er 
sprake is van leervermogen, is een psychologische behandeling zeer goed 
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mogelijk. Deze behandeling heeft tot doel mensen te ondersteunen en te sterken 
in het omgaan met cognitieve stoornissen en de gevolgen die leiden tot verhoogde 
stress. In het eerste deel van dit proefschrift worden de gevolgen voor de patiënt 
met MCI nader onderzocht. In het kader van de ontwikkeling van de psychologische 
interventie wordt vervolgens een evaluatieonderzoek van een bestaande onder-
steuningsgroep voor patiënten met een dementie van Alzheimer beschreven en 
de eerste bevindingen en resultaten met de nieuw-ontwikkelde interventie. In het 
derde deel van dit proefschrift wordt de interventie met een gecontroleerd onder-
zoeksdesign geëvalueerd en is onderzocht wat er op de  langere termijn gebeurt. 
Tot slot worden de belangrijkste bevindingen bediscussieerd om met aanbevelingen 
voor de interventie en vervolgonderzoek te eindigen.
Deel 1: Gevolgen van MCI 
Uitgebreide interviews met MCI patiënten die geanalyseerd werden volgens een 
 wetenschappelijke methode, de grounded theory ,lieten zien dat naast de geheugen-
klachten of klachten van de andere cognitieve functiedomeinen de patiënten vaak 
ook last kregen van subtiele veranderingen in mobiliteit, stemming en vitaliteit 
(Hoofdstuk 2). Dit brede scala aan klachten beïnvloedde zowel het persoonlijke als 
ook interpersoonlijke welbevinden. Zo beschreven patiënten vaker onenigheid en 
irritaties met hun naast-betrokkenen. Tot slot kwam naar voren dat patiënten veel 
piekerden over mogelijke oorzaken, wat gepaard ging met een negatieve stemming. 
Het onderzoek bevestigde de informatiebehoefte bij patiënten en gaf inzicht in 
relevante themas voor de psychologische behandeling voor MCI patiënten. Deze 
interventie zou informatie moeten geven over oorzaken van MCI, het beloop, 
bijkomende symptomen, sociale consequenties en mogelijke behandelingen. De 
interventie moet tevens gericht zijn op strategieën om het cognitief functioneren te 
verbeteren. Het wordt aanbevolen om irreële attributies te herkennen en veranderen, 
om interacties tussen de MCI patiënt en zijn sociale omgeving te bevorderen. 
Het ziekte-inzicht is bij patiënten met een dementie vaak verminderd. Er is echter 
nog weinig bekend over het ziekte-inzicht bij patiënten met MCI; dit werd 
onderzocht in Hoofdstuk 3. Hierin werd aangetoond dat het ziekte-inzicht bij 60% 
van de onderzochte patiënten verlaagd was, vergeleken met een gezonde groep 
mensen met vergelijkbare leeftijd en opleiding.  Aandacht voor (verminderd) 
ziekte-inzicht bij MCI patiënten is derhalve wenselijk, enerzijds om in de 
behandeling hierover uitleg te geven aan patiënt en zijn naaste(n), anderzijds om 
het ziekte-inzicht te vergroten omdat een beter inzicht samengaat met een groter 
therapiesucces.   
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Deel 2: ontwikkeling van de interventie
Allereerst werd een doorlopende ondersteuningsgroep voor patiënten met een 
beginnende tot matig ernstige ziekte van Alzheimer geëvalueerd (hoofdstuk 4). 
Het belangrijkste doel was inzicht te krijgen in de door patiënten gewaardeerde 
themas en werkwijze. Ook wilden we  weten wat de interventie hen had 
opgeleverd. Deze gegevens konden vervolgens gebruikt worden om een 
interventie gericht op MCI op te zetten. Analyses van interviews alsmede gestruc-
tureerde vragenlijsten lieten zien dat patiënten het informatieve, leerzame karakter 
en het contact met lotgenoten waardeerden. Ook kwam een toegenomen co-
pingrepertoire naar voren. Patiënten konden de aandoening beter accepteren als 
gevolg van deelname aan de ondersteuningsgroep. Kennis, coping en acceptatie 
waren hierbij sterk verweven. De resultaten lieten zien dat patiënten met een 
beginnende tot matig-ernstige alzheimerdementie op een betrouwbare en valide 
manier een interventie konden evalueren, zowel schriftelijk als mondeling. Ook 
gaf het onderzoek informatie over uitkomstmaten van een ondersteunende en 
copingversterkende interventie. Gebaseerd op deze inventariserende studies en 
literatuuronderzoek hebben we vervolgens een psychologische interventie 
vormgegeven. De werkwijze, doelstellingen en eerste bevindingen zijn  beschreven 
in hoofdstuk 5.  Onze interventie beoogt het welbevinden te bevorderen door de 
kennis, inzicht en acceptatie van de lichte geheugenstoornissen te vergroten en 
de coping te versterken. De behandeling is gebaseerd op de adaptatie- coping 
theorie van Lazarus en Folkman en de methodes zijn afkomstig uit de cognitieve 
gedragstherapie, cognitieve revalidatie en psychoeducatie. De behandeling 
bestaat uit tien wekelijkse bijeenkomsten, elk met een duur van twee uur. Zowel 
de patiënt met MCI als een naastbetrokkene neemt deel aan de behandeling, 
veelal de partner,  maar dit kan ook een dochter, zoon of goede kennis zijn. De 
volgende themas zijn opgenomen in het programma: 1) Kennismaken, 
verwachtingen en doelen formuleren, 2) het begrip MCI, 3) De werking van het 
geheugen en hoe het geheugen te optimaliseren, 4) spanning en ontspanning, 5) 
piekeren en probleem oplossen, 6) het belang van plezierige activiteiten en de 
activiteitenbalans, en 7) omgaan met meningsverschillen en conflicten. De 
MCI-patiënt en zijn partner volgen, elk in hun eigen lotgenotengroep, het 
programma. Er zijn parallelle bijeenkomsten met dezelfde themas die zij 
voorbereiden met registratieopdrachten en een informatieve tekst over het 
betreffende thema.  Ze sluiten elke bijeenkomst gezamenlijk af in het laatste halve 
uur. Hierin worden eye openers en voornemens uitgewisseld en wordt het 
huiswerk toegelicht. Het huiswerk is erop gericht om het thema voor de volgende 
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bijeenkomst voor te bereiden door hierover informatie te lezen en in het dagelijkse 
leven te kijken naar situaties die het thema betreffen. Deze situaties worden 
geregistreerd, waarbij de situatie en de reacties beschreven worden. Deelnemers 
wordt geleerd om hun reactie te ontleden in gedachten, gevoelens of emotionele 
reactie en gedrag. Bijvoorbeeld: wanneer een situatie spanning oproept, wordt 
gevraagd om ook te onderzoeken welke gedachten en welk gedrag hierbij optreden. 
Door hiermee te oefenen wordt het zelfregulerend vermogen vergroot. Zo kunnen 
de aan het falend geheugen gerelateerde reacties en de verklaringen en ideeën 
over de gevolgen onderzocht worden. Niet-helpende of irreële gedachten kunnen 
bijgesteld worden. Reële zorgen of angstige gedachtes daarentegen kunnen 
gedeeld worden met andere deelnemers, wat als steunend ervaren wordt. 
De eerste bevindingen waren positief te noemen (Hoofdstuk 5). Het programma 
en de werkwijze bleken geschikt en toepasbaar. Het viel op dat er vrijwel geen 
uitval was in de loop van de 10 tot 12 weken, wat de indruk bevestigde dat de 
deelnemers zeer gemotiveerd waren voor deze behandeling. 
Een niet-gecontroleerde vergelijking tussen de voor- en nameting liet zien dat de 
acceptatie bij patiënten groter werd na de interventie, evenals de tevredenheid 
met de partnerrelatie (bij de deelnemers die met hun huwelijkspartner meededen). 
Patiënten met een lager opleidingsniveau en met minder gerapporteerde geheugen-
klachten bij aanvang van de behandeling, leken het meeste baat te hebben gehad 
bij de behandeling. Het welbevinden en de stemming werden niet beïnvloed. Het 
bleek dat in deze groep zowel de stemming alsook het welbevinden al op een 
goed niveau waren, waardoor verbetering niet goed mogelijk was. Naar aanleiding 
van deze resultaten werd het programma gecontinueerd en geëvalueerd middels 
een gecontroleerd onderzoeksdesign. 
Deel 3: evaluatie van de interventie
Met een wachtlijst-gecontroleerd, semi-gerandomiseerde, multicenter-onderzoek 
werd de interventie geëvalueerd met als primaire uitkomstmaat acceptatie en als 
secundaire maten het welbevinden, de distress en de hulpeloosheid. 93 Patiënten 
participeerden in de interventie, waarvan dertig patiënten ook in de wachtlijstcon-
ditie werden opgenomen (Hoofdstuk 6). Dit gebeurde op basis van moment van 
aanmelding. Wanneer een patiënt meer dan acht weken voor aanvang van de 
interventie werd aangemeld, kon deze opgenomen worden in de wachtlijstcondi-
tie. Gebaseerd op onze eerste bevindingen en andere studies werd verwacht dat 
de interventie de acceptatie zou verhogen. Acceptatie speelt een cruciale rol in 
het omgaan met een aandoening en is gerelateerd aan welbevinden. Inderdaad 
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bleek dat na de interventie de acceptatie toenam, vergeleken met de wachtlijst-
conditie. Bij vrouwelijke patiënten bleek verder dat gevoelens van hulpeloosheid 
afnamen.  Het welbevinden en de distress veranderden niet. Wel werd een 
correlatie gevonden tussen de verandering in acceptatie en een verandering in 
het welbevinden. Dit is in overeenstemming met de vermeende relatie tussen 
acceptatie en welbevinden en zou kunnen betekenen dat toename van acceptatie 
voorafgaat aan een (meetbare) toename in welbevinden. 
Hoofdstuk 7 beschrijft de resultaten van de wachtlijst-gecontroleerde studie voor 
de naastbetrokkenen. Hierbij werden dezelfde veranderingen verwacht als bij de 
patiënten, maar bij de naast-betrokkenen werd ook het gevoel van competentie 
geëvalueerd.  Vergeleken met de wachtlijstconditie werden er geen significante 
veranderingen aangetoond na de interventieperiode bij de naast betrokkenen. 
Met een op de grounded theory gebaseerde kwalitatieve analysemethode werden 
de evaluaties van de naastbetrokkenen onderzocht. Deze resultaten gaven een 
positieve effect aan op distress, kennis, inzicht en coping met de veranderingen 
als gevolg van de MCI bij de naastbetrokkenen. Samengevat geven deze 
resultaten aan dat de interventie het leren leven met een naaste met MCI faciliteert. 
De naastbetrokkenen rapporteerden een algemeen toegenomen gevoel van 
ontspanning en innerlijke rust. 
Tenslotte is onderzocht wat er gebeurt ten aanzien van acceptatie, algemeen 
welbevinden, distress en hulpeloosheid op de langere termijn. Hiertoe werd zes 
tot acht maanden na afloop van de interventie nog een meting uitgevoerd. Deze 
werd vergeleken met de meting direct na afloop van de interventie. Hieruit bleek 
dat het hogere niveau van acceptatie bij patiënten wordt vastgehouden. 
Bovendien kwam naar voren dat het ziekte-inzicht bij patiënten toenam. Ten 
aanzien van het welbevinden was er zowel bij patiënten als de naast betrokkenen 
sprake van een afname van het algemeen welbevinden. Patiënten lieten in het 
bijzonder een afname van het mentaal welbevinden zien. Er bleek echter bij de 
patiënten geen sprake te zijn van een verslechtering van de stemming. Bij de 
naastbetrokkenen werd wel een lichte vermindering van de stemming waar - 
genomen, maar de stemmingsklachten lagen ver beneden het niveau van een 
evident depressieve stemming. Bij de naastbetrokkenen bleven acceptatie en 
hulpeloosheid op hetzelfde niveau. Het gevoel van competentie nam bij de naast 
betrokkenen af. Bij deze follow-up-meting moet wel opgemerkt worden dat er 
sprake is van een selectie van de deelnemers. Op de uitnodiging voor deze lange 
termijn meting deden 50,5% van de patiënten en 52,8% van de naastbetrokkenen 
mee. De niet-deelnemende patiënten hadden bij aanvang van de interventie een 
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lager acceptatie niveau en een lager opleidingsniveau dan de deelnemende patiënten. 
Bij de naast betrokkenen hadden de niet-participerenden een lager niveau van 
hulpeloosheid en juist een hoger niveau van acceptatie. Ondanks deze selectie kan 
geconcludeerd worden dat de interventie ook op de langere termijn een positief 
effect lijkt te hebben op de acceptatie van de patiënten en dat er zelfs een groei in 
het ziekte- inzicht lijkt te zijn. 
Discussie
De deelnemers
In tegenstelling tot onze verwachting werd bij de deelnemers in onze studie geen 
stemming verbetering gemeten. Het zou kunnen zijn dat de mensen die mee 
willen doen aan een dergelijke interventie (ongeveer 60-70% van de mensen die 
een MCI-diagnose kregen), geen stemmingsproblemen hebben omdat juist zij al 
een adequate manier van omgaan met de problemen hanteren. Ook vonden wij 
dat deelnemers met een lager ziekte-inzicht voorafgaand aan de behandeling 
meer profijt hadden van de behandeling. Daarom is het aan te bevelen dat 
behandelaars patiënten met een lager ziekte-inzicht motiveren voor onze  behandeling. 
Een andere verklaring voor de geringe (groeps)effecten kan voortkomen uit  de 
heterogeniteit van de deelnemers. Er zijn 3 MCI-subtypes die allen vertegenwoordigd 
waren in onze interventie. Het zou kunnen zijn dat de verschillende MCI-subtypes 
zich onderscheiden in de ervaren problemen en manier van omgaan met deze 
problemen. Onze interventie zou dan ook verschillende resultaten per subtype 
kunnen hebben. Dit hebben we echter niet kunnen onderzoeken omdat de 
subgroepen te klein waren. Toekomstig onderzoek zou dit aspect mee kunnen 
nemen, bijvoorbeeld door recent gepubliceerde criteria voor MCI als gevolg van 
de ziekte van Alzheimer te hanteren als inclusiecriterium, waardoor de interventie 
bij een homogene patiënten groep onderzocht wordt. Behandelingen zoals onze 
interventie zullen naar ons idee echter wel geschikt zijn voor mensen in vroege 
fases van verschillende neurodegeneratieve aandoeningen, waaronder de ziekte 
van Alzheimer. 
De therapeutische methodes
De elementen en werkwijze van de behandeling hebben veel overeenkomsten 
met het zelfmanagementprogramma zoals dat door Lorig beschreven is bij 
chronische ziekten. In dit programma worden patiënten getraind om als therapeut 
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de training te geven. Omdat deze programma's goed geëvalueerd zijn en kosten-
effectief blijken te zijn, zou deze werkwijze ook een toevoeging in onze werkwijze 
kunnen zijn. Complicerend bij onze MCI patiënten zijn echter de cognitieve 
stoornissen. Een dergelijk zelfmanagementprogramma veronderstelt veel kennis 
en leervermogen om tot een ervaringsdeskundige therapeut opgeleid te worden.
Om wederzijds betrokkenheid en samenwerking te bevorderen hebben wij ervoor 
gekozen om in de parallelle bijeenkomsten bij patiënten en partners dezelfde 
onderwerpen te behandelen. Uit evaluaties komt echter naar voren dat partners 
en patiënten verschillen in de prioriteiten die zij geven aan de verschillende thema's. 
Een overweging zou kunnen zijn, om het programma hierop aan te passen. 
Tot slot is er toenemend wetenschappelijk bewijs voor de effectiviteit van 
cognitieve revalidatiemethoden. Hierbij worden patiënten getraind om geheugen-
strategieën te gebruiken en aldus hun cognitieve prestaties te optimaliseren. In 
onze interventie wordt hier slechts in enkele sessies (kort) aandacht aan besteed. 
Uitbreiding van de cognitieve revalidatieonderdelen en evaluatie hiervan kan 
daarom zeker overwogen worden.
De instrumenten
In dit onderzoek bleek met de gekozen instrumenten geen effect van de interventie 
op algemeen welbevinden noch op distress aangetoond te kunnen worden. 
Daarentegen bleek uit kwalitatief onderzoek bij de naast betrokkenen wel degelijk 
dat zij na afloop minder stress ervoeren. Bovendien beschreven zij veranderingen 
in hun omgaan met de MCI en de gevolgen hiervan. In de discussie over de 
gebruikte instrumenten worden enkele suggesties voor alternatieve instrumenten 
gedaan. 
Algemene conclusie en aanbevelingen
De onderzoeken in dit proefschrift hebben aangetoond dat het hebben van MCI 
voor patiënten en hun naastbetrokkenen betekent dat zij leven met onzekerheid, 
wat psychologische en sociale gevolgen heeft. Het interventieprogramma zoals 
beschreven in dit proefschrift is geschikt gebleken om patiënten met MCI en hun 
naast betrokkenen te ondersteunen in deze stressvolle situatie en hen voor te 
bereiden op een onzekere toekomst. 
Het huidige gecontroleerde onderzoek heeft aangetoond dat de behandeling bij 
patiënten effectief is. Bij de naastbetrokkenen komt dit alleen middels niet gecontroleerd, 
kwalitatief onderzoek naar voren. Gezien deze gunstige aanwijzingen is vervolg-
onderzoek met andere maten voor disstress, ziektespecifieke coping en self- 
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efficacy gewenst. Ook is onderzoek naar kosteneffectiviteit  aanbevolen. Onderzocht 
zou kunnen worden of de interventie inderdaad het ziektemanagement vergroot, 
wat zich later in het ziektebeloop kan vertalen in minder gedragsproblemen bij de 
patiënten en minder belasting bij de partner. Dit zou uiteindelijk  kunnen resulteren 
in het langer uitblijven van een opname in een verpleeghuis.  
Gebaseerd op resultaten in dit proefschrift lijkt de behandeling in het bijzonder 
aanbevolen voor patiënten met verhoogde hulpeloosheid, meer stemmingspro-
blemen, een lager opleidingsniveau en lager ziekte-inzicht of acceptatieniveau. 
Dat onze interventie voorziet in een behoefte blijkt uit de implementatie ervan in 
verschillende Nederlandse geheugenpoliklinieken als onderdeel van het 
behandelaanbod in het nazorgtraject. Ook wordt de behandeling toegepast in 
instellingen voor de geestelijke gezondheidszorg. 
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Dankwoord
Na een lang promotietraject is het mooie moment gekomen om dit dankwoord te 
schrijven. Wat soms nooit leek te eindigen kan nu toch afgerond worden. De tijd 
als promovenda is geweest. Ik wil graag iedereen bedanken die op wat voor 
manier dan ook betrokken was. En dan is er een grote kans dat ik mensen vergeet, 
maar gelukkig weet iedereen dat vergeten menselijk is en foutjes hersteld kunnen 
worden. 
Dit project is tien jaar geleden eigenlijk al begonnen in San Diego. Toen deed Jan 
Pieter per mail een voorstel voor een psychologische behandeling voor mensen 
met MCI. Mijn dank dat je me toen attendeerde op een artikel van Lisa Snyder. De 
toeval wilde dat Lisa Snyder ondersteuningsgroepen voor mensen met de ziekte 
van Alzheimer in San Diego deed. Toen ik door haar in november 2001 hartelijk 
ontvangen werd en zij me de gelegenheid gaf om met haar groep mee te doen, 
werd dit prachtige traject al concreet. Lisa, thank you so much for your warm 
welcome and hospitality. Your attitude inspired me so much! Jan Pieter, bedankt 
voor jouw initiatief en die gouden tip. Wat hebben we hierna heerlijk samengewerkt 
en nog prachtige aanvullende projecten uitgevoerd. Jan Pieter, ik heb veel geleerd 
van je in die eerste paar jaar. Hoe jij bijvoorbeeld vlotjes zo’n ‘klein’ extra subsidie-
aanvraagje de deur uit deed. 
Bij terugkomst, September 2002, was er weer zo’n warm welkom, nu door Floor. 
Na je interesse in ons verblijf en ervaringen in San Diego gaf jij het groene sein 
voor dit project. Al was ik niet meteen enthousiast bij het idee van een promotie, 
het onderwerp van dit onderzoek was op mijn lijf geschreven. Je wist me 
gemakkelijk te overtuigen dat het ook zonder poespas kon en dat een nietje door 
de artikelen ook een goede afsluiting kon zijn. Floor, heel erg bedankt voor jouw 
vertrouwen in mij, voor je geduld bij mijn schrijversschroom en je adviezen om dit 
te overwinnen. Ik heb bovendien erg genoten van je statistiek uitleg. Myrra, jij was 
ook vanaf het prille begin betrokken. Bijzonder was het om met jou samen te werken, 
zeker toen onze wegen opnieuw kruisten na mijn eerste idee om onderzoek te 
gaan doen naar het effect van de diagnose dementie. Myrra, jij bent voor mij een 
voorbeeld van een vrouw die haar mannetje staat voor de goede zaak, die 
tegelijkertijd een aardige collega kan zijn, en al haar bordjes op elegante wijze in 
de lucht houdt. Ik wil je hartelijk bedanken dat je me wegwijs hebt gemaakt in de 
waarde en uitvoering van het kwalitatief onderzoek. Beste Marcel, een groot 
woord van dank aan jou, zoals jij vanaf het begin hebt meegedacht en het project 
vanuit afdeling Geriatrie hebt gefaciliteerd. Bewonderenswaardig hoe je, ondanks 
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